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Abstract
Pathogenic theories of Restless Legs Syndrome
and Periodic Limb Movements in Sleep
and critiqued,

(PLMS)

(RLS)

were reviewed

and a new theory for the pathogenesis of

RLS and PLMS was presented.

It was proposed that both

disorders are caused by sleep-related hypoperfusion in the
area of the cerebral cortex that mediates sensation and
movement in the legs.

The hypoperfusion was proposed to

be caused by high amplitude oscillations in total cerebral
blood flow known as B-waves and by flow-reducing
turbulence at several of the bifurcations in the anterior
cerebral artery.

This theory was tested by using near

infra-red spectroscopy

(NIRS)

to measure cerebral

hemoglobin oxygen saturation and total blood flow in three
groups of subjects:
with PLMS,

nine patients with RLS,

six patients

and eleven age-matched control subjects.

Cerebral oximetry was performed during both wakefulness
and sleep.

Polysomnography was used to assess sleep.

It

was predicted that high amplitude B-waves would occur in
the RLS subjects during wakefulness,
PLMS subjects during sleep.

and in both RLS and

In addition,

it was predicted

that the abnormal sensations and movement in RLS patients
and the PLMS in both RLS and PLMS patients would occur
during the B-wave troughs in cerebral hemoglobin
vii
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oxygen saturation.

As expected,

significant differences

among the groups in abnormal leg sensations and leg
movements while awake,
asleep were found.
the proposed theory.

and periodic leg movements while

However,

the results did not support

Although there was a statistically

significant non-random occurrence of abnormal sensations
and movements

(both waking RLS movements and PLMS)

B-wave cycle,

the tendency was for these events to occur

at both B-wave peaks and t roughs.

in the

B-wave amplitudes and

cerebral hemoglobin oxygen saturation levels were not
significantly different among the three groups.

There

were also no significant differences within the RLS and
PLMS groups in hemoglobin oxygen saturation levels at
event onset as compared to periods when no events were
present.

Future studies should attempt to replicate the

previous research that has implicated circulatory
insufficiency in the pathogenesis of both disorders.

viii
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Introduction
Restless legs syndrome

(RLS)

is a neurological

disorder characterized by the appearance of lower leg
paresthesias during periods of prolonged motor inactivity.
The symptoms appear most commonly in the evening,
relieved by movement of the legs.
paresthesias

and are

Because the

(and subsequent motor hyperactivity)

prominent as the patient attempts to fall asleep,

are most
chronic

insomnia and sleep deprivation often occur in more
severely affected patients.
Almost all patients who have RLS also have periodic
limb movements in sleep

(PLMS),

which are stereotypic

movements of the feet and lower legs that occur at semiperiodic intervals of between 20 and 40 seconds.

The

movements are generally restricted to non-rapid eye
movement

(NREM)

sleep.

Videotaped analyses of these

movements have shown that they appear similar to the
abnormal plantar reflex or Babinski response
1985).

(Smith,

The movements may cause brief arousals from sleep,

and thus impair sleep quality,

although it is also common

for affected patients to have no sleep complaints.
example,

Kales et al.

(1982)

For

studied 200 patients with

complaints of insomnia and 100 control subjects without
any sleep complaints.

The prevalence of PLMS was exactly
1
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2

the same

(11%)

in both groups,

suggesting that

approximately half of all subjects who have PLMS do not
have a sleep complaint.
patients have PLMS
Warnes,

(Montplaisir, Godbout,

1994), many persons who have

For example,
(1975)

Although about 90% of RLS

Guilleminault, Raynal,

Pelletier,

PLMS do not have RLS.
Weitzman,

and Dement

found that only two of sixteen insomniacs

who had PLMS also had RLS.

and

Despite this,

(12.5%)

because most RLS

patients also have PLMS, and because many treatments which
are effective for RLS are also effective for PLMS

(e.g.

dopamine and opioid agonists) , it is generally accepted
that the pathogenic mechanisms of the two disorders are
closely related.
The pathogenesis of these two disorders remains
unknown

(Montplaisir,

O'Keeffe,

1996),

Godbout,

Pelletier,

and Warnes 1994;

although four pathogenic theories of RLS,

and two pathogenic theories of PLMS have been discussed
with somewhat greater frequency.

The pathogenic theories

of RLS include reduced peripheral blood flow, peripheral
neuropathy,

central dopaminergic dysfunction,

opioid neurotransmitter dysfunction.

and central

Reduced peripheral

blood flow has also been proposed as a pathogenic
mechanism for PLMS.

Other pathogenic theories of PLMS

include oscillations of reticular system excitability and
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spontaneously occurring Babinski responses.

In general,

these theories are vague and poorly developed.

A critical

review shows that there is very little direct evidence to
support any of them.

Furthermore,

none of these theories

seem to be able to account for all of the well-established
features of either disorder.
Even though the pathogenic mechanisms of RLS and PLMS
remain unknown,

effective treatments for both disorders

are available.

These include correction of anemia,

agonists,

dopamine agonists,

clonazepam), clonidine,

benzodiazepines

opioid

(especially

and the anti-convulsants

carbamezapine and gabapentin.

The discovery of the

effectiveness of these drugs has often come about through
chance observation or through empirical trial and error
investigation in single patients.

Because the

pathogenesis of RLS and PLMS remains unknown,

the

mechanisms by which these drugs exert their therapeutic
effect is also unknown

(correction of anemia being the

apparent exception to t h i s ) .

This is problematical

because many of these drugs can have serious side effects,
and because it is possible that the therapeutic effect of
these drugs arises from a secondary or non-specific
effect,

such as their sedative effects or their effects on

cerebral blood flow,

rather than their primary effect

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission .
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(e.g. increasing dopamine levels

in the case of dopamine

agonists).
In this paper a new theory for the pathogenesis of
RLS and PLMS will be presented.

Briefly,

it is proposed

that both disorders are caused by sleep-related changes in
cerebral blood flow which lead to periodic cerebral
ischemia and hypercapnia that are most prominent in the
distal territory perfused by the callosomarginal branches
of the anterior cerebral arteries.

This territory

includes the somatosensory cortex for the feet and lower
legs.

It is further suggested

(in agreement with Smith's

spontaneous Babinski response theory of PLMS)

that this

cortical ischemia causes the normal descending pyramidal
tract inhibition of the Babinski response to be
periodically released,

resulting in the spontaneous and

periodic occurrence of the reflex.
periodic cerebral ischemia theory

The ability of this
(the PCI theory)

to

account for all of the well-established features of both
RLS and PLMS will be briefly discussed.
One important implication of the PCI theory that will
also be discussed concerns the treatment of RLS and PLMS.
The proposed PCI theory suggests that cerebral
vasodilators should be the most effective means of
treatment for both disorders,

and further that the drugs

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

which have been found to be beneficial
clonazepam)

(e.g.

L-dopa,

exert their therapeutic effect by either

increasing cerebral blood flow or by reducing the
amplitude of the oscillations in cerebral blood flow
waves)

(B-

that are proposed to be one of the physiological

bases of both disorders.

Thus,

vasodilators have the

potential for offering a more effective means of treating
RLS and PLMS.
The present study was an attempt to test this new
theory of RLS and PLMS by recording cerebral hemoglobin
oxygen saturation levels during wakefulness and sleep in
three groups of subjects:

RLS patients,

PLMS patients,

and control subjects without any sleep complaints.

It was

predicted that both RLS and PLMS patients would have
oscillations of total cerebral blood flow and cerebral
oxyhemoglobin levels
present.

(i.e.

B-waves) when symptoms were

It was further predicted that the waking sensory

and motor symptoms in RLS patients,
sleep in RLS and PLMS patients,

and the PLMs during

would occur at the troughs

of the cyclic oscillations of cerebral oxyhemoglobin
levels

(i.e. when cerebral oxyhemoglobin levels were at

their lowest).
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Restless Legs Syndrome (RLS) and Periodic Limb Movements
in Sleep (PLMS): A Brief Review
Clinical Features
Restless legs syndrome was first described by Willis
(1685), but was almost unknown to the modern medical
community until 1944 when Karl Ekbom described a series o
eight cases

(K. A. Ekbom,

1944).

Ekbom later described

several larger case study series in extensive detail
A. Ekbom,

1945,

1960,

1970) .

(K.

Other excellent reviews of

the clinical features of RLS have been presented by
several authors
1967; Walters,

(Gorman,

Dyck,

1995; Young,

and Pearson,

Humphries,

1965; Morgan,

and DeWolfe,

1969)

and the following description of the clinical features of
RLS is based on these r e v i e w s .
Although the name "Restless Legs Syndrome" is
suggestive of a motor disorder,
both sensory and motor symptoms.

RLS is characterized by
The sensory symptoms

consist primarily of a difficult-to-describe lower leg
paresthesia.

Terms used most often to describe the

sensations include "creeping," "crawling," "pulling,"
"prickling," etc..

These sensations are usually reported

to occur deep within the leg muscles rather than on the
surface of the skin.

A review of the symptomatology of

112 RLS patients by K. A. Ekbom

(1945)

found that 98% of

6
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patients had paresthesias in the lower legs

(between the

ankle and k n e e s ) , 27% had paresthesias in the thighs,
had paresthesias in the feet,
the arms.

and 6% had paresthesias in

Patients who had paresthesias in the arms often

did not have them in the hands.
usually bilateral,
on one side.

fact,

The paresthesias are

but may be worse or appear exclusively

Some patients do report having pain in

addition to the paresthesias,
quality

15%

(K. A. Ekbom,

1944,

in his 1945 monograph,

usually of a dull aching

1945;

Young et al.,

1969).

In

K. A. Ekbom initially divided

RLS into separate painful and paresthetic forms.

However,

he did not maintain this distinction in his later reviews
(K. A. Ekbom,

1960,

1970).

Finally,

also complain of cold legs and feet
Seifert,

and Lemon,

1986;

Blumoff,

and Pittard,

K. A.

some RLS patients
(Ancoli-Israel,

Ekbom,

1945; Ware,

1988).

One of the most characteristic features of RLS is
that the sensory symptoms appear almost exclusively during
periods of prolonged motor inactivity.

Another

characteristic feature is that movement of the legs
provides temporary relief from the paresthesias.
relief may be partial or complete,

This

and is usually

effective only when the patient is actually engaging in
movement and for a relatively short time after the

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.
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movement has been stopped.

Although it is generally

accepted that RLS patients move their legs to gain relief
from their paresthesias,
and Montplaisir

(1992)

a study by Pelletier,

Lorrain,

found that only about half of the

recorded waking leg movements

in RLS patients were

associated with sensory events,

while almost all sensory

events were associated with leg movements.

Thus,

waking

movements in RLS patients may occur in the absence of any
sensory event.

Pelletier et al.

concluded that the sensory

and motor events in RLS were independent manifestations of
a common underlying pathogenic mechanism.

Finally,

there

is a definite circadian periodicity to the appearance of
RLS symptoms;

regardless of whether they occur in the

waking or sleep state,

they are most common in the late

evening and during the night
DeLaCueva,

1993; Walters,

Chokroverty,

and Rahman,

(Becker,

Trenkwalder,

Jamieson,

and

Hening,

1995) .

The motor symptoms in RLS consist primarily of
excessive voluntary motor activity such as rubbing or
massaging the legs, rubbing the legs together while in
bed,

and

around.

(eventually)

The motor activity usually has an agitated or

restless quality.
patients,

getting out of bed and walking

In older and more severely affected

waking myoclonic twitches of both upper and

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

lower extremities may be present
Chokroverty,

1988).

(Walters,

Hening,

and

Some studies have also found that RLS

patients may have periodic movements of the feet and lower
legs while awake
al,

1988),

(Pollmacher and Schulz,

1993; Walters et

although it is unclear from these reports if

these movements are similar to the PLMs that occur during
sleep.

Finally,

about 80 to 90 percent of RLS patients

have PLMS during sleep

(Coccagna and Lugaresi,

Montplaisir,

Warnes,

Lapierre,

and Pelletier,

1981;
1992).

Although m a n y authors have emphasized that RLS can
produce severe and chronic insomnia
1945;

1960; Gorman et al.,

1995),

(e.g. K. A. Ekbom,

1965; Morgan,

1967; Walters,

there is surprisingly little quantitative data

available on this subject.

For example,

no studies have

been published in which the nocturnal sleep parameters of
RLS patients have been compared to those of normal
subjects.

In an attempt to address this issue,

one must

turn to the RLS treatment studies in which polysomnography
was performed under either baseline or placebo conditions.
Three such studies
al.,

(Trenkwalder et al.,

1996; and Zucconi et al.,

mentioned here.

1989)

1995; Wagner et

will be briefly

Trenkwalder et al. studied 28 RLS

subjects under placebo and treatment conditions,

and

reported a mean sleep latency of 70 minutes for the

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.
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placebo condition.
under baseline,

Wagner et al.

placebo,

studied ten RLS patients

and treatment conditions,

and

reported a mean sleep latency of 4 7.4 minutes and a mean
sleep efficiency
spent in sleep)
Zucconi et al.

(defined as the percentage of time in bed
of 72.0% for the baseline condition.

studied nine RLS patients and reported a

mean sleep latency of 37.5 minutes and a mean sleep
efficiency of 57.0% under baseline conditions.

When

compared to normative values published by Bixler,
Jacoby,

Soldatos,

22.1 minutes,

and Vela-Bueno

(1984)

sleep efficiency - 88.1%),

Kales,

(sleep latency the values in the

three studies above are clearly indicative of insomnia.
The first description of periodic limb movements in
sleep

(PLMS)

is generally attributed to Symonds

(1953)

who

described five patients with a variety of motor
abnormalities in sleep.

Although Symonds noted that his

patients had nocturnal leg movements,

he did not record

these movements polygraphically or observe them visually,
and he was apparently unaware of their periodic nature.
At least two of his patients also apparently had either
waking or nocturnal epileptic seizures,

a finding which

led Symonds to conclude that PLMS was caused by epileptic
activity.

Symonds used the term "nocturnal myoclonus" to

describe his patients'

abnormal motor activity.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited without p erm ission.

This term

11

persisted until the early 1980s,
term "periodic limb movements

and was replaced with the

in sleep" after the periodic

nature of the movements had become well established,

and

after it had been shown that the movements were neither
myoclonic seizure activity nor exclusively nocturnal in
occurrence
Weitzman,

(Coleman et al.,
and Dement,

and Ambrosetto,

1975;

1968).

1980;

G ui lleminault, Raynal,

Lugaresi,

Coccagna,

Ceroni,

The studies by Guilleminault et

al. and Lugaresi et al.

failed to support Symonds'

hypothesis that the movements were associated with
epileptic activity.
Lugaresi et al.
polygraphically,

(1968)

were the first to record PLMs

and to emphasize their periodic nature.

Their initial recordings of PLMS were in patients with
RLS, but they soon found that PLMS could occur in patients
without RLS or sleep complaints.

Their recordings showed

that the movements occurred at semi-periodic intervals of
between 20 and 40 seconds,
bilateral,
legs.

simultaneous,

and that they were generally

and occurred primarily in the

They also noted that the movements were most common

in light NREM sleep

(Stages 1 and 2),

and were often

accompanied by brief electroencephalographic
arousals from sleep.
Schulz

(1993)

(EEG)

A recent study by Pollmacher and

found that PLMs were most frequent during
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wakefulness and sleep Stages 1 and 2,
Stages 3 and 4

less frequent in

(slow wave sle ep ), and relatively uncommon

in rapid eye movement

(REM)

the inter-movement-interval

sleep.
(IMI)

They also found that
was shortest during

wakefulness and Stage 1 (mean IMIs of 33.3 and 34.4
seconds respec ti ve ly ) , got longer during NREM stages 2, 3,
and 4 (combined IMI of 41.0 seconds),
during REM sleep

and was longest

(mean IMI 53.2 seconds).

duration was longest during wakefulness
Stage 1 (2.6 seconds),
NREM stages 2,
REM sleep

The movement

(2.9 seconds)

got progressively shorter during

3, and 4 (2.3 seconds),

(1.8 seconds).

Thus,

and was shortest in

the movements were clearly

too long to be considered myoclonic.

An examination of

IMI distributions for both groups of PLMS patients
Roberts,

and

(Kayed,

and Davies,

1990)

and individual patients

(Montplaisir et al.,

1985)

shows that the modal IMI is

often in the 20 to 30 second range,

and that the mean IMI

is usually higher than this because of outliers at the
upper end of the distribution.
Two studies have provided detailed descriptions of
PLMs based on videotaped analyses of the movements
(Guilleminault et al.,
et al.

1975; Smith,

1985).

Guilleminault

reported that the movements consisted of "a rapid

partial flexion of the foot at the ankle,

extension of the
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big toe, and partial

flexion at the knee and hip..."

(Guilleminault et al.,

1975, p. 19).

Smith

(1985)

found

results that were very similar to those obtained by
Guilleminault et al..

Smith reported that 91% of the PLMs

he recorded were characterized by dorsiflexion of the foot
at the ankle,
small toes,

82% showed dorsiflexion and fanning of the

72% showed dorsiflexion of the big toe, and

28% showed partial flexion of the leg at the knee and hip.
Smith pointed out that this pattern of movements was
similar in appearance to the abnormal plantar reflex
(Babinski's response),

and he proposed that PLMs were in

fact spontaneously occurring Babinski responses which
occurred because of a reduction in supraspinal inhibition
of lower motor neurons during NREM sleep.
Several different sets of scoring criteria have been
used to score PLMs over the years,

and unfortunately,

of them have been empirically derived.
a l . (1975)

none

Guilleminault et

scored any movement as a PLM if it had a

duration of between 0.5 and 15 seconds and an IMI of less
than 120 seconds.

In addition,

each movement had to part

of a series of at least three such movements.
Poliak,

and Weitzman

(1980)

Coleman,

scored movements as PLMs if

they were between 0.5 and 4.5 seconds in duration, had an
IMI of between 20 and 40 seconds,

and were part of series
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of at least five such movements.

Coleman

(1982)

later

modified his criteria such that any movement which was 0.5
to 5.0 seconds in duration with an IMI of between 5 and 90
seconds,

and part of a series of four such movements was

scored as a PLM.

Several years earlier,

of Sleep Disorders Centers

(ASDC,

1979)

the Association
used movement

duration criteria of 0.5 to 10 seconds,

and IMI criteria

of 5 to 120 seconds in its diagnostic criteria for
nocturnal myoclonus.

In addition,

three separate series

of at least 30 PLMs each had to be present for a diagnosis
of nocturnal myoclonus to be given.
Sleep Disorders Association

(ASDA,

Finally,
1993)

the American

has recently

published a set of guidelines and scoring criteria for
recording and scoring PLMs.
as the current standard,

These criteria are recognized

and are a revision of those

presented earlier by Coleman

(1982).

Briefly,

PLMs are

recorded polygraphically by placing two small surface
electrodes over the anterior tibialis muscle
muscle involved in flexion of foot).
can be summarized as follows:

(the primary

The scoring criteria

1) each movement must be

part of a series of at least four PLMs,

2) the movement

duration must be between 0.5 and 5.0 seconds,
IMI must be between 5 and 90 seconds.
occur at the end of respiratory events

and 3) the

Movements which
(i.e. apneas and
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hypopneas)

are not counted as PLMs.

per hour of sleep

The number of PLMs

(the PLM index or PLMi)

is tabulated,

and five or more movements per hour of sleep is considered
abnormal.
As noted above,

these criteria have not been derived

from an empirical analysis of the temporal characteristics
of PLMs,

but instead reflect the consensus of various

researchers

familiar with this disorder.

The current ASDA

criteria can be criticized for being somewhat liberal in
both the IMI and number of movements in a series criteria.
For example,

according to these criteria,

with IMIs of 7,
PLMs,

four movements

90, and 30 seconds would be scored as

despite the obvious lack of any consistent

periodicity in their IMIs.
definition of PLMs,

Given this somewhat liberal

the diagnostic criterion for the PLMi

of five or more events per hour of sleep also seems
liberal,

and it is possible that it may be resulting in a

significant number of false positive PLMS diagnoses.
The issue of whether or not PLMS leads to daytime
sleepiness or to nocturnal sleep disruption has received
much attention over the years.
study by Guilleminault et al.

The early descriptive
(197 5) was based on PLM data

from 16 patients who were part of a total sample of 140
patients who were referred for evaluation of insomnia.
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These 16 patients thus represented 11.4% of the total
sample,

a finding which led Guilleminault to conclude that

PLMS could be an important cause of insomnia

[122].

The

association of PLMS with insomnia in some patients,

and

its well known association with RLS seemed to indicate
that it might always represent a pathological
disrupting)

finding.

However,

it was soon shown that PLMS

could occur in a variety of sleep disorders
narcolepsy and sleep apnea),

(or sleep

(such as

and that its prevalence in

these disorders was not significantly different from its
prevalence in insomnia
a study by Kales et al.

(Coleman et al.,
(1982)

1980).

Moreover,

also showed that the

prevalence of PLMS in insomnia was not significantly
different from its prevalence in normal subjects.
work has shown that the PLM arousal

index

Other

(PLMAi) is

poorly correlated with subjective sleep complaints
(Ancoli-Israel et al.,

1991; Dickel and Mosko,

has either low correlations
1982)

or is not correlated

(Coleman,
(Mendelson,

Bliwise,

1990),

and

et al.,

1996) with the

average sleep latency on the Multiple Sleep Latency Test
(MSLT), an objective test of sleepiness.
It is clear from these studies that PLMS is often not
associated with subjective sleep complaints or with
objective evidence of abnormal sleep or excessive daytime
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sleepiness.

Because of this, a distinction is usually

made between periodic limb movements in sleep
periodic limb movement disorder
movement disorder

(PLMD)

(PLMD) .

(PLMS)

and

Periodic limb

is a clinical diagnosis in which

PLMS are present and have been determined to lead to
either a complaint of insomnia or excessive sleepiness or
to cause sleep disruption

(i.e. excessive arousals)

determined by polysomnography,
complaint may not be present
Steering Committee

[DCSC],

summarized as follows:

even though a subjective

(Diagnostic Classification

1990,

diagnostic criteria for PLMD

pp.

(DCSC,

stereotyped and repetitive,

1990)

The

can be briefly

2) the leg movements are

and 3) polysomnographic

monitoring shows five or more PLMs

present,

65-68).

1) a complaint of insomnia or

excessive sleepiness is present,

arousals or awakenings)

as

(which often cause

per hour sleep.

If PLMS are

but there is no subjective sleep complaint or

objective evidence of abnormal sleep or excessive
sleepiness,

then the movements are generally not

considered to be clinically significant and/or worthy of
treatment.

Finally,

it is generally agreed that PLMs

exert their pathological influence by causing EEG arousals
and awakenings during sleep
however,

as noted earlier,

(Rosenthal et al.,

1984);

the PLM arousal index may be
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poorly correlated or not correlated with the average sleep
latency on the MSLT
Mendelson,

(Coleman,

Bliwise,

et al.,

1982;

1996).
Prevalence

Ekbom was the first to attempt to determine the
prevalence of RLS in the general population
1945).

(K.A.

Ekbom,

He questio ned 503 normal individuals and 503

neurological outpatients,

and found prevalence rates of

5.2 and 7.8 percent respectively.
of these were mild cases,

Ekbom noted that most

but he did not provide any clear

definition of "mild" in terms of the frequency and
severity of symptoms.

The value of 5.2 percent in normals

is in good agreement with a recent study by O'Keeffe,
Noel,

and Lavan

(1993) which found a prevalence rate of

4.9 percent in 307 older subjects seen at an outpatient
medical clinic.
(1997)

In addition to these two studies,

Hurry

reviewed eleven additional studies which examined

the prevalence of RLS in various normal or outpatient
samples.

The large majority of these studies found

prevalence rates in the two to six percent range,

although

three studies found prevalences of over ten percent.

When

those three studies were excluded and the results were
averaged across studies,
be 4.1 percent.

the mean prevalence was found to

One general pro ble m with these studies
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was that RLS was often assessed by questionnaires
with only one or two items),
interviews.

Despite this,

(usually

rather than by clinical

there was general agreement

across studies that the prevalence of RLS in the general
population was about five percent,

with most of these

being mild cases.
Several prevalence studies and large case study
series have found that the prevalence of RLS appears to be
higher in women.

For example, O'Keeffe et al.

(1993)

found prevalence rates of 6.3% for females and 3.0% for
males.

Of 237 RLS cases studied by Ekbom,

patients were women

(K. A. Ekbom,

58% of the

1970).

There is general agreement across a number of studies
that about one-third to one-half of RLS patients report a
positive family history of RLS

(K. A.

Walters,

1996).

1995; Walters et al.,

Ekbom,

1945;

Several authors

have presented family pedigrees that are consistent with
an autosomal dominant mode of inheritance
Peyronnard,
Lugaresi,
Lazzarini,

1976; Montagna,

1983; Walters,

Coccagna,

Picchietti,

(Boghen and

Cirignotta,
Hening,

and

and

1990).

The age of onset appears to be variable.

Ekbom found

that 15% of the cases he studied first experienced
symptoms before the age of 20, while the remaining cases
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had their ages of onset fairly evenly distributed across
the next four decades
(1996)

(K. A. Ekbom,

1945).

Walters et al.

found that 43% of 138 RLS patients they interviewed

first had symptoms before the age of 20, while the
remaining patients had their ages of onset fairly evenly
distributed across the next four decades.

Both Ekbom and

Walters et a l . found that periods of remission were
common,

and that there was a general tendency for symptoms

to worsen with increasing age.
A higher than normal prevalence of RLS has been
reported in a fairly large number of medical conditions
and disorders.
deficiency
1993),

These include the following:

(K. A. Ekbom,

uremia

(Banerji and Hurwitz,

Winkelman and Lazarus,
(Reynolds,
Mills,

Blake,

Brodie,

Hurwitz,

1970;

1995;
Botez,

1994),

Pall,

and Webley,

Goodman,

1993),

1945; O'Keeffe,

Schiavi,

and Lavan,

1986; Salih,

(K. A. Ekbom,

1988), diabetes

Stimmel, Mandeli,

Cadote,

1963),

Beaulieu,

Sjogren's syndrome
Hallgreen,

folate deficiency

1993),

1945;

and Rayfield,
(Kanter,

(Botez,

Pichette, and Pison,

(Gudbjornsson,

Gray,

(Banerji and

varicose veins and venous insufficiency
Popkin,

1971a;

rheumatoid arthritis

pregnancy

and Ayida,

Noel,

1970; Nielsen,

and Williams,

1994),

iron

1976;
1976),

Broman, Hetta,

and as a complication following
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gastrectomy

(Banerji and Hurwitz,

1970; K. Ekbom,

1966).

There are also case reports of individuals who developed
RLS in association with various forms of peripheral
neuropathy or radiculopathy
1968;

Salvi et al.,

Chokroverty,
Matheson,

(Ambrosetto and Lugaresi,

1990; Walters,

1996); however,

and Logigian

(1996)

Hening,

Wagner,

and

a recent study by Rutkove,
found that only 5.2% of 154

patients with polyneuropathy had RLS.

Thus,

it does not

appear that patients with peripheral neuropathy have a
higher than normal prevalence of RLS.

Spillane

(1970)

reported that he had seen eight consecutive cases of RLS
in a period of four years,
chronic lung disease.

all of whom suffered from

Because this was not an unselected

sample of lung disease patients,

it remains unclear if

patients with lung disease have a higher than normal
prevalence of RLS.

It is worth noting; however,

that a

recent prevalence study of PLMS by Ancoli-Israel et al.,
(1991)

did find that persons with lung disease had a

higher than normal prevalence of PLMS.

Hurry

(1997)

reviewed the RLS prevalence literature in detail,
the results were summarized across studies,

and when

the prevalence

rates for RLS in the various disorders listed above were
found to be as follows;
(31%),

Sjogren's syndrome

iron deficiency
(24%),

(38%), uremia

rheumatoid arthritis
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(23%), venous insufficiency
pregnancy

(16%),

(22%), diabetes

and following gastrectomy

(20%),
(14%).

A

prevalence estimate for folate deficiency could not be
derived because it was unclear if the subjects in the
studies reported were unselected with respect to the
presence or absence of RLS.
the estimates

It should also be noted that

for diabetes and Sjogren's syndrome were

based on data from less than 100 patients across studies,
and as such,

could be expected to be less reliable than

the estimates of RLS prevalence in the other disorders.
In recent years it has become an accepted practice to
refer to the RLS that occurs in the conditions above as
secondary RLS,

while the terms primary or idiopathic RLS

are reserved for RLS patients who do not have any of the
above conditions

(Walters,

1995).

It should be noted that

there do not appear to be any differences in symptom
presentation between the primary and secondary forms
(Walters,

1995).

An obvious question that arises from a review of this
literature is what one factor,
these conditions.

if any,

is common to all of

Although a number of authors have

pointed out that iron deficiency and/or anemia are common
in several of these conditions
and Blake,

1987;

(Pall, Williams,

Reynolds et al.,

1986; Roger,
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Stewart,

1991),

it has not been emphasized that anemia

and/or circulatory problems are common in all of them.
Iron deficiency is common in pregnancy
Rothman,

1971),

(Eschbach,

in uremia patients on hemodialysis

Cook,

Scribner,

and Finch,

complication following gastrectomy
1977).

and as a

(Lloyd and Valberg,

(Beck,

199 1a ), and is also common in uremia

(Beck,

1991b), rheumatoid arthritis

1989),

diabetes

Peterson,

(Bern and Busick,

1981),

and Bunim,

1991c).

1965),

Jones and

(Bloch,

Buchanan,

and folate deficiency

(Beck,

Circulatory problems are common in varicose veins

Ibrahim,

diabetes

(Cash and Sears,

1985;

Sjogren's syndrome

and venous insufficiency
1994;

1977),

Anemia is a well-known complication of iron

deficiency

Wohl,

(Chanarin and

(Goldman, Weiss,

MacPherson,

(Colwell,

and Goldhaber,

and Bergan,
1996)

and in

1986).

Peripheral neuropathy is also common in several of
these conditions including uremia
rheumatoid arthritis
and Tarter,
syndrome
1982),

1965),

(Good, Christopher,

diabetes

(Alexander,

(Nielson,

(Walker,

Provost,

and folate deficiency

Koepke,

1986),

Stevens,

Bender,

Sjogren's

and Alexander,

(Botez et al.,

The high rates of iron deficiency,

1971),

1976).

anemia,

and

peripheral neuropathy in many of the conditions above is
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important because these data are supportive of three of
the four major theories of the pathogenesis of RLS.
Experimentally produced iron deficiency has been shown to
lead to reductions in dopamine receptor density in rats
(Ashkenazi,

Ben-Shachar,

and Youdim,

1982).

Thus, the

theory that RLS is caused by dopaminergic dysfunction
could account for the higher than normal prevalence of RLS
seen in iron deficiency,

pregnancy,

and in post-gastrectomy patients.

hemodialysis patients,
The theory that RLS is

caused by peripheral neuropathy could explain the higher
than normal prevalence of RLS in uremia,

rheumatoid

arthritis,

and folate

diabetes,

deficiency.

Finally,

Sjogren's syndrome,

the theory that RLS is caused by

impaired peripheral circulation

(or by reduced oxygen

delivery secondary to impaired peripheral circulation)
could potentially account the higher than normal
prevalence of RLS in all of the conditions listed above,
since all of them are associated with either impaired
circulation or high rates of anemia.
Unlike RLS,

there are relatively few prevalence

studies of PLMS in normal subjects.

Only three studies

with a combined total of 620 subjects have investigated
this issue,
subjects)

and the largest of these

(which included 420

used portable home recordings to assess PLMS
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rather than laboratory polysomnography
al.,

1991).

(Ancoli-Israel et

These home recordings did not include

measurements of EEG or other physiologic variables
normally used to measure sleep; sleep was assessed using a
wrist-worn actigraph.

The

other two

large studies used

laboratory polysomnography

to assess

PLMS. In addition

these three large studies,

there are

three additional

studies of PLMS prevalence

in various patient groups which

to

have included small control groups of normal subjects
(i.e. those either unselected for the presence or absence
of sleep complaints or without any sleep c o m p l a i n t ) .
Bixler et al.

(1982) were the first to investigate

the prevalence of PLMS in normal subjects,

and they

reported a total PLMS prevalence of 11% in a sample of 100
subjects who did not have any sleep complaints.

They

found that the prevalence of PLMS was strongly agerelated.

In their sample,

29 had PLMS,

none of the subjects aged 18 to

only five percent of subjects aged 30 to 49

had PLMS, and 29% of subjects aged 50 to 74 had PLMS.
They also found that more men
had PLMS.

Dickel and Mosko

(14.6%)

than women

(8.5%)

(1990) performed three

consecutive nights of polysomnography on 100 subjects who
were over the age of 60.

These subjects were selected

without any regard to the presence or absence of sleep
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complaints.

Using the average PLMi from all three nights

for each subject,
sample of 58%.
age,

they found a total prevalence for the

The PLMi was significantly correlated with

but not with sex.

Ancoli-I sra el et al.

portable home recordings to assess
subjects over the age of 65.

(1991)

used

PLMS prevalence in 420

These subjects were also

selected without any regard to the presence or absence of
sleep complaints.

Using a PLMi criterion of five or more,

45% of the sample had PLMS.

When PLMi criteria of 10 or

more and 20 or more were used,
of the sample had PLMS.

34% and 20%

In the three studies with small

control groups of normal subjects,
found that

Schiavi et al.

(1993)

18% of 40 male subjects with a mean age of 52.8

years had a PLMi of 10 or greater;
(1994)

(respectively)

Ferini-Strambi et al.

found that eight percent of 25 subjects

(who were

age-matched to a patient group with a mean age of 39.9
years)

had PLMS;

and Hanly and Zuberi-Khokhar

(1996)

found

that one of nine subjects with a mean age of 65 had PLMS.
Although there have been relatively few younger subjects
in these six studies,

there is general agreement among

them that the prevalence of PLMS increases sharply in
older age groups.

However,

patients with insomnia

studies of PLMS prevalence in

(in which higher than normal rates

of PLMS have not been documented)

have found a much more
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linear increase in PLMS prevalence with increasing age,
the age of onset issue remains unresolved.

so

Despite this,

it is clear that the prevalence of PLMS is very high in
older subjects.
A large number of studies have investigated the
prevalence of PLMS in various medical disorders and/or
patient groups.

Unfortunately,

only a few of these

studies have included age matched control groups of normal
subjects.

This represents a serious shortcoming given the

apparent sharp increase in PLMS prevalence in older
subjects,

and the small amounts of data that are actually

available on PLMS prevalence in normal subjects.

In

addition to the lack of control groups, many of the
studies discuss ed below arbitrarily used PLMi criteria
that were different from the standard of five or more leg
movements per hour.

Another point worth noting is that

only a few of the disorders in which a higher than normal
prevalence of RLS has been documented have been
investigated with respect to the prevalence of PLMS.
probably reflects the time,

expense,

This

and inconvenience

involved in conducting the large scale polysomnography
studies which are needed to investigate PLMS

(but not RLS

since RLS is not defined by polysomnographic m ea su res) .
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As reviewed by Hurry

(1997),

there are four medical

disorders in which a higher than normal prevalence of PLMS
has been well established.

The term "well established"

was arbitrarily defined as indicating that a higher than
normal PLMS prevalence
the age of subjects)

(than would be expected based on

was found when the results were

averaged across studies.

An additional stipulation was

that the total number of subjects included across all
studies for a given disorder had to be 100 or greater.
These disorders include the following:
Lugaresi,
(Baker,
Mosko,

1981; Montplaisir et al.,

Guilleminault,
Shampin,

(Hirshkowitz,
Schmidt,
Miller,

Wise,

Nino-Murcia,

and Sassin,

1984),

Karacan, Arcasoy,
and Jackson,

and Mendelson,

1989;

1992),

(Coccagna and
narcolepsy

and Dement,

1986;

organic impotence

Acik,

1981),

RLS

and Williams,

and uremia

Pressman,

1989;

(Kimmel,

Benz, and Peterson,

1995).
The prevalence of PLMS has been investigated in two
other disorders in which the total number of subjects
included across studies was greater than 100.

These two

disorders are insomnia and obstructive sleep apnea.
mentioned earlier,

Kales et al.

(1982)

As

found the same

prevalence rate of PLMS

(11%)

in 100 normal subjects and

200 insomnia patients.

Guilleminault et al.

(1975)
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reported an 11% prevalence of FLMS in 140 insomnia
patients.

Coleman et al.

(1980)

found an 18% prevalence

of PLMS in 140 insomnia patients.
collaborative study,

Coleman,

In a large multi-center

Roffwarg,

et al.

(1982)

found that 12.2% of 1,214 patients with disorders of
initiating and maintaining sleep
nocturnal myoclonus or RLS

(insomnias)

(the percentage of subjects

with both disorders was not me ntion ed ).
Seidel,

and Dement

subjects

(1985)

Wittig,

Bliwise,

Petta,

reported that 37% of 63 older

(mean age of 66 years)

Sicklesteel,

had either

and Roth

had PLMS.

(1983)

of 562 patients with sleep complaints

Roehrs,

Zorick,

reported that 10.5%
(but without

polysomnographic evidence of sleep apnea or narcolepsy)
had either RLS or PLMS.

The prevalence of PLMS in these

patients showed a positive relationship with age:

only

4.0% of patients between the ages of 20 and 40 had PLMS,
while 11.4% and 21.6% of patients in the 41 to 60 and 61
and older age groups had PLMS,
(1982,

Figure 12.2, p. 270)

respectively.

Coleman

presented a figure of

previously published data showing the PLMS prevalence for
two groups of patients
patients)

(with sample sizes of 441 and 506

referred for polysomnography.

The data showed

that PLMS prevalence increased linearly with increasing
age.

For example,

in both groups of patients about eight
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percent of the subjects in the 20 to 29 age group had
PLMS, wh il e about 20% of subjects in the 50 to 59 age
group of both samples had PLMS.

Overall,

the results from

these studies do not indicate that insomnia patients have
a higher than normal prevalence of PLMS than would be
expected given their age.
(1983)

and Coleman

(1982)

In addition,

the Roehrs et al.

data suggest that the prevalence

of PLMS increas es in a relatively linear fashion with
increasing age,

rather than showing a sharp increase in

older age groups.
Several studies have reported on the prevalence of
PLMS in pat i en ts with sleep apnea.

Coleman et al.

reported that 14% of 63 apnea patients had PLMS.

(1980)
In their

study of PLMS prevalence in 100 older subjects who were
selected without regard for the presence or absence of
sleep complaints,

Dickel and Mosko

(1990)

found that 56%

of the subject s who had sleep apnea also had PLMS
as a PLMi of 5 or greater).

(defined

This value of 56% was very

similar to the 58% prevalence of PLMS for the entire
sample of 100 subjects.
(1991)

Similarly,

Ancoli-Israel et al.

fou nd that 42% of their subjects with sleep apnea

had PLMS,

a value that was very similar to 45% prevalence

of PLMS for the entire sample of 420 subjects

(subjects

were s e le cted without regard for the presence or absence
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of sleep c o m p l a i n t s ) .
(1995)

George,

Ferguson,

and Flaherty

recently reported that 27% of 636 apnea patients

with a mean age of 51.4 years had a PLMi of 10 or more.
By comparison,

Ancoli-Israel et al.

found that 34% of

their sample of 420 subjects with a mean age of 72.5 years
had a PLMi of 10 or more.

Overall,

these studies indicate

that the prevalence of PLMS in persons with sleep apnea is
either very similar to or only slightly higher than its
prevalence in normal individuals.

One point worth

repeating is that leg movements that occur at end of
respiratory events in patients with sleep apnea are not
counted as PLMs according to the current scoring criteria
(ASDA Atlas Task Force,

1993).

It is unclear whether or

not this criterion was applied in the studies above.
Another interesting report with respect to sleep
apnea and PLMS was a study by Fry,
Pressman

(1989)

DiPhillipo,

and

which found a significant increase in PLMS

when apnea patients were treated with nasal continuous
positive airway pressure

(CPAP).

reported by two other groups,
had relatively severe apnea
Minhoto,

and Karacan,

Shaffer et al.

Similar results were

but only for patients who

(Gokcebay,

Hirshkowitz,

1993; Shaffer et al.,

Clay,

1993).

concluded that the improved sleep

continuity during CPAP treatment allowed PLMS to emerge in
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those patients whose sleep had been previously severely
disrupted by sleep apnea.
George et al.

(1995)

In contrast to these findings,

reported only 18% of 174 apnea

patients with PLMS had an increase in their PLMi during
CPAP treatment

(82% had a decrease in their PLMi).

These

later results,

which were based on a very large sample,

indicated that CPAP tended to improve rather than
exacerbate PLMS.
A higher than normal

(or high)

prevalence of PLMS has

been reported in nine additional medical disorders,

in

which the total number of subjects included across studies
was less than 50.

Because of the small number of subjects

studied with each of these disorders,

these results should

probably be viewed as preliminary findings.
disorders will only be mentioned here.

As such, the

These nine

disorders include the following:

congestive heart failure

(Hanly and Zuberi-Khokhar,

diabetes

al.,
1994;

1993),

multiple sclerosis

Potolicchio,

Calderon,

fibrositis syndrome

coma

and Braha,

(Oskenberg,

(Walters,

Hening,

1994),

(Schiavi et

(Ferini-Strambi et al.,

and Richert,

(Moldofsky,

chronic fatigue syndrome
Marrie,

1996),

Tullis,

1991),

and Lue,

(Morehouse, MacDonald,
leukemia

1986),
Haase,

(Kotagal et al.,

1985),

1989), neuroleptic-induced akathisia
Rubinstein,

and Chokroverty,
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in family members of children with hereditary progressive
dystonia

(Gadoth,

Costeff,

Harel,

and Lavie,

1989) .

There

are also case reports of PLMS in patients with spinal cord
injury

(Dickel,

Hirose,

Tanabe,

(Budha,

1996) .

Unlike RLS,

Renfrow,

Moore,

and Tsukagoshi,

and Berry,
1991)

1994;

Yokota,

and head injury

there is no one factor or pathology

common to all of these conditions,

although anemia and/or

circulatory problems are common in several of them
(leukemia,

uremia,

diabetes,

impotence,

and congestive

heart f a i l u r e ) , and abnormalities of dopamine or dopamine
receptors have been reported
progressive dystonia

(Segawa,

neuroleptic-induced akathisia
impotence

(Lai et al.,

1989).

(or postulated)
Ohmi,

and coma)

and Itoh,

(Sachdev,

1971),

1995),

and

One general aspect of

several of the remaining conditions
sclerosis,

in hereditary

(narcolepsy,

multiple

is that they are disorders in which a

major pathology of the central nervous system is involved.

Eathophygj.q3-Qqj.gaJ. .Einriinga
Most studies of RLS based on large case study series
of patients are in agreement that physical and
neurological examinations are usually normal in idiopathic
RLS patients
Morgan,

(K. A. Ekbom,

1945; Gorman et al.,

1967; Walters and Hening,

1987).

1965;

The neurological
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examination may be abnormal if the patient has diabetes,
uremia,

or rheumatoid arthritis

Nielsen,

1971a,

Salih et al.,

be considered secondary,

(Gorman et al.,

1994),

1965;

but such cases would

rather than idiopathic,

RLS.

The

physical and neurological examinations are also usually
normal in PLMS patients
Guilleminault et al.,
McCall,

Edinger,

PLMS patients

(Coleman et al.,

1975),

1980;

although a recent study by

and Lininger

(1991)

found that nine of 17

(53%) had one or more neurological

abnormalities.

Unfortunately,

patients with diabetes,

the percentage of these

uremia,

or other conditions that

might have led to these abnormal findings was not
r epo rted.
Many studies of RLS patients have reported that a
significant number of them
deficiency
Gavin,

(K. A. Ekbom,

and Lavan,

1994;

(up to 20% to 30%)

1960; Norlander,
Parrow and Werner,

have iron

1953; O'Keeffe,
1966),

although

other authors have reported only isolated cases in their
samples

(Gorman et al.,

1969) .

A recent study by Baran,

Curran,

and Fry

(1996)

1965; Morgan,

1967; Young et al.,

Goldberg,

DiPhillipo,

found that three of 20 PLMS

patients had low ferritin levels.

Some studies have found

elevated blo od urea nitrogen values suggestive of uremia
in PLMS patients

(Bliwise,

Petta,

Siedel,

and Dement,
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1985; Coleman et al.,

1980).

Because RLS may be

associated with iron deficiency or other anemias,
diabetes,

and uremia,

it is generally recommended that

laboratory tests for these conditions be done whenever a
patient presents with RLS
However,

(Montplaisir et al.,

1994).

the question of what percentage of RLS patients

have secondary versus idiopathic RLS
well-investigated issue.

(or PLMS)

is not a

The only data pertinent to this

question are from the prevalence study by O'Keeffe et al.
(1993) .

They found that 15 of 307 patients seen at a

geriatric outpatient care facility had RLS.
these 15 patients

(53%)

be associated with RLS
2 had diabetes,

Eight of

had conditions that are known to
(4 had iron deficiency anemia,

and

and 2 had chronic lung dis ease).

The theory that RLS

(and PLMS)

is caused by

peripheral neuropathy has been popular over the years,

and

a large number of neurophysiological studies in RLS and
PLMS patients have been reported.

A total of eight such

studies in idiopathic or unselected RLS patients and four
in PLMS patients have been reported.

Each of these will

be briefly discussed below.
Gorman et al.
electromyogram
patients,

(1965) briefly mentioned that

(EMG)

studies were performed in 11 RLS

and found to be abnormal in only two of these
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patients.

In both cases,

the abnormalities were thought

to be secondary to diabetes.

Coccagna and Lugaresi

(1981)

briefly mentioned in a review paper that they found
positive Babinski signs and delayed nerve conduction time
in their RLS patients in the evening when symptoms were
present,

and in addition,

they found that these signs were

reduced or absent the following morning.

It was unclear

from their paper how many subjects they actually studied,
and what percentage of them had abnormal findings.
Guilleminault and Flagg

(1984) mention ed that EMGs and

nerve conduction studies were normal
patients they studied.

in the five PLMS

Mcsko and Nudleman

(1986)

found no

differences in auditory and somatosensory evoked
potentials between a group of ten RLS/PLMS patients and
ten normal controls.
(1986)

Wechsler,

Stakes,

performed nerve conduction,

EMG,

and reflex studies in six PLMS patients.
conduction,

EMG,

in all cases,

Shahani,

and Busis

evoked potential,
The nerve

and evoked potential studies were normal

but two patients had abnormal H-reflexes and

all six had abnormal blink reflexes
additional long latency components).

(consisting of
Wechsler et al.

concluded that these findings were indicative of increased
excitability of brainstem and spinal reflexes.
(1987)

Akpinar

briefly mentioned that neurological examinations,
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EEGs,

and EMGs were normal in 16 RLS patients he studied.

Martinelli,

Coccagna,

and Lugaresi

(1987)

found abnormal

H-reflexes and other reflexes in three of six RLS/PLMS
patients they studied.

Zucconi et al.

(1989)

performed

neurological examinations and sensory and motor nerve
conduction studies on nine RLS patients,
only one patient had abnormal findings
suggestive of Parkinson's disease).
Date,

and Dement

and found that

(which were

Bliwise,

Ingham,

(1989) performed sensory and motor nerve

conduction studies in both upper and lower extremities of
24 elderly PLMS patients.
used,

Although no control group was

the values obtained were stated to be within the

normal range for the age group of the subjects.
al.

(1992)

Smith et

used central magnetic stimulation to study

motor nerve conduction in four RLS patients and nine PLMS
patients.

There were no differences in conduction times

between these subjects and normal controls.
Lapierre,

and LaVigne

Montplaisir,

(1994) performed spectral analyses

of EEGs that were recorded during the evening when
symptoms were present in RLS patients,

and reported that

there was per iodic slowing that was correlated with waking
leg movements in these subjects.

They concluded that this

slowing was indicative of drowsiness,

and postulated that

leg movements in both RLS and PLMS required a critical
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level of cortical arousal to appear.
(1995)

Iannaccone et al.

performed neurological examinations,

motor nerve conduction studies,

EMGs,

sensory and

and temperature

perception tests in eight patients with primary R L S .

The

neurological examinations and nerve conduction studies
were normal

in all patients,

but five of them had abnormal

EMGs and seven had impaired temperature perception test
re sults.
Overall,

the large majority of the patients in these

twelve studies had no abnormal electrophysiological
findings.
RLS

Thus,

(or PLMS)

there is little support for the idea that

is caused by peripheral neuropathy.

abnormal reflex findings

(Coccagna and Lugaresi,

Martinelli et a l ., 1986; Wechsler et al.,

1986)

probably the most consistent across studies.
by Coccagna and Lugaresi

(1981)

The
1981;

are

The report

that abnormalities were

seen primarily during symptom presentation is also very
interesting,

but unfortunately,

there has not been any

attempt to replicate those results.
Four studies have investigated the prevalence of
neurophysiological abnormalities in patients with
secondary RLS

(three studies with uremic RLS patients,

in RLS patients with rheumatoid arthrit is ).

one

Because

peripheral neuropathy is known to occur in both uremia and
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rheumatoid arthritis

(Good et al.,

it is not surprising that

1965; Nielsen, 1971a),

some RLS patients with uremia or

rheumatoid arthritis have peripheral neuropathy.

What is

of interest is the question of whether or not peripheral
neuropathy occurs in more

commonly in the uremic and

arthritis patients who do

have RLS than in those who do

not.

Callaghan

(1966) was the first author to suggest

that RLS could be caused by peripheral neuropathy.
1966 study,

In his

he reported that five patients who had RLS

secondary to uremia all had either clinical or
neurophysiological evidence of peripheral neuropathy.
However,
study.

he did not include any non-RLS patients in his
Nielsen

(1971b) studied 109 patients with uremia,

and found no relationship between the presence or absence
of RLS and clinical signs suggestive of peripheral
neuropathy

(i.e. peripheral neuropathy was equally common

in RLS and non-RLS patients).
reported by Roger et al.

(1991)

Similar results were
in 55 uremic patients who

were receiving either renal or peritoneal dialysis.
et al.

(1994)

Salih

performed sensory and motor nerve conduction

studies and somatosensory evoked potentials on 14
rheumatoid arthritis patients with RLS and nine rheumatoid
arthritis patients without RLS.
patients

(71%)

Ten of the 14 RLS

had abnormal studies while only three of
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nine non-RLS patients
However,

(33%)

had abnormal findings.

there was clinical and laboratory data which

suggested that the RLS group had more severe arthritis
than the non-RLS group,
disease severity.

so the groups were not equated for

Taken together,

the results from these

last three studies do not provide convincing evidence that
secondary RLS is caused by peripheral neuropathy.
Two studies have used muscle and/or nerve biopsies to
further investigate the possibility of neuropathy or
myo pathy in RLS patients.
(1970)

Harriman,

Taverner,

examined biopsies of the peroneus brevis muscle

(and associated nerve endings)
with RLS.

in ten patients diagnosed

Although a number of abnormalities were found

(e.g. excessive axonal sprouting,
spherical axonal swellings),

end-plate abnormalities,

these were seen with equal

frequency in an age-matched control group.
al.

and Woolf

(1995)

Iannaccone et

examined sural nerve biopsies in eight patients

with primar y RLS.

The RLS biopsies showed significantly

lower m ye linated fiber density and more evidence of axonal
atrophy and myelin alterations than biopsies from agematched controls.

Despite these abnormal findings,

should be noted that the sensory and motor nerve
conduction studies in these subjects were normal.
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Two studies have used neuroradiological techniques to
investigate possibl e CNS abnormalities in RLS/PLMS
patients.

Staedt et al.

(1995a)

used single photon

emission co mput ed tomography to investigate striatal D2
dopamine receptor density in 20 RLS/PLMS patients
RLS,

6 with only PLMS)

(14 with

and 10 age m a t ch ed controls.

A

ratio of basal ganglia to cortical tracer uptake was used
as the dependent variable.

The actual values of tracer

uptake in the cortex and basal ganglia were not presented;
only the ratio was used.

The value for the patients

(1.40) was about nine percent lower than the value for the
controls

(1.53),

significant.

a difference that was statistically

Both values indicate that dopamine receptor

density is higher in the basal ganglia,

while the lower

value for the RLS/PLMS group indicates that their basal
ganglia dopamine receptor density was lower than that of
the controls.

In a follow-up study on four patients who

were treated wit h L-Dopa, an unexpected up-regulation in
striatal dopamin e receptor density was found
al.,

1995b).

(Staedt et

Staedt et al. suggested that this might

indicate a dysfunction in the corticostriatal input to the
basal ganglia.

Walters et al.

(1995)

used positron

emission to mog raphy to investigate global and regional
brain glucose metabolism in five RLS patients and 20
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normal controls.

There were no significant differences

between the groups.
A number of authors have noted that RLS and PLMS
patients often complain of cold feet
al.,

1986;

K. A. Ekbom,

(Ancoli-Israel et

1945; Ware et al.,

1988).

Ware et

al. performed photoplethysmographic examinations of
peripheral blood flow in two RLS patients who complained
of cold feet,

and found evidence suggestive of excessive

peripheral vasoconstriction in both of these patients.
Similar examinations on their next ten PLMS patients found
that four of these subjects also had evidence of excessive
peripheral vasoconstriction.

Ware et al.

suggested that

this excessive vascular tone was caused by excessive
sympathetic nervous system activity.

Unfortunately,

control group was included in this study,

no

so it remains

unclear if RLS/PLMS patients are more likely to have
impaired peripheral circulation than normal controls.
In summary,

there are few pathophysiological findings

in the maj ori ty of patients with both RLS and PLMS.
RLS patients do have anemia,

uremia,

associated peripheral neuropathy,

diabetes,

Some

and

and such secondary RLS

cases may represent a significant percentage of total RLS
cases.

Most other abnormal findings which have been
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reported have not yet been replicated,

and there is

obviously much work that remains to be done in this area.
Treatment
A large variety of drugs have been used to treat RLS
and PLMS over the years.
treatment of RLS

Ekbom was the first to attempt

(K. A. Ekbom,

1944,

1945).

Based on his

theory that RLS was caused by impaired peripheral
circulation,

Ekbom administered the vasodilators carbachol

(an acetylcholine agonist)
adrenergic blocker)

and tolazoline

(an alpha

to a large number of RLS patients,

and

he reported that about two thirds of his patients had an
improvement in their symptoms with each of these drugs
A. Ekbom,

1945) .

(K.

Ekbom defined "improvement" as a report

from the patient that "the symptoms occurred so seldom or
in such a mild degree that the patient no longer bothered
much about them."

(K. A. Ekbom,

1945; p.

51).

However,

other investigators found that only small percentages of
patients improved with either carbachol
or tolazoline

(Parrow and Werner,

1966).

(Brenning,

1971)

Norlander

(1953)

found that injections of iron-dextran had a beneficial
effect on RLS symptoms even in patients who were not iron
deficient.

This led him to suspect that the dextran

component of the iron-dextran injections was exerting a
therapeutic effect.

When he used dextran alone in three
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patients,

two of the three had an improvement in their RLS

symptoms.

In one of the two patients who improved,

was a complete remission of symptoms,
symptoms remitted only for one day.
(1966; p. 402)

there

while in the other,
Parrow and Werner

later reported that 55 of 64 RLS patients

(86%) they treated with dextran injections became
completely symptom free, while an additional four patients
"improved but were not completely free from symptoms".
This improvement often lasted weeks or months.

Dextran is

a high molecular weight branched polysaccharide which is
used clinically as a plasma volume expander in patients
who have lost large amounts of blood
1991).

(Mattox et al.,

Because it expands plasma volume,

is lowered;

this lowers the blood viscosity and improves

blood flow in the microcirculation
Niemczyk,

the hematocrit

and Messmer,

1990).

(Kreimeier,

Brucker,

Because the plasma half

life of dextran is only about 15 hours,

the mechanism by

which it might have acted to produce the long-lasting
relief of symptoms reported by Parrow and Werner is not
evident.

Kanter

(1995)

recently reported that

sclerotherapy treatment of varicose veins had the
unexpected beneficial side effect of producing dramatic
relief from RLS symptoms in 111 of 113 varicose vein
patients who also had RLS.

Relief was defined in this
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study by a patient report of "either complete resolution
or sustained marked improvement of symptoms"
1995; p. 329).

(Kanter,

Sc ler othera py is a technique in which a

sclerosing agent

(usually sodium tetradecyl sulphate)

is

injected into a varicose vein after it has been occluded.
The vessels eventually undergo complete fibrosis and
reabsorption,

with a resulting improvement in peripheral

venous circulation.

This improvement in peripheral

circulation was the appare nt mechanism by which
sclerotherapy improved RLS symptoms.

Recently,

a number

of studies have shown that the anti-hypertensive agent
clonidine has a beneficial effect on RLS symptoms
and Westervelt,
Steiner,

1987;

Handwerker and Palmer,

1987; Wagner et al.,

1985;

1996), although in the one

study in which polyso mno graphy was performed,
in PLMs was observed

(Bastani

(Wagner et al., 1996).

no reduction
Clonidine is

an alpha-2 adrenergic agonist which is believed to reduce
total peripheral vascular resistance by acting on central
adrenergic autoreceptors

(Hoffman and Lefkowitz,

1990).

It may also have a direct peripheral vasodilatory effect
(Shaw, Hunyor,

and Korner,

1971).

Unfortunately,

side

effects such as sedation and dry mouth are common with
clonidine

(Hoffman an d Lefkowitz,

1990).

Such side

effects were noted b y both Bastani and Westervelt
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and Wagne r et al.

(1996),

and were severe enough to

necessitate cessation of therapy in three of six patients
in the Bastani and Westervelt study and in three of seven
"responders" in the Wagner et al. study.

These side

effects may limit the clinical usefulness of clonidine in
treating RLS.
studies,

Despite this,

when taken together,

the results of the above
suggest that drugs which

exert a vasodilatory effect or which improve circulation
have a beneficial effect on RLS symptoms.
Several studies over the years have noted that
correction of anemia and iron or folate deficiency are
effective in relieving RLS symptoms.

Norlander

(1953)

found that blood transfusions to correct anemia were
effective in all six RLS patients to whom they were
administered.
(1966)

Both Norlander

(1953) and Parrow and Werner

found injections of iron-dextran to be effective in

treating RLS patients;

although,

as noted above,

this

effect ma y have been partially mediated by the dextran
component of the iron-dextran injections.
No rla nder

(1953) and O'Keeffe et al.

(1993)

However,

both

also found

that oral iron supplementation was effective in relieving
RLS symptoms.

Finally,

Botez and his colleagues found

folate supplements to be effective in treating RLS
symptoms in patients who were folate deficient
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1976; Botez et al.,

1976).

These studies are consistent

in finding that correction of anemia and related
deficiency states is effective in treating RLS,

and they

further suggest a causative role for anemia in the
pathogenesis of some RLS cases.
Ekbom noted in his 1945 monograph that several of his
RLS patients had discovered on their own that opioids were
very effective in relieving RLS symptoms.

This

observation was subsequently confirmed by a number of
investigators in both open
1986; Trzepacz,

Violette,

controlled trials

{Akpinar,

1982; Hening et al.,

and Sateia,

(Walters et al.,

1984)

1993).

all five RLS patients studied by Akpinar
three patients studied by Trzepacz et al.

and placebo
For example,

(1982)
(1984)

reported to have improved with opioid treatment

and all
were
(in both

studies "improvement" was assessed by patient report
and/or clinical interviews;

objective measures of RLS

symptomatology were not obtained).

Four of five patients

studied by Hening et al. had decreases in waking leg
movements of 65% or more.

In the placebo controlled study

conducted by Walters et al.

(1993), rating scales were

used to assess waking leg sensations and motor
restlessness.

Both variables decreased significantly

during the treatment period.

An examination of the data
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presented for individual subjects showed that six of ten
subjects had a 70% or more decrease in their ratings of
leg sensations while five of ten had similar decreases in
their ratings of motor restlessness.

The effect of

opioids on PLMS appears to be less pronounced.
al.

(1993)

found a 53% decrease in the PLMi from baseline

with oxycodone,
(1993)

while Kaplan, Allen,

Buchholz,

and Walters

reported a 35.4% decrease in the PLMi from placebo

with propoxyphene
significant) .
(1988)

Walters et

(this decrease was not statistically

Kavey, Waiters,

Hening,

and Guidro-Frank

used a variety of opioids in four PLMS patients,

and found that two patients had their leg movements almost
completely eliminated while there was no effect in the
other two.

The clinical use of opioids in RLS and PLMS

patients is also limited by concerns about the possible
development of tolerance,
(Montplaisir et al.,

dependence,

and abuse

1992).

A fairly large number of benzodiazepines have been
used to treat both RLS and PLMS.

Several early open

trials found that diazepam was effective in treating RLS
(K. A. Ekbom,
Matthews

1970; Morgan,

(1979)

1967; Spillane,

1970).

was the first to report that clonazepam

was beneficial in treating RLS patients.

The efficacy of

clonazepam in treating both RLS and PLMS has subsequently
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been shown in a large number of studies

(see Hurry,

1997,

for a detailed r e v i e w ) , including double-blind placebo
controlled studies
Cirignotta,

(Montagna,

and Lugaresi,

In the three studies
PLMS,

de Bianchi,

1984;

Peled and Lavie,

Zomer,

and Timms,

and Lavie,

1986),

1985),

have been reported.

1987).

in which clonazepam was used to treat

decreases in the PLMi of 34%

Gujavarty,

Zucconi,

65%

and 43%

Scharf,

(Mitler,

(Ohanna,

Browman, Menn,

Peled,

Rubin,

(Peled and Lavie,

Brown,

1987)

and Hirschowitz

(1986)

reported that alprazolam was effective in treating eight
of ten RLS patients in an open trial.
Quance,

and Lue

(1986)

Moldofsky,

Tullis,

found that nitrazepam produced a

65% decrease in the PLMi of 13 PLMS patients they treated.
Mitler et al.

(1986)

found that temazepam improved sleep

quality but did not decrease the PLMi in ten PLMS patients
they treated.

Similar results

(i.e.

improved sleep

quality but no decrease in PLMs) have been reported for
triazolam in three studies

(Bonnet and Arand,

1990,

Doghramji,

and Walsh,

In summary,

Browman,

Gaddy,

several benzodiazepines,
clonazepam,

1991).

including alprazolam,

1991;

diazepam,

and n itrazepam have been found to be

beneficial in treating RLS and PLMS.

Clonazepam is

currently regarded as the treatment of choice for younger
and less severely affected RLS/PLMS patients,
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is contraindicated in cases where there is a comorbid
sleep-related respiratory disorder

(Montplaisir et al.,

1992) .
Akpinar

(1982)

was the first to report that L-DOPA

was effective in treating RLS symptoms.

Because his

results were published in a letter to the editor,
apparently went unnoticed for several years.

they

Montplaisir

and his colleagues independently discovered the
effectiveness of L-DOPA in treating RLS several years
later

(Montplaisir,

Godbout,

Poirier,

Since these two initial studies,

and Bedard,

1986).

a large number of studies

have been published in which L-DOPA has been used to treat
both RLS and PLMS.
(e.g. Akpinar,

These have included both open trials

1987),

studies

(e.g. Boivin,

Brodeur,

Montplaisir,

et al,

1993) .

and double-blind placebo controlled
Montplaisir,
Godbout,

and Poirier,

and Marinier,

1989;

1988; Kaplan

There is almost uniform agreement across

these studies that L-DOPA is very effective in treating
RLS and PLMS,

although it is interesting to note that PLMs

are usually not completely eliminated
for a detailed r e v i e w ) .

(see Hurry,

1997,

The dopamine agonist

bromocriptine has also been found to be effective in
treating both RLS
and Chokroverty,

(Akpinar,
1988)

1982; Walters,

and PLMS

(Boivin,

Hening, Kavey,

Lorrain, and
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Montplaisir,

1993).

Several studies have noted that a

morning rebound or evening augmentation of RLS symptoms
may occur with L-DOPA treatment in some RLS patients
(Allen and Early,

1996b;

Becker,

1993; Guilleminault, Cetel,
this,

Jamieson,

and Philip,

and Brown,

1993).

Despite

L-DOPA is clearly effective in treating both RLS and

PLMS, and it is currently regarded as the treatment of
choice for older and more severely affected RLS/PLMS
patients

(Montplaisir et al.,

1992).

Several studies have found that anti-convulsants may
be beneficial in treating RLS.

Hogg

(197 2)

reported that

phenytoin was effective in relieving RLS symptoms in seven
of his RLS patients.

Carbamezapine was later reported to

be effective in treating RLS in three studies,

two of

which were double-blind placebo controlled trials
(Lundvall, Abom,
Zucconi et al,

and Holm,

1989),

1983; Telstad et al.,

although in the one study in which

nocturnal leg movements were recorded
1989),

1984;

PLMs were not affected.

(Zucconi et al.,

More recently,

gabapentin

has been reported to be effective in treating RLS in two
open trials
Mellick,

(Cochran and Williams,

1996).

third study

1996;

Mellick and

These results were not replicated in a

(Allen and Early,

1996a) which found that only

5 of 11 RLS patients had any improvement with gabapentin.
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In summary,
opioids,

vasodilators,

benzodiazepines,

correction of anemia,

dopamine agonists,

and anti

convulsants have all been reported to be effective in
treating either RLS,
mentioned earlier,

PLMS,

or both conditions.

As

clonazepam and L-DOPA are currently

regarded as the treatments of choice.

Problems such as

drug tolerance and morning rebound and evening
augmentation of symptoms are currently being managed by
rotating patients to a different drug every few months,
more often,

as needed

(Allen and Early,

or

1996b).

Pathogenesis
Over the years many authors have speculated about the
pathogenesis of RLS and PLMS, but only four theories of
RLS and two of PLMS have been discussed with some
frequency.

These include the following for RLS:

peripheral blood flow,
dysfunction,

peripheral neuropathy,

and dopaminergic dysfunction.

reduced

opioid

The two major

theories of PLMS include oscillations of reticular system
excitability and the spontaneous Babinski response theory.
In addition to these theories,

it should be noted that

before it became widely known that PLMS occurred in most
RLS patients,

a fairly large number of authors suggested

that RLS was psychogenic in origin
1965; Morgan,

1967;

Spillane,

(e.g. Gorman et a l .,

1970; Young et al.,
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Ekbom was the first to speculate on the pathogenesis
of RLS

(K. A. Ekbom,

lines of evidence,

1944,

1945),

and based on several

he proposed that RLS was caused by a

buildup of toxic metabolites in the lower limbs secondary
to reduced peripheral blood flow.

Evidence that he cited

in favor of this theory was as follows:

the symptoms were

relieved by drugs which had a peripheral vasodilatory
effect, many patients complained of cold feet,

the

symptoms seemed to be caused by prolonged exposure to cold
in several patients,
acroparesthesia,

and the symptoms resembled

an upper limb paresthesia which was

thought to be vascular in origin.

Ekbom

(1945)

also

pointed out that RLS symptoms were intermittent rather
continuous;

continuous symptoms would have suggested a

physical lesion,

whereas intermittent symptoms were

consistent with a transient ischemia-induced paresthesia.
In his later reviews

(K. A. Ekbom,

1960,

1970),

Ekbom also

noted that anemia and iron deficiency exercerbated the
symptoms of RLS.

In fact,

as noted earlier, most of the

medical conditions in which a higher than normal
prevalence of RLS and PLMS has been demonstrated are
associated with either anemia or impaired circulation.
Like Ekbom,
RLS

other researchers have also reported that many

(and PLMS)

patients complain of cold feet
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Israel et al.,

1986; Ware et al.,

1988).

Ware et al.

also

found direct evidence of reduced peripheral blood flow in
two of two RLS patients and four of ten PLMS patients.
Ware et al.

suggested that excessive sympathetic nervous

system activity might have caused this excessive vascular
tone.

They also suggested that oscillations of

sympathetic nervous system activity might underlie the
periodicity of PLMS, and cited a number of studies
(primarily those on Mayer waves of peripheral blood
pressure)

in which a 20 to 40 second periodicity of

sympathetic activity had been demonstrated.

Finally,

in

their recent clonidine treatment study of RLS, Wagner et
al.

(1996)

proposed that clonidine exerted its therapeutic

effect by improving peripheral blood flow.
Callaghan

(1966) was the first to suggest that RLS

might be caused by peripheral neuropathy.
been popular over the years,

This theory has

and despite the overall lack;

of support for it, the occasional positive finding
Iannaccone et al,

1996;

have kept it alive.

Wechsler et al.,

1986)

(e.g.

seems to

The high prevalence of peripheral

neuropathy in several conditions in which RLS is common
(e.g. uremia,

rheumatoid arthritis,

diabetes)

is

additional evidence in support of this theory,
noted earlier,

although as

RLS is seen with the same frequency in
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uremic patients with and without peripheral neuropathy
(Nielsen,

1971b).

Studies which have shown opioids to be effective in
treating RLS have led to the theory that RLS might be
caused by some dysfunction in the endogenous opioid system
(Hening et al.,
1986).

1986; Walters,

Walters et al.

Hening,

Cote,

and Fahn,

(1986) have specifically suggested

that the mu opioid receptor might be involved in RLS,
since all of the drugs which have been shown to be
effective in treating RLS are mu agonists.
treatment data,

Apart from the

there is essentially no other evidence

which supports this theory.
The finding that L-DOPA was very effective in
treating RLS led to the theory that RLS is caused by a
dopaminergic dysfunction.

As reviewed earlier,

there is

substantial evidence that dopamine agonists are very
effective in treating both RLS and PLMS.
earlier was the study of Staedt et al.

Also noted

(1995a)

which found

direct evidence of reduced dopamine receptor density in
the basal ganglia of RLS and PLMS patients.

The finding

that iron deficiency can cause reductions in dopamine
receptor density

(Ashkenazi et al.,1982)

coupled with the

high prevalence of iron deficiency in many conditions in
which RLS is common

(pregnancy,

hemodialysis,

gastrectomy)
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is further evidence in support of the dopamine theory.
Finally,

several authors have pointed out RLS has many

similarities to neuroleptic induced akathisia

(NIA), a

disorder which is seen as a side effect of dopamine
blocking neuroleptic medications
Waiters et al.,

(Blom and Ekbom,

1961;

1991) .

In one of the earliest descriptions of PLMS in RLS
patients,

Behrman

(1958)

suggested that these symptoms

were "a manifestation of a raised excitatory state
referable to bulbar reticular activity".
review paper,

Lugaresi et al.

(1968)

In their 1968

agreed with Behrman

that both RLS and PLMS might be caused by abnormal
activity in the brainstem reticular formation.

They

specifically suggested that RLS and PLMS might result

from

"rhythmical fluctuations of reticular excitability" which
in turn might be caused by periodic oscillations in blood
flow

(i.e. Mayer waves)

study Lugaresi,

to the brainstem.

Coccagna,

Mantovani,

In a later

and LeBrun

(1972)

showed that several periodic phenomena in sleep

(PLMs,

apneic events in persons with sleep apnea,

Mayer waves of

systemic blood pressure in normal subjects)

all had

similar periodicities of 20 to 30 seconds.

They suggested

that all of these phenomena might be caused by
oscillations of reticular excitability,

and again
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suggested that the oscillations of reticular tone might be
due to periodic oscillations in blood flow or to
oscillations in pH,
flow changes.

02, and C02 secondary to these blood

Unfortunately,

Lugaresi and colleagues

never did measure systemic blood pressure or reticular
activity in PLMS patients,
theory is lacking.

so direct confirmation of this

Despite this,

the idea that a

brainstem oscillator mediates the periodicity of PLMs has
been generally well accepted over the years.
Smith

(1985)

proposed that PLMs were spontaneously

occurring Babinski responses.

He based this idea on

videotaped analyses of PLMs which showed that they did in
fact appear to be similar to Babinski responses.

The

Babinski response is an abnormal reflex which is seen
following damage to the pyramidal tracts

(van Gijn,

1995).

It is thought to be inhibited in normal individuals by
descending inhibition from the pyramidal tracts.

In

support of Smith's idea that there is a reduction in this
descending inhibition during NREM sleep,

two studies have

shown that the Babinski response can be elicited during
NREM

(but not REM)

Fressy,

sleep in normal individuals

and Gastaut,

Yamamoto,

1964;

and Kaneko,

Babinski responses)

Fujiki,

1971).

Shimizu,

(Batini,

Yamada,

The absence of PLMs

during REM sleep may both be
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attributable to the generalized muscle atonia seen in this
sleep stage.

This atonia has been shown to be mediated by

the nucleus reticularis gigantocellularis, a medullary
reticular nucleus which projects to all levels of the
spinal cord

(Kanamori,

Sakai,

and Jouvet,

1980).

Apart

from his observation that PLMs appear to be spontaneously
occurring Babinski responses,

Smith has offered little

additional explanation of how such responses might occur
spontaneously,
others,
Thus,

why they occur in some individuals but not

and how they might be linked to RLS symptoms.

this theory represents primarily an explanation for

what PLMs

are,

rather than why they occur.

Critique of Pathogenic Theories
There are several major problems with the pathogenic
theories of RLS and PLMS discussed above.

The first and

most important of these is the small number of studies
which have directly investigated the main tenets of the
theories discussed above

(the peripheral neuropathy theory

of RLS is

the one exception to th i s ) .

For example, there

have been

no studies attempting to determine if there

opioid receptor abnormalities in RLS/PLMS patients,
only one such study investigating

are
and

(D2) dopamine receptor

distributions in RLS/PLMS patients.

The only study

investigating peripheral blood flow in RLS and PLMS
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patients included only two RLS patients and did not have a
control group of normal subjects.

There has been no

attempt to determine if Mayer waves,
system activity,
correlated with
movements.

sympathetic nervous

or reticular system activity are
(and time-locked with)

periodic leg

There also has not been any attempt to

determine if RLS/PLMS patients are more likely to show
elicited Babinski responses during NREM sleep than normal
controls.

The eventual acceptance or rejection of the

theories above can only be based on such direct
investigation,

and there is clearly much work that remains

to be done in this regard.
Another problem with these theories is that they are
vague and poorly developed.

For example,

there has been

no attempt to suggest which peripheral nerves might be
most likely to be involved in producing RLS symptoms,
RLS is indeed due to peripheral neuropathy.

if

There also

has been no suggestion of which brain or spinal cord areas
rich in opioid receptors might be responsible for
producing RLS.

Similarly,

there has been little

discussion of which dopaminergic projections within the
CNS might be involved in RLS/PLMS.

In general,

the

pathogenic theories of RLS and PLMS consist primarily of
unelaborated statements and proposals,

such as the idea
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that RLS is due to an opioid

(or dopaminergic)

dysfunction.
A related problem is that there has been no attempt
on the part of the proponents of the theories listed above
to explain all of the well-established features of either
RLS or PLMS in terms of their theories.

Instead,

most

authors have emphasized only those features of the
disorder that they can explain in terms of their theories.
Hurry

(1997)

suggested that there are at least seven

unique and well established features of RLS and PLMS that
any pathogenic theory of the two disorders should be able
to

(or attempt to)

explain.

These seven features are:

(1) the restriction of RLS paresthesias to the lower legs
excluding the feet;
by inactivity;

(3)

(4) the circadian

(2) the precipitation of RLS symptoms
the relief of RLS symptoms by movement;

(and/or sleep-related)

symptoms in RLS and PLMS;

appearence of

(5) the higher than normal

prevalence of RLS and PLMS in the various disorders
reviewed above;

(6) the reason for the effectiveness of

the various drugs that have been shown to be b eneficial in
treating RLS and PLMS;

and

(7) the mechanism responsible

for the periodicity of PLMs.

In addition,

any theor y of

either RLS or PLMS should be able to explain the strong
tendency of the two disorders to occur together.
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each of the major pathogenic theories of RLS and PLMS will
be considered with respect to how well it appears to be
able to explain all of these features.

Only brief comment

will be made on Smith's spontaneous Babinski response
theory,

since, as noted earlier,

it is primarily an

explanation of what PLMs are rather than why they occur
and how they are related to RLS.
The reduced peripheral blood flow theory

(and the

related suggestion of excessive sympathetic tone; Ware et
al.,

1984)

can potentially explain many of the features of

RLS and PLMS, but the restriction of sensory symptoms to
the lower legs excluding the feet represents a very
difficult issue for this theory.

If RLS is in fact caused

by reduced blood flow to the lower legs,

then it is very

difficult to understand why the paresthesias in RLS are
not generally seen in the feet.

The reduced peripheral

blood flow theory would presumably suggest that they
should be most common in the feet because all of the major
arteries which supply blood to the lower legs also supply
the feet

(see Moore,

1985,

Figure 4-31, p. 432),

blood flow is reduced in general,

and if

then the most distal

areas supplied by a given artery should be affected the
most.

The precipitation of RLS symptoms with inactivity

and their relief with movement are potentially explainable
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in terms of this theory,

since a number of studies have

shown that blood flow to legs is substantially less while
an individual is at rest than while he or she is engaging
in even mild or moderate exercise
d'Hollander,

Coussaert,

Lassen and Kampp,

1965).

Rasquin,

(Hinsenkamp,
and Schoutens,

Similarly,

1980;

this theory can

potentially explain the circadian variation in RLS/PLMS
symptoms,

since there are well known reductions in heart

rate, blood pressure,

and peripheral blood flow during the

evening and during non-REM sleep
Smith,

1968; Littler,

Millar-Craig,
Morrison,

Bishop,

Honour,

(Kanecko,

Carter,

and Raftery,

and Goldfrank,

1964).

Zechman,

and Sleight,

1978; Synder,

and
1975;

Hobson,

As noted earlier,

anemia

and/or impaired circulation are common to the large
majority of medical conditions in which there is a higher
than normal prevalence of RLS and PLMS,

so the reduced

peripheral blood flow theory can potentially account for
much of these data as well.

Although some of the

treatment data can be explained in terms of the reduced
peripheral blood flow theory
vasodilators),
explain.

(e.g. correction of anemia,

some of these data are more difficult to

This includes the beneficial effects of opioids,

benzodiazepines,

and anticonvulsants.

It is apparently

not well known among RLS researchers that dopamine
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agonists have been shown to increase both peripheral and
cerebral blood flow
Edvinsson,
Finally,

(Bogaert and De Sc h a e p d r y v e r , 1 9 6 7 ;

MacKenzie,

and McCulloch,

1993,

p. 245).

the periodicity of PLMs is also potentially

explainable in terms of the reduced peripheral blood flow
theory.
(1972)

Both Ware et al.

(1988)

and Lugaresi et al.

suggested that the 20 to 40 second oscillations in

systemic blood pressure known as Mayer waves might
underlie this periodicity.

Although neither author gave a

detailed proposal of how Mayer waves might actually cause
PLMs, these oscillations are one of the few physiologic
phenomena that are known to have the same period
to 40 seconds)

as PLMs.

In summary,

(i.e. 20

the reduced

peripheral blood flow theory of RLS and PLMS can
potentially explain most of the well established features
of both disorders.

Its main shortcomings are its apparent

inability to explain the anatomic distribution of
paresthesias in RLS and its inability to explain some
treatment data.
As reviewed above,

there have been a large number of

studies attempting to demonstrate peripheral neuropathy in
RLS and PLMS patients;

however,

most of these studies have

failed to document such pathology in the large majority of
RLS and PLMS patients.

In addition to this lack of direct
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evidence,

the peripheral neuropathy of RLS also has

difficulty in explaining many of the well established
features of RLS and PLMS.

The anatomic distribution of

paresthesias in RLS is the first of these.

A careful

review of the dermatomes supplied by the nerve roots at
various spinal cord segments,

and of the cutaneous areas

of the legs supplied by individual peripheral nerves,
shows that none of these areas match the areas on the
lower legs where the paresthesias in RLS typically occur
(see Carpenter and Sutin,

1983, pp 190-191 for a review of

dermatomes and peripheral nerve distributions).
intermittent nature of RLS symptoms
at rest,

their relief with movement,

variation)

(i.e.

The

their appearance

and their circadian

are also difficult to explain in terms of the

peripheral neuropathy theory,

since peripheral neuropathy

generally produces persistent rather than intermittent
symptoms

(Thomas,

1984).

A similar argument could apply

to the periodic nature of PLMS.

As noted earlier,

some of

the conditions in which a higher than normal prevalence of
RLS and PLMS occur do have peripheral neuropathy as an
associated feature

(e.g. uremia,

rheumatoid arthritis,

diab e te s) , so the peripheral neuropathy theory of RLS
could potentially account for some of this data.
many of those conditions are not associated with
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peripheral neuropathy,
patients with uremia,

and as reviewed earlier,
rheumatoid arthritis,

many RLS

and diabetes

do not have any evidence of peripheral neuropathy.

The

treatment data are also difficult to understand in terms
of the peripheral neuropathy theory,

since the standard

therapy for peripheral neuropathy consists of treating the
underlying condition which caused it, and utilizing
various forms of physical therapy to overcome its residual
effects

(Stillwell,

1984).

In summary,

not only does the

peripheral neuropathy theory of RLS have little empirical
support,

but it is also apparently unable to explain most

of the well established features of RLS and PLMS.
As reviewed above,

the opioid theory is based solely

on the treatment data which has shown opioids,
agonists in particular,

and mu

to be effective in treating RLS.

The putative opioid dysfunction in RLS could consist of
decreased levels of endogenous opioids,
of opioid receptors,

decreased levels

or some combination of these factors.

In attempting to explain the anatomical distribution of
the paresthesias in RLS in terms of the opioid theory,

it

is first necessary to review which CNS areas mediate
somatosensation in the lower legs.

Because there is

clinical evidence that several sensory modalities may be
involved in the paresthesia of RLS

(e.g. deep tactile

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout perm ission

66

sense, pain), all of the dorsal horn lamina and ascending
tracts of the spinal cord might potentially need to be
considered,

although those that mediate touch and

proprioceptive information from the lower legs
fasiculus gracilis,
dorsalis of Clark)

(e.g.

anterior spinothalamic tract,
are obviously more important.

the brainstem and diencephalon,

nucleus
Within

the nucleus gracilis in

the medulla and the ventral posterior nuclear complex of
the thalamus both mediate somatosensory information from
the lower legs.

In the cerebral cortex,

the somatosensory

cortex for the lower legs is on the part of the post
central gyrus that begins just dorsal to the cingulate
gyrus,

and ends on the cortical surface near the

longitudinal fissure.
Opioid receptors are widely distributed within brain
and spinal cord.
spinal cord,

In lumbosacral segments of the human

there are dense concentrations of kappa

receptors in Lamina II and III, while binding of ligands
specific for mu and delta receptors is very low in all
lamina

(Gouarderes,

Quirion and Pilapil

Kopp,
(1991)

Cros, and Quirion,

1986) .

have reviewed the distribution

of opioid receptors in the human brain in d e t a i l .
According to their report, mu receptors are the most
abundant opioid receptors,

and are found in high
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concentrations in the cerebellum, most basal ganglia
structures,

the amygdala,

the motor and premotor cortices,

the auditory cortex and inferior lobe in the temporal
cortex,

Brodmann's area 40 in the parietal lobe,

the visual cortex.

The distribution of delta receptors

closely parallels that of mu receptors,
are not present in the cerebellum,

except that they

and are present in high

concentrations in the hippocampal formation.
receptors are found in premotor, motor,
cortices,

some thalamic nuclei

m entioned), the amygdala,
hypothalamus,
cerebellum.
receptor,

Kappa

and somatosensory

(specific nuclei were not

the hippocampal formation,

the neostriatum,
Thus,

and in

the pallidum,

only the kappa receptor,

the

and the
and not the mu

is localized in those areas mentioned above that

mediate somatosensation in the lower legs,

and these areas

represent only a small portion of its total distribution
within the brain.

Thus,

the anatomical distribution of

paresthesias in RLS is difficult to explain in terms of
the opioid theory.

The intermittent nature of RLS and

PLMS symptoms

their appearance at rest,

with movement,

(e.g.

their circadian variation,

periodicity of PLMs)

and the

are also difficult to understand in

terms of the opioid theory,
deficiency

their relief

since the putative opioid

(e.g. decreased receptor density)

should
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produce symptoms that are persistent rather than
intermittent.

The prevalence data are also difficult to

understand in terms of the opioid theory,

since none of

the conditions in which a higher than normal prevalence of
RLS or PLMS occurs has been associated with opioid
abnormalities.

Finally,

the opioid theory can explain

only a small part of the treatment data,

since most of the

drugs shown to be effective in RLS and PLMS are unlikely
to affect opioid functioning within the CNS.

In summary,

although opioids are clearly effective in treating RLS,
most of the well-established features of RLS and PLMS are
difficult to understand in terms of this theory.
The putative dopamine abnormality in RLS and PLMS
could consist of reduced dopamine levels,
of receptors,

reduced number

impaired receptor functioning,

combination of these factors.

or some

Much is known about the

distribution of dopamine releasing neurons and dopamine
receptors in the CNS
and Murray,

1994),

(Bjorklund and Lindvall,

1984; Joyce

and some dysfunction of one or more of

these pathways or receptors could be responsible for
producing the paresthesias in RLS.

There are eight major

dopamine pathways in the mammalian CNS
Lindvall,

1984),

involved in RLS:

(Bjorklund and

three of which potentially could be
the mesostriatal pathway,

the
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mesolimbocortical pathway,
pathway.

and the diencephalospinal

The reduced D2 dopamine receptor density in the

basal ganglia shown by Staedt et al.

(1995)

implicates the

mesostriatal pathway in the pathogenesis of RLS.

However,

when dopamine release by this pathway is substantially
decreased,
akinesia,
1993).

symptoms of Parkinsonianism
b r a d y k i n e s i a ) are the result

(e.g. rigidity,
(Adams and Victor,

These symptoms are quite different from the

paresthesias and motor hyperactivity seen in RLS.
Blockade of dopamine receptors that are the targets of the
mesolimbocortical dopamine neurons is believed to be the
cause of neuroleptic-induced akathisia
Jenner,

1980; Sachdev,

1995).

(NIA, Marsden and

As mentioned earlier,

does resemble RLS in some respects.

NIA

Neuroleptic-induced

akathisia is characterized by an inner sense of
restlessness which leads to motor hyperactivity
Barnes,

and Gore,

1983; Sachdev and Kruk,

1994).

(Braude,
The

motor hyperactivity is most commonly manifested in an
inability to keep the legs still,
place,

body rocking, walking in

and shifting position when seated.

In addition,

about half of all patients with akathisia do report
abnormal leg sensations
Kruk,

1994).

However,

(Braude et al.,

1983; Sachdev and

because the cortical projections of

the mesolimbocortical pathway do not include the
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somatosensory cortex
and Murray,

1994),

(Bjorklund and Lindvall,

1984; Joyce

it is difficult to understand how a

dysfunction of this pathway could produce the paresthesias
seen in RLS.

Several authors have suggested that the

diencephalospinal dopamine pathway might be involved in
RLS

(Guilleminault et al.,

Bamford,

1988).

1993; Sandyk,

the zona incerta,

1983).

1984; Lindvall,

Bjorklund,

(Bjorklund and

and Skagerberg,

It is believed to be involved in pain modulation

and in autonomic and motor responses
1983) .

and the

and projects to the dorsal horn grey

matter at all levels of the spinal cord
Lindvall,

and

This pathway has its cell bodies of

origin in the hypothalamus,
caudal thalamus,

Iacono,

However,

spinal cord,

(Lindvall et al.,

because it projects to all levels of the

it is difficult to understand how a

dysfunction in this pathway could produce a paresthesia
that is restricted to the lower legs,
In summary,

excluding the feet.

given the distribution of the three major

dopamine pathways listed above,

and the symptoms that are

known to be caused by their dysfunction,

it is difficult

to understand how a dopaminergic dysfunction could cause
the paresthesias seen in RLS.

The intermittent nature of

RLS and PLMS symptoms are also difficult to understand in
terms of the dopamine theory for reasons similar to those
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mentioned above for the peripheral neuropathy and opioid
theories

(i.e.

a dopaminergic dysfunction should produce

persistent rather than intermittent s y mp t o m s ) .
earlier,

As noted

because iron deficiency causes reductions in

dopamine receptor density

(Ashkenazi et al.,

1982),

the

dopamine theory can account for the higher than normal
prevalence of RLS that is seen in conditions associated
with iron deficiency
g as tr ec to my ) .

(pregnancy,

However,

hemodialysis,

these conditions represent only a

few of those

in which a higher than normal prevalence

RLS and PLMS

has been shown to occur.

Similarly,

of

the

dopamine theory can only account for a small portion of
treatment data as well,

since ma n y of the drugs effective

for RLS and PLMS apparently do not affect dopamine
pathways.

In summary,

although dopamine agonists are

effective in treating RLS, and a small reduction in
striatal dopamine receptor density has been demonstrated
in RLS/PLMS patients, it is difficult
the features

to explain many of

of RLS and PLMS in terms of the dopamine

theory.
Before discussing the theory that RLS and PLMS are
caused by oscillations of reticular system excitability,
the anatomy and functions of this system should be
reviewed briefly.

The reticular system consists of the
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reticular formation and its associated nuclei within the
medulla,

pons,

and midbrain.

Some of the more important

nuclei are the gigantocellular nucleus,
caudal pontine nuclei,
coeruleus

the Raphe nuclei,

(Barr and Kiernan,

212-215).

the oral and
and the locus

1993; Carpenter,

1991, pp.

This system begins caudally within the upper

segments of the spinal cord, and ends rostrally in the
midbrain.

The reticular formation consists of numerous

small groups of cell bodies that are extensively
interconnected with each other and interspersed with white
matter.

Afferents to the reticular system originate in

the cerebral cortex,
(Carpenter,

1991,

pp.

the cerebellum,
127-128).

and the spinal cord

Sensory afferents include

both spinoreticular fibers and axon collaterals that are
given off by tracts transmitting information from cranial
nerve nuclei as they ascend to the thalamus.
projections include reticulospinal fibers,
projections,

Efferent

cerebellar

and projections to the cortex which are

relayed via both thalamic and non-thalamic routes.

The

ascending cortical projections exert a potent arousing
effect on the cortex,

a finding which has led to the

concept of the ascending reticular activating system.
reviewed by Carpenter

(1991, p. 103),

As

stimulation of the

pontine and medullary reticular formation can exert a
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variety of

(descending)

effects which include facilitation

and inhibition of motor activity
reflexes),

(including motor

changes in the level of muscle tone

(mediated

via the gamma system), changes in respiratory and
cardiovascular activity,

and facilitation and inhibition

of the central transmission of sensory information from
the spinal cord.

The Raphe nuclei are also known to be

involved in modulating pain sensation

(Barr and Kiernan,

1993) .
Given that the reticular formation can exert an
influence on the transmission of sensory information from
the spinal cord,

it is plausible that this system might be

involved in producing the paresthesia seen in RLS.
However,

the descending reticulospinal fibers originating

in both the medulla and pons project to all levels of the
spinal cord

(Carpenter,

1991, pp.

101-103),

so it is

difficult to understand how oscillations in reticular
system activity could cause a paresthesia that is
restricted only to the lower legs.

However,

the

intermittent nature of RLS and PLMS symptoms are
potentially explainable in terms of the reticular system
theory.

For example,

during inactivity and sleep,

it is

reasonable to assume that there is a reduction in afferent
input to the reticular system

(from both the sensory and
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cortical afferents).

Likewise,

during waking activity

(and perhaps during REM sleep ), these inputs should be
increased.
section,
pressure,

In addition,

as it will be noted in the next

several periodic physiologic phenomena
respiration,

(blood

and cortical arousal oscillations)

have been shown to have a period similar to that of PLMs
(20 to 40 seconds),

and all of these phenomena could

potentially be caused by oscillations in reticular system
activity.

Despite this,

it is difficult to understand how

the reticular system could directly cause PLMs,

especially

if it is correct that these movements are in fact Babinski
responses

(which are caused by damage to the corticospinal

tracts rather than the reticulospinal t r a c t s ) .

The

prevalence data are also potentially explainable in terms
of the reticular system theory.

Because most of these

conditions have been associated with anemia or impaired
oxygen transport secondary to impaired circulation,

it is

reasonable to assume that patients with many of these
conditions may have altered levels of blood gases.
Moreover,

most brainstem neurons,

including those of the

reticular system are very sensitive to changes in blood
gases

(Dell,

1958; Jiang and Haddad,

1992) .

Thus, it is

possible that many patients with secondary RLS might have
alterations in blood gases,

and consequently,

reticular
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system activity levels.

The treatment data,

however,

are

somewhat difficult to explain in terms of the reticular
system theory.
(opioids,

Many of the drugs effective in RLS

benzodiazepines,

anti-convulsants) have well

known depressant effects on the CNS,

while dopamine

agonists generally exert an arousing effect on the
cerebral cortex and basal ganglia
pp. 240-241) .
on cortical

(Edvinsson et al.,

1993,

Given the opposing effects of these drugs

(and reticular system)

arousal levels,

it is

difficult to understand how they could all exert a
therapeutic effect on RLS and PLMS via a reticular system
mechanism.

In summary,

the reticular s ystem theory can

possibly explain some of the features of RLS and PLMS
(especially the intermittent nature of the symptoms) , but
it is difficult to explain other features of the two
disorders,

particularly the anatomical distribution of

paresthesias in RLS,
Smith

(1985)

in terms of this theory.

proposed that PLMs were spontaneously

occurring Babinski responses,

and he suggested that they

occurred during sleep because of a sleep-related reduction
in descending pyramidal tract activity.
suggestions,

Apart from these

Smith did little else in the way of

attempting to integrate his theory with other theories of
RLS and PLMS.

He also did not attempt to explain how RLS
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and PLMS might be related,

and why some persons have these

conditions while others do not.
cortical activity,
pyramidal tracts,
sleep,

Moreover,

because

and descending inhibition from the
is at its lowest level during slow wave

his theory is at odds with the data reviewed above

which has shown that PLMs are most common in sleep stages
1 and 2.

Despite this, Smith's observation that PLMs

appear similar to the Babinski response was an important
one, and it is generally well accepted.
In summary,

none of the major theories of RLS and

PLMS appears to be able to explain all of the wellestablished features of either disorder.

The feature that

appears to be the most difficult to explain is the
localization of the paresthesias in RLS to the lower legs,
excluding the feet.
Before turning to a detailed description of the
periodic cerebral ischemia theory of RLS and PLMS,

it will

first be necessary to review the literature on a number of
periodic physiologic phenomena that have been shown to
have the same periodicity as PLMs.

It will also be

necessary to present a selected review of several general
principles related to the control of cerebral blood flow.
The next two sections are devoted to a review of these two
to p i c s .
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Mayer Waves,

B Waves,

and Other Periodic Phenomena

Maver Waves and Traube-Herinq Waves
Mayer waves and Traube-Hering waves are both periodic
oscillations of systemic blood pressure levels.
case of Traube-Hering waves,

In the

the oscillations are

synchronous with respiration,

with one cycle of blood

pressure oscillation occurring during each respiration.
Traube-Hering waves are also known as second order blood
pressure waves

(first order waves are blood pressure

oscillations associated with each heartb e at ).

Mayer waves

are slower oscillations of blood pressure with a period of
between 20 and 40 seconds in humans,
than this in cats and dogs.

and slightly less

Mayer waves are also known as

third order blood pressure w a v e s .

Both Mayer waves and

Traube-Hering waves are vasomotor in origin; that is,

they

are caused by periodic vasoconstriction and vasodilation.
Electrophysiologic studies have shown that the periodic
vasomotor activity is synchronous with single unit
activity in sympathetic vasoconstrictor fibers
1984;

Preiss and Polosa,

1974),

(Polosa,

so it is generally

accepted that the vasomotor oscillations have a neural
rather than humoral or paracrine origin

(for example,

they

are not caused by periodic release of endothelium-derived
relaxing f a c t o r ) .

Mayer waves have also been shown to be
77
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accompanied by corresponding oscillations of blood flow
volume,

although the exact relationship is dependent on

which vascular bed is studied

(Killip,

1962).

Killip

found that during the systemic blood pressure peaks,
flow in the aorta,

muscles,

blood

and intestines was decreased,

while blood flow in the skin and renal arteries was
increased.
Traube-Hering waves are thought to be present
continuously

(Andersson,

Kenney,

and Neil,

1950; Koepchen,

1984), while Mayer waves are most commonly observed after
an animal has had some sort of insult to the circulatory
system

(e.g. hemorrhage;

Koepchen,

1984).

Mayer waves are

somewhat difficult to produce experimentally,
several methods

(e.g. hemorrhage,

carotid artery occlusion,
acidosis)
animals

although

complete or partial

hypobaric ischemia, metabolic

can produce them reliably in experimental

(Andersson et al.,
Polosa,

1950;

Ferretti et al.,

1984b; Ueda et al.,

1965;

Miyakawa,

1984;

1984).

In

addition,

it has also been shown that Mayer waves can be

elicited in spinal animals by increasing the CSF pressure
in the subarachnoid space
1970).

In humans,

(Kaminski,

Meyer, and Winter,

Mayer waves have been recorded in

patients with raised intracranial pressure and in normal
subjects during sleep

(Hayashi et al,

1984; Lugaresi et
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al,

1972).

Traube-Hering and Mayer waves are usually

recorded from the femoral artery,

but they have also been

recorded in foot and pulmonary arteries
1965; Hayashi et al.,

1984),

(Ferretti et al,

so it is likely that they

occur throughout the peripheral vasculature.

Oscillations

of cerebral blood flow similar to and synchronous with
peripheral Mayer waves have also been reported
et a l ., 1986;

(Einhaupl

these are referred to as B-waves,

and will

be described in detail in the next s e c t i o n ) .
The amplitude of Traube-Hering waves is generally
relatively small(e.g.

about five to fifteen percent of the

mean systemic pressure;
1969; Cherniak,

Cherniak,

Heymann,

Edelmann,

and Chisholm,

and Fishman,

1967),

while the

amplitude of Mayer waves is much larger and more variable.
For example,

in hemorrhaged animals

carotid artery occlusion)

(with or without

Mayer wave amplitudes of 25% to

80% of the m ea n arterial pressure have been reported
(Andersson et al.,
1962).
(1972)

1950; Cherniak et al.,

1969; Killip,

In the human subjects studied by Lugaresi et al.
the Ma ye r waves recorded during sleep had

amplitudes ranging from 15 to 20 m m Hg

(mean blood

pressure values were not r e p or te d) .
Several studies in experimental animals have found
that the procedures used to produce Mayer waves also
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produced periodic breathing that was synchronous with the
blood pressure waves

(Andersson et al.,

1962;

and Polosa,

Preiss,

Iscoe,

1975).

1950; Killip,
This pattern of

periodic breathing was characterized by a waxing and
waning of tidal volume without actual apnea.
no periods of apnea were present,

Even though

the waxing and waning of

tidal volume was quite similar to that seen in CheyneStokes breathing.

The nadir of the tidal volume in these

experiments was synchronous with the nadir of blood
pressure;

thus,

the two oscillations were in phase with

each other.
Both Traube

(1865)

and Hering

(1869) proposed that

blood pressure oscillations they observed were caused by
an irradiation of excitation from medullary respiratory
centers to medullary vasomotor centers.

The finding that

phenoxybenzamine administration abolishes Traube-Hering
waves

(Cherniak et al.,

1969)

vasomotor origin for the waves

is consistent with a
(as opposed to a fluid

mechanics o r i g i n ) , and indirectly supports the original
theories of Traube and Hering.
In his historical review of the literature,
(1984) pointed out that Mayer

(1876)

Koepchen

believed he had

observed waves that were essentially the same as those
reported by Traube and Hering despite the fact that they
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were not synchronous with respiration.

Other authors in

the first half of this century disputed this,
that there were clearly two types of waves:

and showed
one type that

was synchronous with each respiration and since referred
to as Traube-Hering waves,

and one type with a longer

period since referred to as Mayer waves
1984,

(see Koepchen,

for a review of this early literature).

1950s,

1960s,

and 1970s,

In the

a number of studies were reported

in which efforts were undertaken to determine the cause of
the slower 20 to 40 second vasomotor oscillation.
on those studies,

two theories,

and central oscillator theories,

Based

the peripheral feedback
have emerged

(Polosa,

1984).
Andersson et al.,

(1959)

used hemorrhage combined

with either unilateral or bilateral carotid artery
occlusion to produce Mayer waves in cats.

Because the

waves could be abolished by either cooling or sectioning
the vagus and carotid sinus nerves, Andersson et al.
concluded that peripheral feedback from the chemoreceptors
and baroreceptors was the source of the oscillations.

In

addition, because the mean systemic pressure in their
animals was quite low

(40 to 70 mm H g ) , they concluded

that afferent information from the chemoreceptors was more
important than that from the baroreceptors.

Guyton and
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Harris

(1951)

performed experiments in which the

baroreceptors were selectively denervated.

This procedure

either abolished or greatly reduced the amplitude of the
Mayer waves,

leading these authors to conclude that

afferent feedback from the baroreceptors was more
important than the feedback from the chemoreceptors.
Armstrong and Irby

(1962)

used intra-arterial injections

of acetic acid to destroy the carotid and aortic
chemoreceptors,

and found that Mayer waves persisted

following this manipulation.

When both the chemoreceptors

and baroreceptors were destroyed,

no Mayer waves could be

elicited.

(1951), Armstrong and

Like Guyton and Harris

Irby also concluded that the baroreceptors were more
important than chemoreceptors in producing Mayer waves.
In contrast to the findings by Armstrong and Irby

(1962),

two groups of researchers found that Mayer waves could
persist after total denervation of the peripheral
chemoreceptors and baroreceptors
Ferretti et al.,
in amplitude.

(Cherniak et al.,

1969;

1965), although they were often reduced

This suggested one of two possibilities;

first, central chemoreceptors might be generating periodic
excitation of the vasomotor centers;

or second,

a central

oscillator might be providing periodic excitation to the
vasomotor centers independent of the sensory input from
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the chemoreceptors and baroreceptors.
experiments done by Ferretti et al.
first possibility was correct.

One of the

suggested that the

In this experiment,

injections of dilute hydrochloric acid were used to
produce metabolic acidosis of sufficient intensity to
cause Mayer waves in dogs that had undergone complete
denervation of the chemoreceptors and baroreceptors.
Subsequent injection of a buffer solution eliminated the
Mayer waves.

A later study by Preiss et al.

(1975)

found

evidence which strongly suggested that a central
oscillator was generating the Mayer waves.

In this study,

sympathetic nerve activity was found to be synchronous
with the blood pressure o s c i ll a ti on s.

This sympathetic

nerve activity persisted after several manipulations
designed to eliminate rhythmic sensory input from both
central and peripheral chemoreceptors and
baroreceptors.

(peripheral)

These manipulations included simultaneous

artificial ventilation to maintain constant blood gas
levels,

chemoreceptor and baroreceptor denervation,

and

alpha adrenergic blockage to eliminate the actual
vasomotor oscillations.

In other animals,

the vasomotor

oscillations were eliminated by connecting a pressure
stabilizing device to the animals'

aorta.

The persistence

of periodic sympathetic activity in spite of all these
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manipulations

indicated that although peripheral afferent

mechanisms may have initially triggered the waves

(the

waves were produced by hemorrhage), they were not needed
to maintain the periodic sympathetic output once the
circulatory insult had occurred.

The results of all of

these experiments can be summarized by noting that there
is evidence to support both the peripheral and central
theo ri es .
In spite of all this work,

there is no clear

consensus among researchers on how important the various
central and peripheral mechanisms are in the generation of
Mayer waves.

Moreover,

although there is some evidence to

indicate that a central oscillator does exist,
anatomical location remains obscure.
and Lambertz
others,

(1984)

its precise

Langhorst,

and Lugaresi et al.

Schulz,

(1972), among many

have argued that the brainstem reticular formation

represents this central oscillator.

Unfortunately,

there

is little direct experimental evidence that reticular
neurons have periodic oscillations in their firing rates
with periods similar to those of Mayer waves.
example,

Langhorst et al.

(1984)

For

recorded the spontaneous

activity of m edullary reticular neurons,

and although some

neurons with periodic firing were found,

their period

durations were usually about six seconds

(this was twice
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the respiration rate).

It should be noted that Mayer

waves were not observed in their animals,

nor was there

any attempt to generate them experimentally.
Steriade

(1982)

Oakson and

found oscillations in the firing rates of

mesencephalic reticular neurons with periods varying
between eight to twelve seconds
minute).

(5 to 7.5 waves per

Of interest was the finding that these

oscillations appeared only during quiet waking
wakefulness without movement)

(i.e.

and non-REM sleep.

Other

investigators who have studied the firing rates of
brainstem reticular neurons during the sleep-wake cycle
have not found such oscillations
1972; Vertes,

1979),

(Manohar,

Noda,

and Adey,

although it is likely that

methodological differences between these studies and that
of Oakson and Steriade
findings

(1982)

account for the negative

(see Oakson and Steriade,

1982,

the pertinent methodological issues) .

for a review of

Despite this,

it is

worth emphasizing that oscillations of reticular neuron
firing rates with periods longer than about 12 seconds
have not been reported.
Another approach to studying firing rate rhythmicity
was employed by Corner and Crain

(1972).

These

investigators studied single unit activity of medullary
neurons in slices of fetal tissue

(from rodents)
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maintained in vitro.

The advantage of this technique was

that the neurons studied were isolated from peripheral
(i.e. chemoreceptor and bar or ec ep t or ) afferent input.
About half of the neurons studied by these investigators
showed periodicity in their firing.

The majority of these

neurons had active and inactive phases of approximately
equal length,

with the length of the total cycle varying

between 1.0 and 5.0 minutes.

Shorter period durations

(always less than two minutes)

were seen in two other

periodically firing neurons in which the active phase was
much shorter than the inactive phase.

Unfortunately,

the

total number of neurons studied in this experiment was low
(n = 39),

and no detailed information on the anatomical

location of the periodic neurons was provided.

A more

recent in vitro study of medullary neurons by Bingmann,
Baker,

and Ballantyne

activity,

(1991)

also found periodic neuronal

but the mean period duration of these neurons

was 2.7 seconds

(the range was 0.5 to 10 se c o n d s ) .

These

authors noted that periodicity was not confined to any one
anatomic region.

They also suggested that the 2.7 second

periodicity reflected the activity of respiratory-related
neurons.

In summary,

these is very little direct

experimental evidence to support the idea that neurons in
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the reticular system have an intrinsic slow oscillation in
their firing rates.
Still other work has shown that pharmacologic
depression of the ventrolateral

surface of the medulla

(the central chemosensitive area)

with lidocaine and

benzodiazepines can abolish Mayer waves produced by
hypoxia or hypercapnia
Cherniak,

1989).

(Haxhiu,

Van Lunteren,

Deal,

and

Other investigators have demonstrated

that lesions of the area postrema in the dorsal medulla
can also abolish Mayer waves
Ferrario,

(1970)

Barnes,

and

1987) .

Finally,
al.

(Pollick,

as mentioned earlier,

a study by Kaminski et

found that Mayer waves could be produced in

spinal animals by increasing the subarachnoid CSF
pressure.

Kaminski et al.

suggested that the increased

pressure produced local spinal ischemia and a resulting
excitation
neurons.

(and vasopressor response)

of sympathetic

They suggested that the resulting increased

blood pressure improved spinal perfusion which then led to
a decrease in sympathetic output and further oscillations
of the system.

The data from this study clearly indicate

that spinal sympathetic vasomotor neurons are capable of
periodic oscillations irrespective of their supraspinal
afferent input.

The issue of whether or not this
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oscillation is due to a feedback mechanism or an
endogenous periodicity in these neurons remains
unresolved.
B Waves
The term "B wave" was introduced by Lundberg
to refer to oscillations of intracranial pressure

(1960)
(ICP)

with a frequency ranging from .5 to 2 per minute.
1960 study,

In his

Lundberg reported on his experience with

continuous monitoring of ICP, and drainage of
cerebrospinal fluid

(CSF) to control this pressure,

large sample of patients.

These techniques were just

coming into widespread clinical use at that time.
report,

in a

In his

Lundberg described three types of oscillations or

short term increases in ICP.
to these as A, B,

Lundberg initially referred

and C waves,

and although he also

proposed more descriptive names
minute waves,

(plateau waves,

and six-per-minute waves,

one-per-

respectively),

term "B wave" has persisted in the literature.

the

A-waves

were large increases in ICP levels which usually lasted
from five to twenty minutes.

These were often accompanied

by adverse neurological con se qu en ce s .
earlier,

As mentioned

B waves were ICP oscillations of variable

amplitude which had a period ranging from about 30 seconds
to about two minutes.

In Lundberg's sample of patients
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with intracranial hypertension,
one minute predominated.

periods of approximately

C waves were relatively low

amplitude ICP oscillations which occurred at a frequency
of approximately six waves per minute.
and B waves,

In contrast to A

C waves were observed only infrequently.

Two important observations with respect to B waves
were pointed out by Lundberg

(1960).

First,

the waves

occurred most commonly during natural sleep and during
periods of impaired consciousness,
Second,

like Mayer waves,

stupor,

and coma.

B waves were frequently

accompanied by Cheyne-Stokes respiration or periodic
breathing,
volume)

with the periods of apnea

(or decreased tidal

occurring in phase with the low pressure points of

the ICP tracing.

Although the association of B waves and

periodic breathing was common,

B wave activity was also

noted in some patients who were artificially ventilated.
More recent studies have confirmed that B-waves may occur
both with

(Einhaupl et al.,

and without
Stooss,

1986; Hashimoto et al.,

(Einhaupl et al.,

and Reulen,

1986; Newell,

1989)

Aaslid,

1992) Cheyne-Stokes respiration or

periodic breathing.
Lundberg

(1960) proposed that both B and C waves were

caused by oscillations of cerebral blood flow which led to
corresponding oscillations of cerebral blood volume.
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suggested that B waves were caused by periodic
vasodilation and vasoconstriction which occurred because
of the oscillating blood gas levels produced by the
Cheyne-Stokes respiration.
that some authors

(e.g.

However,

Lundberg also noted

Hoff and Breckenridge,

1954)

believed that Cheyne-Stokes respiration was due to an
intrinsic brain stem rhythm,

and he suggested that a

similar rhythm affecting the vasomotor center might be
responsible for generating the B waves that were observed
in patients who were artificially ventilated.
respect to the C waves,

With

Lundberg suggested that these were

caused by oscillations of blood flow due to Traube-Hering
waves

(which he incorrectly referred to as Traube-Hering-

Mayer w a v e s ) .

It should be pointed out that in the

original studies by Traube

(1865)

and Hering

(1869)

the

blood pressure waves that were observed had a frequency of
about six per minute.
historically,

It should also be noted that

the terms Traube-Hering waves and Mayer

waves have often been used interchangeably;

apparently

because many researchers were not aware of the literature
showing that these were two distinct phenomena
1984).

(Koepchen,

Although the predominant B wave frequency in

Lundberg's patients was about one per minute,

Lundberg did

note that waves with frequencies in between those of B and
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C waves

(i.e. waves with frequencies between 2 and 4 per

minute)

sometimes occurred.

Alth ou gh Lundberg's proposal that B and C waves were
caused by oscillations in cerebral blood volume was
generally well accepted,

direct evidence to support this

theory wasn't obtained until Auer and Sayama

(1983)

showed

that B waves in experimental animals were accompanied by
synchronous vasodilation and vasoconstriction of cerebral
(pial)

arteries.

Other more recent studies have shown that blood flow
velocity in the middle cerebral artery
transcranial Doppler sonography)

(as assessed by

shows oscillations that

are synchronous with the B waves seen in the ICP tracing
(Droste an d Krauss,
Ozaki,

Hara,

1993; Mautner et al.,

and Mogami,

1989; Nakatani,

1989; Newell et al.,

1992).

These oscillations are in phase with each other,
increased flow velocity

with

(and total blood flow volume)

occurring during the periods of increased ICP.

A number

of researchers have used transcranial Doppler sonography
(alone)

to investigate whether or not similar oscillations

of blood flow velocity occur in normal subjects.

These

studies have shown that B wave-like oscillations in blood
flow velocity occur in the majority of subjects studied in
both wakefulness

(Mautner et al.,

1989;

Diehl,
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Sitzer,

and Hennerici,

Berger,

Schuler,

1991)

and Krauss,

and during sleep
1993) .

et al. studied 20 normal subjects,
wave activity.

(Droste,

For example,

and found that

Mautner
16 had B

The mean amplitude of the B waves in these

subjects was 9.2% of the mean blood flow velocity.
subjects,

In two

amplitudes representing 19 and 21 percent of the

mean flow velocity were found.

Diehl et al.

found mean B

wave amplitudes of up to 30% of the mean flow velocity in
the normal subjects they studied; and in addition,

they

reported that the amplitude of these B waves was
significantly higher in a group of older subjects with a
mean age of 70.0 years than a group of younger subjects
with a mean age of 26.2 years
subjects studied).

(B waves were found in all

Diehl et al. did not report group

means for the period of the B waves in their normal
subjects,

but they did note that all subjects had B wave

periods similar to one normal subject whose spectral
analysis showed two B wave peaks representing periods of
37 and 150 seconds.

Droste et al.

(1993)

found B wave

periods during sleep which ranged from 20 to 75 seconds,
and like Diehl et al., they also found that some subjects
had two B wave peaks in their spectral analyses.
example,

For

one subject whose data was presented graphically

had B wave period peaks at 25 and 45 seconds.
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Several studies have simultaneously monitored both
ICP and systemic blood pressure in an attempt to determine
if B waves occur synchronously with Mayer waves.
et al.

(1984)

Hayashi

found that B waves and Mayer waves

from the femoral or foot arteries)
and in phase with each other

(recorded

occurred synchronously

(i.e. the peak of ICP

occurred at the same time as the peak in systemic blood
pressure)

in most of their patients who had intracranial

hypertension.

Patients who were in terminal stages often

had ICP B waves without any corresponding oscillations of
systemic blood pressure.

Newell et al.

(1992)

studied 20

patients with intracranial hypertension secondary to head
injury,

and found that B wave activity in the ICP and

transcranial Doppler recordings was generally not
accompanied by Mayer waves in the systemic blood pressure
recordings.

When both Mayer and B waves did occur,

were in phase with each other.

Einhaupl et al.

they

(1986)

found that B waves and Mayer waves occurred in phase with
each other 78% of the time in patients who had CheyneStokes respiration and 72% of the time in patients who did
not have Cheyne-Stokes respiration.

Thus,

B waves and

Mayer waves were out of phase with each other about one
fifth of the time in their patients.
(1989)

Hashimoto et al.

found that B waves and Mayer waves occurred
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synchronously and in phase with each other in 20 patients
with raised ICP.

They also noted that the B wave peak

occurred shortly before the Mayer wave peak
seconds).

(by a few

The recording site used for monitoring systemic

blood pres su re was not specified in their report.
In contrast to these studies in human patients,
Higashi et al.

(1989)

found that B waves and Mayer waves

did not occur in phase with each other in cats whose ICP
was raised by infusion of moc k CSF.

The two waves were

approximately 180 degrees out of phase

(i.e. the B wave

peaks corresponded to the Mayer wave troughs).

This

relationship was reversed only when the ICP was raised to
the level of the systemic blood pressure.

Simultaneous

recording of unit activity from sympathetic nerves showed
that distinct oscillations synchronous with the Mayer
waves were present only during the experiments where the
ICP was raised to match the systemic blood pressure.

In

these experiments the peaks of the sympathetic nerve
discharge were synchronous with the troughs of the
systemic blood pressure.

This relationship was identical

to that observed by Preiss and Polosa

(1974)

for Mayer

waves p r o d uc ed by hemorrhage and carotid artery occlusion
in cats.

When Higashi et al.

cervical sympathectomy

performed a bilateral

(i.e. the sympathetic innervation
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to the cerebral vasculature was removed), the B waves
persisted.

This finding led Higashi et al. to suggest

that an intrinsic noradrenergic pathway contained entirely
within the brain mediated the B wave activity.
findings,

These

taken together with those showing that B waves

can occur in humans in the absence of Mayer waves,

provide

convincing evidence that neural pathways intrinsic to the
brain may mediate the vasomotor oscillations that cause B
waves.

Reis

(1984)

brainstem nuclei,

reviewed evidence that several

including the dorsal medullary reticular

formation and parabrachial nuclei in the pons,
potent influences on cerebral blood flow.

can exert

Thus,

it seems

quite possible that separate neural pathways may mediate B
waves and Mayer waves under at least some circumstances.
The research reviewed above has been conducted
primarily by investigators whose main research interest
was the study of intracranial hypertension in human
patients.

A separate line of work in experimental animals

and humans was conducted in the late 1950s and the 1960s
in which intracerebral electrodes were used to monitor
oxygen availability and blood flow levels.
Misrahy,

and Fox

(1958)

Clark,

conducted one of the earliest of

these studies in experimental animals.

Using chronically

implanted platinum electrodes through which a small
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electrical current was passed
electrodes),

(i.e. polarographic

these researchers found oscillations of

oxygen availability with a frequency of about six waves
per minute and an amplitude of up to 30 percent of mean
oxygen levels in unanesthetized cats.

Waves recorded from

several different sites in the same animal were usually
not synchronous with each other.

Moreover,

the waves did

not correspond to any observed oscillations in heart rate,
respiration,

or systemic blood pressure;

not Traube-Hering waves.

thus,

they were

Similar waves with a frequency

of about six per minute were observed in human psychiatric
and epileptic patients in a series of studies by a group
of researchers in England

(Cooper, Crow,

Winter,

Cooper,

1966; Moskalenko,

Walter and Crow,

1964).

Crow,

Walter,

and

and Walter,

1964;

The psychiatric patients studied

by these workers were undergoing electrolytic frontal
leucotomy,

while the epileptic patients had the electrodes

implanted for the purpose of identifying seizure foci.
addition to the six per minute waves in these patients,
some of the figures presented by Cooper et al.

(1966)

appear to show slower waves with a period of about 50
seconds
al.,

(for example,

1966).

see Figure 2, p. 178, of Cooper et

A later reanalysis of this data using

spectral analysis showed that slower waves with a period
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similar to that of B waves were indeed present in these
subjects
(1966)

(Moskalenko,

1980, p.

122).

Cooper and Hulme

also implanted polarographic electrodes in a sample

of 24 patients who were undergoing continuous monitoring
of intracranial pressure.
both A and B waves,
during sleep.
REM sleep.

Like Lundberg,

they observed

and noted that both were more common

The A waves occurred most commonly during

The most important finding pertinent to this

review is that the B waves were accompanied by synchronous
oscillations of oxygen availability
1966,

Figure 5, p. 567).

(see Cooper and Hulme,

In these instances,

the peaks of

ICP were associated with decreases in oxygen availability;
thus,

the two waves were approximately 180 degrees out of

phase.

In a later report,

Cooper and Hulme

(1968) showed

that the ICP peaks which occurred during the B waves were
also accompanied by bursts of slow wave activity in the
EEG.
In summary,

patients with intracranial hypertension

frequently show oscillations of intracranial pressure
which have a frequency ranging from .5 to 2 per minute.
These so-called "B waves" are caused by oscillations of
cerebral blood flow, and are more common during sleep than
during wakefulness.
blood flow

(velocity)

Similar oscillations of cerebral
have been documented in normal human
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subjects,

and the amplitude of these waves has been shown

to be larger in older subjects

(Diehl et al.,

patients with intracranial hypertension,
often accompanied by Mayer waves,
respiration or periodic breathing,
slow wave activity in the EEG.

1991).

In

these B waves are

Cheyne-Stokes
and periodic bursts of

The synchronous occurrence

of these phenomena suggests that they may all be caused by
an intrinsic b r a in s te m rhythm.
In November,
Krauss,

Hagedorn,

1996 a study was published by Droste,
and Kaps

(1996)

in which B-waves of

cerebral blood flow velocity were documented in four
patients with P L M S .

In this study it was found that the

flow velocity values were significantly higher at the
moment the PLMs occurred than during the interval between
PLMs.

Droste et al.

concluded that B-waves and related

oscillations in EEG activity

(cyclic alternating pattern)

were part of a common endogenous rhythm,

and they further

postulated that PLMs were an epiphenomenon of this rhythm.
They did not elaborate on this,
B-waves might cause PLMs,

nor did they suggest that

either directly or indirectly

(e.g. by producing cerebral ischemia).

This study is

important because it provides the only direct evidence
obtained thus far that abnormalities in cerebral blood
flow

(i.e. B-waves)

are present in patients with PLMS.
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The finding by Droste et al.

(1996)

that flow

velocity was higher at the moment the PLMs occurred
deserves additional comment.

Previous work has shown that

B-waves in flow velocity and intracranial pressure are in
phase with one another
et al.,
Hulme

(Droste and Krauss,

1989; Newell et al.,

(1966)

1992).

1993; Mautner

However,

Cooper and

found that B-waves in oxygen availability and

intracranial pressure were 180 degrees out of phase

(i.e.

oxygen availability was low when intracranial pressure was
high).

Based on these studies,

it is reasonable to assume

that cerebral oxygen levels are lowest when blood flow
velocity is highest.

This also makes sense when one

considers that low oxygen
vasodilators,
blood flow,

(and high C02) are potent

and vasodilation lowers the resistance to

resulting in an increase in flow velocity.

Thus, based on the data reported by Droste et al.

(1996)

it is reasonable to assume that PLMs occurred in their
patients when cerebral oxygen levels were low.
be noted though,

that Cooper and Hulme

psychiatric and epileptic patients;

(1966)

thus,

It should
studied

it is unclear if

their results are generalizable to normal subjects.
Chevne-Stokes Respiration and Periodic Breathing
Cheyne-Stokes respiration

(CSR)

is a form of periodic

breathing in which short periods of respiration alternate
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with short periods of apnea

(the total cycle duration

varies from 0.5 to 1.5 minutes).
present,

When respirations are

a characteristic waxing and waning of tidal

volume is seen.

Although the term periodic breathing has

been used to refer to several forms of abnormal breathing
(including central sleep apnea),

it is most commonly used

to refer to a pattern of respiration that is similar to
CSR, but without periods of apnea

(i.e. only a slow waxing

and waning of tidal volume is o b s e r v e d ) .

The original

descriptions of these forms of abnormal respiration are
attributed to Cheyne

(1818) and Stokes

(1854).

A large

number of studies investigating CSR have appeared since
these early studies,

and several excellent reviews of the

CSR literature are available
Dowell, Buckley,
and Snyder,

Cohen,

1984).

(Brown and Plum,

Whalen, and Sieker,

1961;

1971; Tobin

The following review draws heavily

from these sources.
Cheyne-Stokes respiration is seen clinically in
several diseases.

These include heart disease

congestive heart failure),

(including

neurological disease

(including

intracranial hypertension and bilateral cortical damage),
and uremia.

Cheyne-Stokes respiration is also seen in

premature infants and in normal human subjects undergoing
acclimatization to high altitude.

Cheyne-Stokes
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respiration is often augmented during sleep,

and periodic

breathing of variable amplitude and duration is seen many
normal subjects during sleep, especially near sleep onset
(Robin, Whaley,

Crump,

and Travis,

1958;

Bulow,

1963).

Most patients with CSR have both heart disease and
neurological disease;
of these is present

however,

CSR may occur if only one

(Brown and Plum,

1961).

Historically,

the importance of heart disease versus neurological
disease in the pathogenesis of CSR has been controversial.
Stokes

(1854) believed that CSR was always associated with

heart disease.

Heart disease is thought to cause CSR

primarily by prolonging the lung to medullary
chemoreceptor circulation times
Brown and Plum

(1961)

(Dowell et al.,

1971).

described the clinical

characteristics of CSR in detail in a sample of 28
patients.
disease,

All 28 of their patients had neurological
while only 23 had heart disease.

This finding

led Brown and Plum to conclude that neurological disease
was necessary for CSR to occur.

Brown and Plum also found

that their patients had average C02 levels that were lower
than normal

(i.e. respiratory alkalosis),

and had

ventilatory responses to C02 administration that were
three times higher than those seen in normal subjects.
They concluded that CSR was a pattern of "neurogenic
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hyperpnea in which intense hyperventilation alternates
with posthyperventilation apnea"
859).

(Brown and Plum,

1961;

p.

They further suggested that the supramedullary

neurological damage in their subjects was the source of
the increased sensitivity to C0 2.

This idea that

neurological damage in CSR patients could produce an
increased sensitivity of the medullary respiratory centers
with subsequent hyperventilation had been suggested by
several earlier workers,

including Jackson

(1895).

This

is in contrast to the opinion expressed by Hoff and
Breckenridge

(1954)

that the neurologic damage in CSR

released an intrinsic brainstem rhythm,

which then

resulted in a periodic activation of the medullary
respiratory center.
A number of physiologic parameters alternate with
respiration during CSR.
C 0 2 levels are highest

With respect to blood gas levels,
(and 0 2 levels are lowest)

the hyperventilation phase
Snyder,

1984).

(Dowell et al.,

during

1971; Tobin and

The pupils usually dilate during the

hyperpneic phase and constrict during the apneic phase;
this reflects the predominant autonomic activity during
each phase.

In their 1971 review,

Dowell et al. reported

that the EEG is characterized by predominately fast
activity during the hyperpneic phase and slow activity
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during the apneic phase.

Similarly,

usually awake and responsive
the hyperpneic phase,

(and often agitated)

and confused,

somnolent during the apneic phase
In patients with CSR,

CSR patients are

stuporous,

during

and/or

(Dowell et al.,

1971).

improvement in the underlying

cardiac or neurological disease often eliminates the CSR,
so the abnormal respiration itself is usually not treated.
However,

CSR can be eliminated with either respiratory

stimulants,

or by having the patient breath gas mixtures

containing higher than normal amounts of either 0 2 or C02
(Dowell et al.,

1971; Tobin and Snyder,

In the 1950s and 1960s,
computer models of CSR

1984).

several mathematical and

(and normal respiration)

were

developed in an effort to understand the causes of CSR.
The first of these models,
Schroeder,

Norins,

developed by Grodins,

and Jones

Gray,

(1954), was an attempt to

model the normal respiratory response to hypercapnia.
This model used tissue C02 (rather than arterial C02) as
the variable sensed by the respiratory controller.

This

model assumed that the sensor for C02 was the medullary
respiratory center

(i.e., peripheral chemoreceptors were

neglected), and also assumed that circulation time was
infinitely short

(i.e.,

zero).

derived by Grodins et al.

The mathematical equations

(1954) were used in simulations
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of the ventilatory response to C02 administration,

and the

results obtained were in good agreement with available
physiologic data from human subjects.

This model was used

a starting point by later investigators who attempted to
model CSR.
Millhorn and Guyton

(1965) were to first to develop a

computer model of the respiratory system in which CSR
could be produced.

In their model CSR could only be

produced if either the arterial circulation time or the
controller gain was manipulated.

The "controller gain"

refers to the amplitude of the ventilatory response
CO; for e x a m p l e ) .

(to

Increases in this variable could be

mediated physiologically by either respiratory motor
neurons or sensory neurons which monitor blood gas levels.
Millhorn and Guyton found that their model could produce
sustained CSR if the circulation time was increased to
three and half minutes or if the controller gain was
increased to 13 times its normal value.

Both of these

values were obviously larger than those that were likely
to be occurring in CSR patients,

a problem which suggested

inadequacies in their model.
Longobardo,

Cherniack,

and Fishman

(1966) presented a

model similar to that of Millhorn and Guyton

(1965),

found that CSR could be induced in this model under
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conditions similar to those in which it occurred
physiologically
normals,

(e.g. sustained hyperventilation in

congestive heart failure,

neurologic disorders,

and altitude ac cl i matization).

However,

in the simulation

of hyperventilation in normals,

the model had to be

hyperventilated to a very low arterial C0 2 value of 14 mm
Hg before CSR occurred,

and in the simulated congestive

heart failure condition

(simulated by increasing the

circulation time and decreasing the cardiac o u t p u t ) , the
model also had to be hyperventilated before CS R occurred.
Overall,

the results were similar to those obtained by

Millhorn and Guyton in that the model showed that there
were only two types of CSR,
circulation times,
sensitivity.

and one caused by abnormal C02

It should be pointed out that neither of

these two models
al.,

one caused by abnormal

(Millhorn and Guyton,

1965;

Longobardo et

1966)

included peripheral ch emoreceptors.

Khoo,

Kronauer,

Strohl,

and Slutsky

(1982)

presented

a model which included peripheral chemoreceptors, and
which was also based on different mathematics than the
earlier models presented above.

The peripheral

(carotid)

chemoreceptors in this model were designed to respond to
arterial 0 2 levels.

CSR could be produced in this model

by a combination of relatively mild hypoxia and
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hypercapnia,
sleep.

similar to that seen in many subjects during

The model also produced CSR when cardiac and

neurological disease were simulated with abnormally long
circulation times and abnormal controller gains
respectively.

Overall,

the results indicated that the

peripheral chemoreceptor input was relatively important in
mediating CSR.

In addition,

the deviations in model

parameters needed to produce CSR were much closer to those
known to be present in actual CSR patients.
It should be poin te d out that in none of the three
models presented above was it necessary to include
external oscillatory input
to produce CSR.

(i.e. a brainstem oscillator)

CSR was produced in these models by

directly manipulating the parameters of the respiratory
system alone

(sensors,

output units,

obtained from these models
of Hoff and Breckenridege

etc).

Thus,

the data

is inconsistent with the idea
(1954) that CSR is caused by

disinhibition or release of an intrinsic brainstem rhythm.
Cyclic Alternating Pattern
Cyclic alternating pattern
Terzano, Mancia,

Calzetti,

(CAP)

Zachetti,

is a term coined by
and Maione

(1981)

to

refer to oscillations in EEG activity occurring in coma
and natural sleep.

These oscillations have a period which

averages about 40 seconds in normal subjects

(Terzano and
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Parrino,

1993).

by Terzano,

According to the scoring system developed

CAP cycles are divided into two phases;

Phase

A reflects arousal and comprises approximately one third
of the total cycle,

and Phase B reflects decreased

arousability and comprises approximately two thirds of the
total cycle time
Parrino,

1993).

(Terzano et al.,

1985; Terzano and

The variation that is observed in the EEG

activity during CAP sequences depends on the sleep stage
(Terzano et al.,
alpha activity,

1985).

In Stage 1, Phase A consists of

while Phase B consists of the normal mixed

frequency theta background.

In Stage 2,

Phase A consists

of K complexes with associated alpha activity and alpha
arousals,

while Phase B consists of the normal Stage 2

background activity with isolated K-complexes.

In Stages

3 and 4, Phase A consists of sequences of K-complexes
and/or reactive delta waves, while Phase B consists of the
normal amount of

(randomly distributed)

CAP was not identifiable in REM sleep
1985).

In comatose patients,

delta activity.

(Terzano et al.,

Phase A is characterized by

high amplitude slow wave activity which appears similar to
the delta activity occurring during slow wave sleep.
Phase B is characterized by relatively fast medium voltage
activity

(Evans,

1976; Terzano et al.,

1981).
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Although Terzano and his colleagues have done the
most extensive work on CAP, a number of earlier
investigators had described this phenomenon in both
animals and humans.

Bonvallet,

Dell,

and Hiebel

(1954)

recorded both EEG and blood pressure in anesthetized cats
and dogs.

They observed a simultaneous oscillation of

both the EEG and blood pressure when the animals were not
being subjected to any sensory stimulation.
activation in the EEG was synchronous
the increases in blood pressure.

(i.e.

The
in phase)

with

A series of brainstem

sectioning experiments indicated that the EEG arousal was
being produced by the ascending reticular activating
system

(ARAS)

formation,

in the rostral portions of the reticular

although Bonvallet et al.

did not rule out the

possibility of a humoral origin for the EEG waves.
Similar oscillations of EEG activity during six per minute
waves in rats have been described more recently by
Golanov,

Yamamoto,

Poole

and Reis

(1994).

(1960) briefly described oscillations of EEG

activity in two patients with subacute encephalitis.

The

EEG waves were synchronous with oscillations of
respiratory activity,

but it was not stated if the

respiratory oscillations were Cheyne-Stokes respiration.
A more detailed description of EEG oscillations in
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comatose patients was provided by Evans

(1976) .

The

oscillations in these patients had a period which varied
from 0.5 to 2.0 minutes,

and they were synchronous with

oscillations in heart rate and respiration rate.

Evans

noted the similarity of the EEG oscillations he described
and the B waves described by Lundberg

(1960).

His paper

is noteworthy in that it is the only paper in which the
similarities of Mayer waves,
respiration,

B waves,

Cheyne-Stokes

and oscillations in EEG activity were

specifically discussed.

Despite this,

Evans was hesitant

to speculate on a pathogenic mechanism by which these
phenomena might be interrelated,
previous investigators

although he did note that

(including Lugaresi)

had suggested

that an intrinsic brainstem rhythm might be the source of
these phenomena.
Terzano and his colleagues first described CAP in
patients with Creutzfeldt-Jakob disease
1981),

but they subsequently found that CAP occurred in

both normal subjects

(Terzano et al.,

patients with epilepsy
Halasz,
apnea

(Terzano et al,

1989),

insomnia

(Terzano,

Parrino,

recently in PLMS
Parrino,

(Terzano,

Boselli,

1985),

Parrino,

and in

Anelli,

(Terzano and Parrino,
and Spaggiari,

(Terzano and Parrino,
Di Giovanni,

1990),

and

1992),

and most

1993; Terzano,

and Spaggiari,

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

sleep

1995).

110

Montplaisir,

Lapierre,

and LaVigne

(1994)

also described

periodic oscillations in EEG activity in RLS/PLMS
patients.

In this study,

the oscillations were observed

during both sleep and wakefulness
Immobilization test).
Montplaisir et al.

(during a Forced

Both Terzano et al.

(1994)

noted that leg movements during

sleep occurred in association with arousal,
which led Terzano et al.

(1995) and

(1995)

a finding

to propose that the

arousal phase of CAP promoted the appearance of PLMs.
However,

Montplaisir et al.

(1994)

found that leg

movements during wakefulness were associated with EEG
slowing.

This finding led Montplaisir et al. to conclude

that leg movements

in RLS and PLMS required a critical

level of cortical arousal to appear.

They further

suggested that this critical level of arousal appeared
during drowsiness in wakefulness

(as indicated by EEG

slowing), and during arousal in sleep.
was a recent study by Montplaisir,
Poirier,

and LaVigne

Also of interest

Boucher,

Gosselin,

(1996) which found that periodic K-

alpha arousals in RLS patients persisted after L-DOPA
treatment even though nocturnal leg movements had been
eliminated.

Montplaisir et al.

suggested that these data

indicated that the periodic EEG arousal

(CAP) was a

primary phenomenon in RLS patients.
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The data obtained by Terzano and colleagues on CAP in
normal subjects is noteworthy in several respects.

First,

CAP sequences occupy a significantly greater percentage of
both total sleep time and non-REM sleep time in older
subjects

(38 to 50% of NREM time)

than in younger subjects

(18 to 25% of NREM time; Terzano et al.,
Parrino,

1993).

As noted earlier,

duration is 40 seconds

38 to 39 seconds).
REM sleep.

the average cycle

(the standard deviation is

approximately 23 seconds); however,
in Stage 1 (54 seconds)

1987; Terzano and

the duration is longer

than in Stages 2, 3, and 4 (range

CAP sequences were not identifiable in

Approximately two thirds of CAP sequences

occur during the first half of the night.

The percentage

of CAP time during each sleep stage was as follows:
1 - 57%,

Stage 2 - 21%, Stage 3 - 31%,

(Terzano et al.,

1985).

similar to PLMS data

Stage

Stage 4 - 16%

Some aspects of this CAP data are

(e.g. CAP being more frequent in

older subjects and apparently not present in REM s l e e p ) ,
while others are not

(e.g. the cycle duration and sleep

stage p e r c e n t a g e s ) .
One serious problem with the definition and scoring
of CAP as developed by Terzano and his colleagues is that
arousals caused by apneas and PLMs and the subsequent
return of normal sleep EEG activity would be

(and are)

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited without p erm ission.

112

scored as CAP cycles.

Thus, based on the scoring system

developed by Terzano et al.

(1985),

no distinction is made

between spontaneous periodic arousals,

and those caused by

specific events occurring during sleep.

Both types of

arousals would be scored as Phase A of CAP sequences.
mentioned above, Montplaisir et a l . (1996)

As

found that

periodic arousals persisted in RLS patients even after leg
movements had been eliminated with L-DOPA treatment.
Although this did suggest that the arousals might be a
primary phenomena,

Montplaisir et al.

also noted that PLMs

recorded during a baseline night were associated with
arousals only 49% of the time.

Moreover,

movements were associated with arousals,

when the
the arousals

followed the leg movements 65% of the time

(indicating

that the movements generally caused the arousals).
summary,

In

the scoring of arousals associated with apneas

and PLMs as part of CAP sequences seems somewhat
questionable.

None-the-less,

CAP is one of only two

periodic phenomena discussed in this review which has
actually been documented to be associated with RLS and
PLMS

(Montplaisir et al.,

1994; Terzano et al.,

1995).

Summary and Integration
The four phenomena discussed above, Mayer waves,
waves, periodic respiration,

and cyclic alternating
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pattern are related in several important ways.
noted above,

below,

as

two or more of these phenomena often occur

simultaneously,
animals.

First,

both in human patients and in experimental

Second,

as it will be discussed in more detail

all of these phenomena are mediated by the

brainstem reticular formation.
exception of Mayer waves,

Third,

with the possible

all of these phenomena are more

likely to appear during sleep

(or in patients with

supramedullary neurological damage)

than wakefulness.

The neural centers that mediate vasomotor functions,
respiration,

and cortical arousal are all located within

the brainstem and are either coextensive with or receive
input from several nuclei of the reticular formation.

The

brainstem vasomotor centers include a pressor region which
begins rostrally in the pons
peduncles)

and ends caudally in the medulla at about the

level of cuneate nucleus
the pons,
brainstem,

(just below the cerebellar

(Gebber,

1980).

At the level of

the pressor region extends across the entire
but at the pontine/medullary junction the

depressor region begins

(it extends to caudal levels of

the me d u l l a ) , and occupies medial areas of the brainstem,
while the pressor region flanks its lateral borders
Gebber,
plane,

1980,

Figure 1, p. H144).

(see

In the dorsoventral

both regions occupy almost the entire dorsoventral
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extent cf the brainstem at rostral levels,

then become

limited to the medial portions of the brainstem at the
level of the medulla.

These regions occupy fairly large

areas within the brainstem,
caudal pontine nucleus,
nucleus,

and are coextensive with the

the gigantocellular reticular

the parvocellular reticular area

(which is just

lateral to the gigantocellular reticular nucleus in the
medulla),

and the lateral reticular nucleus.

The respiratory centers are much more limited in
their extent,

and consist of two dorsomedially located

dorsal respiratory groups which contain primarily
inspiratory neurons,

and two ventrolaterally located

ventral respiratory groups which contain primarily
expiratory motor neurons

(Ganong,

1995; pp.

615-616).

Both groups begin rostrally near the level of the obex,
but the ventral respiratory groups extend caudally about
twice the length of the dorsal respiratory groups to the
caudal extent of the medulla.

The dorsal respiratory

groups are located in and near the caudal portions of the
nucleus of the solitary tract,

while the ventral

respiratory groups are located in and near the nucleus
ambiguus and the nucleus r e t ro am bi gu u s.

Although these

groups are not coextensive with nuclei of the reticular
formation,

stimulation of various reticular nuclei can
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exert an influence on them.

Stimulation of the

gigantocellular reticular nucleus in the medulla augments
inspiration,

while stimulation of the more laterally

located parvocellular reticular area augments expiration
(Barr and Kiernan,

1993).

Orem

(1994)

has suggested that

the reticular formation comprises part of the anatomical
substrate for the so-called wakefulness stimulus on
respiration.

The decreased ventilatory response to C 0 2

that is observed during sleep
1959)

(Birchfield and Sieker,

is one manifestation of this respiratory wakefulness

stimulus system.

In addition to these medullary centers,

there are also a pair of pneumotaxic centers located in
the pons;

these are coextensive with the medial

parabrachial nucleus and the Kollicker-Fuse nucleus,

and

appear to mediate the duration of both the inspiratory and
expiratory phases of respiration
617; Orem,

1994).

Finally,

(Ganong,

1995, pp.

616-

there are several areas on the

ventral surface of the medulla that are chemosensitive
zones,

the most well documented of these being the

ventrolateral medullary surface
1986) .

(Millhorn and Eldridge,

Neurons in this area project to

(and influence)

both respiratory centers and vasomotor centers
and Eldridge,

1986) .
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The concept of the ascending reticular activating
system

(ARAS)

was first proposed by Moruzzi and Magoun

(1949), and was based on studies in which it was shown
that electrical stimulation of the brainstem reticular
formation exerted a potent arousing influence on cortical
activity.

This initial work showed that stimulation of

the reticular formation along almost all of its entire
rostrocaudal extent

(i.e. mesencephalon to medulla)

elicit EEG activation.

could

Later studies have shown that the

mesencephalic reticular neurons are most responsible for
this arousing effect
and Ropert,

1982;

(Steriade,

Steriade,

1996;

Ropert,

Steriade, Oakson,

Kitsikis,

and Oakson,

1980) .
Thus,

vasomotor activity,

respiration,

and cortical

arousal are all mediated by or influenced by the activity
of the brainstem reticular formation.

Because neurons in

the reticular formation are extensively interconnected
(Barr and Kiernan,

1993),

it is perhaps not surprising

that two or more of the periodic phenomena discussed above
often occur simultaneously.

The issue of how this happens

(and why it is more likely to happen during sleep or coma)
is less clear,

but there are at least two possible

explanations.
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The first of these is the idea that neurons in the
brainstem reticular formation have an intrinsic slow
rhythm that becomes relatively more prominent when
afferent input to the reticular formation is reduced.
Because the reticular formation receives substantial
afferent input from both the cerebral cortex and from
sensory systems
pp.

127-128),

(Barr and Kiernan,

1993; Carpenter,

1991,

it is reasonable to assume that a

substantial reduction of this input occurs during sleep
and coma.

The postulated inherent slow rhythm would then

become more prominent,

and would be reflected by

oscillations in the physiologic parameters that are
mediated by the reticular formation
respiration,

(e.g., arousal,

cardiovascular a c t i v i t y ) .

noted earlier,

Unfortunately,

as

there is very little direct experimental

evidence to support the idea of an intrinsic slow r hythm
in the firing rate of reticular neurons,
studies mentioned earlier
and Steriade,

although the

(Manohar et al.,

1982; Steriade et al.,

1972; Oakson

1982, Vertes,

1979)

did find that most reticular neurons have a substantial
decrease in their firing rate in non-REM sleep as compared
to wakefulness and REM sleep.
The second explanation is that wakefulness exerts a
tonic excitatory influence on the vegetative functions of

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

118

respiration,

cardiac activity,

arousal level.

vasomotor functions,

and

This wakefulness stimulus is transmitted

from the cortex and peripheral sensory systems to the
brainstem areas mediating the physiologic functions
mentioned above by the reticular formation.

Removal of

this wakefulness stimulus could then be expected to alter
the properties of one or more of the components of the
systems regulating these functions, making the system more
unstable and more likely to oscillate.
be affected independently,
simultaneously,

Each system could

or they could all be affected

depending on the nature and extent of the

removal of the wakefulness stimulus

(i.e. whether it was

due to natural sleep or to neurological d a m ag e) .
With respect to respiration,

the wakefulness stimulus

is thought to be mediated by both the reticular formation
and by various forebrain structures,

including the limbic

system and mo to r areas in the frontal lobe

(Orem,

1994).

The removal of this stimulus is reflected physiologically
by a decrease in ventilation during sleep
slow wave sleep;

Krieger,

1994), a reduced ventilatory

response to C 0 2 during sleep
1959),

(by about 15% in

(Birchfield and Sieker,

and by the observation that it is easier to produce

post-hyperventilation apnea during sleep or anesthesia
than it is during wakefulness

(Krieger,

1994).
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contrast to these data

(which indicate a reduction in

respiratory drive during sleep)
and Plum

(1961)

are the findings of Brown

in patients with coexisting neurological

damage and Cheyne-Stokes respiration.

These investigators

found that neurological damage caused an increased
ventilatory response to C02, and suggested that
supramedullary centers exerted a tonic inhibitory
influence on respiratory sensitivity.

None-the-less,

the

idea that the sensitivity of the respiratory system varies
during the sleep-wake cycle in neurologically intact
subjects is a well established principle
Orem,

1994).

Moreover,

(Krieger,

as mentioned above,

1994;

when sleep

related changes in chemosensitivity and blood gas levels
are simulated in computer models of the respiratory
system,

periodic breathing can be produced

(Khoo et al.,

1982) .
This idea of the wakefulness stimulus can be extended
to the regulation of cardiac and vasomotor functions
to a somewhat lesser extent,

arousal).

(and

Unfortunately,

there is no available information on changes in vasomotor
functions and reflexes

(such as the baroreceptor reflex or

the cardiovascular response to passive tilting)
sleep-wake cycle.

during the

Although there are reductions in both

heart rate and blood pressure during non-REM sleep
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(Littler et al.,

1975; Millar-Craig et al.,

the changes in ventilation,

1978),

like

these may be secondary to

reductions in metabolic rate during non-REM sleep,

rather

a reflection of an altered sensitivity of the
cardiovascular system or one of its components.
this,

Despite

the regulation of vasomotor tone is similar to the

regulation of respiration in that both are based on
negative feedback systems;

thus,

removal of the

wakefulness stimulus might be a plausible explanation for
the sleep-related appearance of B-waves and Mayer waves in
addition to that of periodic breathing.
As mentioned earlier,

it is common for one or more of

the periodic phenomena discussed above to occur together.
However,

only the cyclic alternating pattern and B-waves

have been shown to be present in patients with RLS and/or
PLMS

(Droste et al.,

Terzano et al.,

1996;

1995),

and

Montplaisir et a., 1994;
it is unclear from these

studies how these phenomena might actually cause RLS
and/or PLMS,

or if in fact

they even do.

cerebral ischemia theory of RLS proposes

The periodic
that B-waves are

present in both RLS and PLMS, and that they represent the
one of the primary physiologic mechanisms responsible for
producing both disorders.
are closely related

Because B-waves and Mayer waves

(i.e. both are vasomotor waves),
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possible that Mayer waves might also be present in RLS and
PLMS.

Despite this possibility,

neither Mayer waves nor

periodic breathing have been shown to be present in
RLS/PLMS.

Thus,

the question of why B-waves and CAP would

be present in RLS/PLMS while Mayer waves and/or periodic
breathing would not be present has to be asked.
Unfortunately,

there is no easy answer to this question.

One possibility is that removal of the wakefulness
stimulus affects vasomotor functions to a greater extent
than respiratory functions because the vasomotor centers
of the brainstem are more extensive than those of the
respiratory centers.

Another possibility is the br a i n s t e m

centers that generate vasomotor waves and CAP are m ore
intimately associated with the reticular formation than
are the centers that generate the respiratory rhythm.
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Regulation of Cerebral Blood Flow:

A Selected Review

Some Basic Principles
In this section,

the anatomy and innervation of the

cerebral vasculature will be briefly reviewed,

and two

basic principles which govern the regulation of cerebral
blood flow,

autoregulation and flow-metabolism coupling,

will be briefly discussed.
Blood flows into the cranial vault via two pairs of
arteries:

the internal carotid arteries w h i c h are located

anteriorly,
posteriorly.

and the vertebral arteries w h i c h are located
At the level of the caudal pons the paired

vertebral arteries join to form the basilar artery.
Before bifurcating near the mammillary bodies to form the
posterior cerebral arteries,

the basilar artery gives off

three large pairs of arteries:
cerebellar arteries,

the anterior inferior

the labyrinthine arteries,

superior cerebellar a r t e r i e s .

and the

The anterior inferior

cerebellar arteries and the superior cerebellar arteries
supply the cerebellum,

while the labyrinthine arteries

supply the cochlea and vestibular apparatus
1991, pp. 449-455).

(Carpenter,

Each of the posterior cerebral

arteries divides into two main branches,

the posterior

temporal artery which supplies part of the ventral surface
of the temporal lobe,

and the internal occipital artery

122
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which supplies most of the occipital lobe and part of the
parietal lobe.
Just lateral to the optic chiasm,

the internal

carotid arteries bifurcate to form the middle and anterior
cerebral arteries.

The middle cerebral arteries are the

largest of the cerebral arteries,

and represent a

continuation of the internal carotid arteries.

Each

middle cerebral artery passes between the medial aspect of
the temporal lobe and the insula,

and gives off a large

number of branches which emerge from the lateral sulcus.
These branches spread out over the surface of the cerebral
cortex,

and supply large areas of the frontal,

temporal,

and parietal lobes.
The anterior cerebral arteries course medially from
their point of origin,
cerebral

and then enter the longitudinal

fissure at the midline.

The anterior arteries

are also connected to one another at the midline via the
small anterior communicating artery.

Each anterior

cerebral artery gives off three large branches and two
small branches.

The large branches include the

frontopolar artery which supplies medial areas of the
frontal lobe,

the callosomarginal artery which supplies

the paracentral lobule and dorsal parts of the cingulate
gyrus,

and the pericallosal artery which supplies medial
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areas of the parietal lobe.

The small branches of the

anterior cerebral artery include the medial striate artery
which supplies the anterior parts of the caudate nucleus
and internal capsule,

and the orbital artery which

supplies orbital and medial surfaces of the frontal lobe.
The posterior cerebral arteries are connected to the
internal carotid arteries via the posterior communicating
arteries near the point where the carotids bifurcate into
the middle and anterior cerebral arteries.

This

connection between the posterior cerebral arteries and the
internal carotids along with the connection between the
two anterior cerebral arteries forms the Circle of Willis.
There is normally little or no blood flow through the
posterior communicating arteries because the pressure in
the posterior cerebral arteries and the internal carotids
is nearly equal

(Carpenter,

1991,

p.

440) .

At the boundaries of the territories perfused by the
three major cerebral arteries in each hemisphere there are
arterial anastomoses through which the terminal branches
of the three major cerebral arteries are interconnected
(Edvinsson,

MacKenzie,

Eecken and Adams,

and McCulloch,

1953).

1993, p. 13; Vander

These anastomoses are believed

to provide a collateral source of blood flow to ischemic
regions in the event of an occlusion in one of the major
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arteries

(Vander Eecken and Adams,

1953).

It has also

been suggested that the presence of these anastomoses
makes the boundaries of the territories perfused by the
major cerebral arteries dynamic rather than static

(Van

der Zwan,

1992).

Hillen,

For example,

Tulleken,

Dujovny,

Van der Zwan and Hillen

and Dragovic,
(1990)

found that the

boundary of the anterior cerebral artery could be shifted
laterally over the cortical surface by a distance of three
centimeters if the perfusion pressure in the middle
cerebral artery was suddenly reduced.
(1992)

Van der Zwan et a l .

also found that there was a large degree of

individual variability in the territories perfused by the
major cerebral arteries.
The venous drainage of the brain is accomplished
primarily via a series of large venous sinuses which are
actually spaces between the periosteal and meningeal
layers of the dura mater.

These dural sinuses receive and

drain a large number of smaller veins which run along the
surface of the cerebral cortex.

The principle venous

sinuses include the superior sagittal sinus which runs
along the longitudinal cerebral fissure in the falx
cerebri,

and the paired transverse sinuses which run

between the cereb el lu m and occipital lobe in the tentorium
cerebelli.

O t he r dural venous sinuses include the
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inferior sagittal sinus,

and the occipital sinus.

The

transverse sinuses run laterally and rostrally around the
cerebellum,
sinuses.

and then turn medially to become the sigmoid

The sigmoid sinuses empty into the large paired

internal jugular veins.

The internal jugular veins also

drain the cavernous sinus,

a network of veins which

surrounds the pituitary gland and other diencephalic
structures.

The cavernous sinus receives blood from

several large veins and sinuses including the middle
cerebral veins,

the sphenoparietal sinuses,

superior and inferior petrosal sinuses

and the

(Carpenter,

1991,

p. 457).
The innervation of the cerebral vasculature has been
reviewed in detail by Edvinsson,
(1993, pp.
follows.

57-91)

MacKenzie,

and McCulloch

and can be briefly summarized as

Sympathetic

(vasoconstrictor)

fibers arise from

the superior cervical and stellate ganglia,

and release

the neurotransmitters norepinephrine and neuropeptide Y.
Parasympathetic

(vasodilator)

fibers arise from the

sphenopalatine and otic ganglia,

and release acetylcholine

and vasoactive intestinal polypeptide.

There is also a

serotonergic innervation that arises from the raphe
nuclei;

these fibers exert a vasodilatory influence when

vascular tone is high and a vasoconstrictor influence when
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vascular tone is low.

Finally,

there are sensory nerve

endings on the cerebral vessels which have their cell
bodies in the trigeminal ganglia.

These fibers release

substance P, neurokinin A, and calcitonin gene-related
peptide from their axon terminals which synapse on second
order neurons in the brainstem.
It should also be pointed out that dopamine Dl and D2
receptors have been localized within all layers of
cerebral arteries,
causes vasodilation
LJematsu, McCarron,

and stimulation of these receptors
(Amenta,
and Spatz,

Ricci,

and Vega,

1991).

1991; Bacic,

The source of the

dopamine that binds to these receptors is unclear
axonal endings,

(e.g.

C S F ) , although there is some evidence of a

dopaminergic innervation of the cerebral vasculature
(Edvinsson, MacKenzie,
In addition,

and McCulloch,

1993,

pp. 231-233).

dopamine receptors have also been localized

in peripheral vessels,

particularly those in the kidney,

and are believed to play a role in the regulation of fluid
volume

(Lokhandwala and Chen,

1994).

The brain is one of several organs in which blood
flow is autoregulated.

This term refers to the ability of

an organ to regulate its own blood flow
542).

In the case of the brain,

(Ganong,

1995; p.

it specifically refers to

the observation that fairly constant levels of total blood
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flow are maintained over a range of systemic blood
pressure values which vary from 60 to 140 m m Hg
(Edvinsson,
Ganong,

MacKenzie,

1995, p.

pressure values,

563).

and McCulloch,

1993,

p.

Above and below those blood

total cerebral blood flow varies directly

with the perfusion pressure.

There are three theories

concerning the mechanism of autoregulation:
theory,

553;

the myogenic

the metabolic theory, and the neurogenic theory

(Edvinsson et al.,

1993, pp. 565-570).

The myogenic theory proposes that autoregulation is
an intrinsic property of vascular smooth muscle.
According to this theory,
increases,

there is a corresponding contraction of the

vascular smooth muscle
decreased pressure).
pp.

as pressure on the arterial wall

565-567),

(and vice-versa with respect to
As noted by Edvinsson et al.

(1993,

the intracellular and biochemical mechanisms

by which this is accomplished remain unclear.

Despite

this, the myogenic theory of autoregulation is generally
well accepted.
The metabolic theory of autoregulation proposes that
global

(or regional)

reductions in blood flow result in an

increased production of vasodilator metabolites which act
to restore blood flow to adequate levels.
thus a flow-metabolism coupling theory,

This theory is

although it should
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be noted that the term fiow-metabolism coupling is
generally used to refer to regional variations in cerebral
blood flow that occur in response to regional changes in
metabolic rate.

Although this theory can potentially

explain the dilatory response to reduced blood flow,

it

does not address the contractile response to increased
blood flow

(and/or increased systemic blood pressure) , and

is thus an incomplete explanation for the phenomenon of
cerebral autoregulation.
The neurogenic theory of autoregulation proposes that
the innervation of the cerebral vasculature

(including the

sensory nerve fibers and possibly peripheral baroreceptors
as well)
theory,

mediates autoregulation.

A c co r di ng to this

perfusion pressure is sensed by either peripheral

baroreceptors or cerebrovascular sensory nerves,

and

corresponding adjustments in vascular tone are effected by
the autonomic innervation.

However,

when either afferent

or efferent fibers in these putative circuits are
sectioned,

the capacity for autoregulation remains

(McCulloch,
support.

1988),

so this theory has poor empirical

In summary,

cerebral blood flow is maintained at

fairly constant levels accross a wide range of perfusion
pressures.

This autoregulation of cerebral blood flow is
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thought to be effected primarily by intrinsic contractile
properties of cerebrovascular smooth muscle.
Another well-established principle of cerebral blood
flow is that regional blood flow is closely coupled to
regional m etabolic rate.

The same principle also applies

to global cerebral blood flow and metabolism.

The

existence of flow-metabolism coupling has been established
by a number of indirect lines of evidence

{e.g. cerebral

blood flow is low during coma and high during seizures;
see Reivich,

1974,

for a review),

and by more rigorous

studies in which it has been demonstrated that there are
high correlations between regional glucose or oxygen
uptake and regional blood flow when both variables are
measured simultaneously
Smith, Wachtel,

{Buxton and Frank,

Gonzalez-Carvajal,

1997; Ginsberg,

and Busto,

1986).

Most

of the early w o rk in which both cerebral metabolic rate
and cerebral b l o o d flow were measured simultaneously was
done with either anesthetized animals or under resting
conditions with human subjects.

More recent studies using

positron emission tomography and functional MRI have found
that cerebral blood flow apparently increases to a much
greater extent than cerebral metabolism
uptake)

(i.e. oxygen

during functional activation produced by

somatosensory stimulation and mental tasks

(Buxton and

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

131

Frank,

1997;

Fox and Raichle,

1986; Hedera et al.,

1995).

These studies were initially interpreted as representing
an uncoupling of flow and metabolism during functional
activation
Frank

(Fox and Raichle,

(1997)

1986).

However,

Buxton and

recently presented a mathematical model of

cerebral oxygen delivery in which small increases in
metabolic rate were accompanied by relatively large
increases in blood flow.

This model indicated that the

disproportionately large increases in cerebral blood flow
seen during functional activation are in fact reflective
of a tight coupling

(rather than an uncoupling)

cerebral blood flow and metabolism.

of

Critical to the model

was the assumption that increases in cerebral blood flow
are effected primarily by increases in blood flow velocity
rather than by recruitment of previously closed
capillaries

(see Buxton and Frank for evidence in support

of this assumption) .

The increased flow velocity lowers

the amount of oxygen that can be extracted from the blood
because the transit time of the blood through the
capillaries is decreased.

This model is important because

it can explain the confusing earlier evidence of flowmetabolism uncoupling during functional activation.
It is generally well-accepted that flow-metabolism
coupling is mediated by an increased regional

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

(or global)

132

production of metabolic by-products which have a
vasodilatory effect
Ganong,

(Edvinsson et al.,

1995, pp. 560-563) .

metabolites

1993, pp.

These so-called vasodilator

include hydrogen ions

0-, increased CO;, potassium ions,

(lowered p H ) , decreased
and adenosine,

it is unclear which of these is most important
et al.,

1993, pp. 567-568).

result from systemic disease,

although

(Edvinsson

Hypoxia and hypercapnia that
such as COPD or anemia,

also produce increases in cerebral blood flow
Brown,

567-568;

can

(Wade and

1988).
Poiseuille's Law and Flow Through Bifurcations

In this section the effects of arterial bifurcations
and artery length and radius on blood flow will be
discussed.

These concepts will be applied to blood flow

in the cerebral arteries
and PLMS)

(and to the pathogenesis of RLS

in the next major section.

The flow

(F) of blood through arteries and veins,

like the flow of any fluid in a tube,
several variables.
radius

These include the length

(r) of the artery

the blood

is affected by
(L) and

(or tube) , the viscosity

(ti) of

(or fluid), and the difference in pressure

between the two ends of the artery

(or t u b e ) .

Poiseuille's law is a formula which describes how these
variables affect the amount of flow.

This formula is
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usually cited in most physiology texts
p. 530),

(e.g. Ganong,

1995,

and is written as follows:
F=

(PA - Pg) x

(ti/8) x

(1/ri) x

where PA

- P5 is

proximal

and distal ends of the tube.

(r4/L)

the difference in pressure

between the

Flow is also equal to the pressure difference
Pa) divided by the resistance to flow
p. 531).

Thus,

resistance to flow

(R)

(Ganong,

(PA 1995,

(R) can also be

described in terms of the variables mentioned above;
is, the length and radius of the artery
viscosity of the blood

(or f l u i d ) .

(or tube)

that

and the

The equation which

describes how these variables affect resistance is written
as follows

(Ganong,

1995,

p.

531):

R = 8tjL/7tr4.
It can be seen from this equation that resistance to blood
flow is d i r ec tl y proportional to the length

(L) of an

artery and inversely proportional to fourth p ower of the
radius of the artery

(r4) .

This means that small

increases in the radius of an artery greatly reduce the
resistance to flow, while small decreases in the radius
greatly increase the resistance to flow.
Blood flow in arteries is laminar under normal
conditions

(Ganong,

1995,

p.

530).

Laminar flow refers to
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the observation that blood flows in a straight
fashion,

line

but with different velocities in different

concentric "layers" or lamina within an artery.
example,
artery,

For

the flow velocity is highest in the middle of the
and lowest

(approaching zero) at the artery wall.

The lamina closest to the wall of the artery is referred
to as the boundary layer.

A variety of factors can cause

disruptions or turbulence in the normal laminar flow.
These include increased flow velocity,
diameter,
viscosity.

increased fluid density,

increased vessel

and decreased blood

The Reynolds number is a ratio which indicates

how likely turbulence is to occur.
the variables listed above,

It takes into account

and is computed as follows:

Re = pDV/t|
where p equals the density of the fluid,

D equals the

diameter of the tube, V equals the flow velocity,
equals the viscosity of the fluid.
conditions in straight vessels,

and ti

Under normal

turbulent flow usually

does not occur until the Reynolds number reaches about
2300,

a value which is usually not attained

O'Rourke,

(Nichols and

1990).

Turbulent flow and other types of non-laminar flow
such as eddying commonly occur at arterial bends and
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bifurcations
Bargeron,

(Fox and Hugh,

and Hutchins,

1966; Friedman,

1983; Roach,

Deters,

1977).

Mark,

The turbulent

flow and eddying that occurs at these sites has been shown
to produce regions of both high and low shear stress,

and

both high and low shear stress have been implicated in the
genesis and progression of atherosclerosis
al,

1983; Gutstein,

O'Rourke,

Schneck,

1990; Roach,

and Marks,

1977).

(Friedman et

1968;

Nichols and

Friedman et al.

(1983)

performed flow studies in casts of human aortas,

and

demonstrated that individual differences in arterial
geometry could account for the variations in shear stress
that were observed.

Roach and her colleagues proposed

that turbulent flow and points of increased shear stress
at bifurcations in the Circle of Willis could lead to the
development and progression of cerebral aneurysms and
cerebral atherosclerosis
Ferguson,

(Roach,

1977; Roach,

Scott,

and

1972).

The turbulence and eddying that occurs at
bifurcations also impedes the flow of blood through these
regions by decreasing the area available for blood flow.
This has been clearly demonstrated in studies which have
shown that blood flows around,

rather than through,

regions of eddying and turbulence
1966;

Fox and Hugh,

the

(Crowe and Krovetz,

1966).

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

136

There are several geometrical features of
bifurcations that appear to increase the probability that
turbulence and eddying will occur.

These include

branching asymmetry and increases in the angle of the
bifurcation
Ferguson,

(Crowe and Krovetz,

1972).

1972; Roach,

Scott,

and

Because these factors affect turbulence,

they also affect flow rates.

Crowe and Krovetz

(1972)

demonstrated that flow rates in arterial branches were
greater in symmetrical "Y" type bifurcations than in the
daughter branches of asymmetrical "parent vessel/daughter
vessel" bifurcations,

a finding which indicated that more

turbulence and flow disruption occurred in the asymetrical
bifurcations.

Crowe and Krovetz

(1972) also showed that

as the angle of bifurcation in an asymetrical bifurcation
increases,
decreases.

the flow rate through the ''daughter vessel"
Similarly,

Roach et al.

critical Reynolds number
turbulence develops)
increased,

(1972)

(the Reynolds number at which

decreased as the angle of bifurcation

although it should be noted that these results

were for symetrical "Y" type bifurcations.
together,

showed that the

Taken

these results suggest that individual

differences in arterial geometry can affect both flow rate
and shear stress.

Friedman et al.

(1983)

suggested that
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such individual differences might represent a risk factor
for the development of coronary atherosclerosis.
Cerebral Blood Flow Purina Sleep
A fairly large number of studies have investigated
cerebral blood flow during normal human sleep and
wakefulness.

Overall,

the results are very consistent

with respect to global cerebral blood flow levels during
the different sleep-wake states.

During non-REM sleep

there is a progressive decrease in total cerebral blood
flow with the lowest levels being achieved in slow-wave
sleep

(SWS)(Masden et al.,

1991; Sakai, Meyer,

Derman,

and Yamamoto,

1973).

The average decrease in cerebral blo od flow during

SWS

1980; Townsend,

(as compared to wakefulness)

in the Masden et al.

study,

Prinz,

Karacan,

and Obrist,

in these studies was 25%

28% in the Sakai et al.

and 10% in the Townsend et al. study.

study,

All of these

studies used the 133Xe inhalation technique to assess
cerebral blood flow.

During REM sleep,

total cerebral

blood flow was either not significantly different from
levels observed during wakefulness

(Masden et al.,

1991)

or was higher than that observed during wakefulness
et al.,

(Sakai

1980; Townsend et al., 1973).

Similar results have been reported for cerebral
metabolic rate as assessed by positron emission tomography
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of

[:aF]2-fluoro-2-deoxy-D-glucose uptake.

Buchsbaum et al.

(1989)

For example,

reported that glucose uptake

decreased by 23% during NREM sleep as compared to
wakefulness,

while there was only a small non-significant

decrease during REM sleep.

Maquet et al.

(1990)

found a

43.8% percent decrease in glucose uptake during SWS as
compared to wakefulness,

and a small non-significant

increase during REM sleep.
The similar pattern of results obtained for cerebral
blood flow and cerebral glucose utilization have been
cited as evidence that flow-metabolism coupling of
cerebral blood flow persists throughout the sleep-wake
cycle

(Masden et al.,

1991).

However,

there are a number

of findings which suggest that cerebral blood flow and
cerebral metabolism are not tightly coupled during sleep,
particularly during non-REM sleep.

The most important of

these is that end-tidal C 0 2 levels increase during non-REM
sleep as compared to wakefulness
Townsend et al.,

1973).

(Sakai et a l ., 1980;

If flow-metabolism coupling

persisted during non-REM sleep,

then one would expect an

increase in cerebral blood flow in response to these
increased C02 levels.

The decreased cerebral blood flow

in spite of these increased C 0 2 levels suggests that there
is a decrease in cerebral vasomotor responsiveness to C02
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during non-REM sleep

(Sakai et al.,

1980).

Results

similar to these were obtained in a recent study which
near-infrared spectroscopy

(NIRS) was used to assess

cerebral oxygenation and blood flow accross an entire
night in seven normal healthy subjects
and Tamura,

1994).

oxyhemoglobin,
be measured.

(Hoshi, Mizukami,

NIRS is a technique in which cerebral

deoxyhemoglobin,

and total hemoglobin can

The total hemoglobin measurement is thought

to correlate well with total blood volume
and as such,

(Brazy,

reflects total cerebral blood flow.

1991),
The

study by Hoshi et al.

showed that oxyhemoglobin decreased

during non-REM sleep,

and returned to waking levels during

REM sleep.
levels,

Despite the decrease in cerebral oxygen

total blood flow

hemoglobin measurement)
Hoshi et al.

(1994, p.

(as assessed by the total
decreased during non-REM sleep.

257)

concluded that their results

suggested that "the flow-metabolic coupling mechanism is
reset to a new level during sleep."
A similar conclusion was reached in another recent
study in which transcranial Doppler sonography was used to
assess cerebral blood flow velocity across the entire
night

(Hajak et al.,

1994).

As noted earlier,

cerebral

blood flow velocity correlates fairly well with cerebral
blood flow volume.

Hajak et al.

found that cerebral blood
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flow velocity decreased during progressively during nonREM sleep

(as compared to pre-sleep baseline values),

and

increased during REM relative to the preceding non-REM
sleep values.

These results were similar to those

obtained by the authors cited above who used the :33Xe
technique to assess cerebral blood flow.

However,

Hajak

et al. observed several things which suggested that flowmetabolism coupling was not present during sleep.

First,

there was a general trend for flow velocity to decrease
across the night.

For example,

flow velocity values for

both non-REM and REM sleep were found to decrease as
compared to those seen in earlier sleep cycles.
during spontaneous or provoked arcusals,
no response in flow velocity,

Second,

there was often

and in many subjects there

was actually a decrease in flow velocity in response to
the arousal.

Finally,

upon awakening in the morning,

there was often a delay of up to 30 minutes before flow
velocity returned to the pre-sleep baseline level.
findings led Hajak et al.

(1994, p.

These

11) to conclude that

"these results imply an uncoupling between cerebral
electrical activity and cerebral perfusion during
s l e e p ...".
Like Hajak et al., Hoshi et al.

(1994)

also used

auditory stimulation to study the cerebral blood flow
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response to arousal during sleep.
large disproportionate increases

Hoshi et a l . observed
in total hemoglobin

during arousais produced during REM sleep,
smaller increases during non-REM sleep.

and relatively

They noted that

the large arousal-induced increases in blood flow during
REM sleep were gualitatively similar to those observed by
other authors during wakefulness in response to
somatosensory stimulation

(e.g.

Fox and Raichle,

1986),

while the arousal-induced increases in blood flow during
non-REM sleep were much more subdued.
The findings suggestive of flow-metabolism uncoupling
during non-REM sleep has led several of the authors in the
studies cited above to conclude that cerebral blood flow
during sleep may be regulated primarily by central
neurogenic mechanisms rather than by local flow-metabolism
coupling
al.,

(Hajak et al,

1994; Hoshi et al.,

1980; Townsend et al.,

the section to follow,

1973).

1994,

Sakai et

As it will be noted in

these changes in the regulation of

cerebral blood flow across the sleep-wake cycle can
potentially explain the sleep-related appearance of both
RLS and PLMS.
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Periodic Cerebral Ischemia:
A New Theory for the
Pathogenesis of Restless Legs Syndrome and
Periodic Limb Movements in Sleep
Anatomical Considerations Regarding the Paresthesia j.n RLS
As reviewed above,

the pathogenic theory of RLS that

has the best support is the reduced peripheral blood flow
theory.

However,

because the same arteries that supply

blood to the lower legs also supply the feet
p. 432),

(Moore,

1985,

this theory cannot explain the restriction of the

paresthesia in RLS to the lower legs.

Despite this,

there

is much evidence to suggest that some impairment in
circulation is present in RLS and PLMS

(e.g.

prevalence data, most of the treatment data,
nature of the symptoms).

Thus,

the
the transient

it is reasonable to assume

that the paresthesia in RLS is caused by a transient
"functional" lesion of neurons mediating somatosensation
in the legs,

and further that this transient "functional"

lesion is caused by ischemia

(and/or hypercapnia)

secondary to insufficient blood flow somewhere in the
nervous system.
If this assumption is taken as an initial working
hypothesis,

the next question that arises is which neurons

that mediate somatosensation in the lower legs undergo
this reduction in blood flow.

Because there are only four

levels of neurons in the somatosensory pathway
142
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(for

proprioception and light touch), there are a limited
number of possible answers to this question.

The primary

or first order sensory neurons in this pathway have their
cell bodies in the dorsal root ganglion of lumbar and
sacral regions of the spinal cord
75-77).

(Carpenter,

1991, pp.

The peripheral processes of these neurons form

the peripheral nerves,

while the central processes

(axons)

ascend in the fasiculus gracilis of the dorsal funiculus
of the spinal cord.

These axons synapse on second order

neurons in the ipsilateral nucleus gracilis of the
medulla.

The second order neurons in the nucleus gracilis

send axons to the ventral posterolateral nucleus of the
contralateral thalamus via the medial lemniscus.

The

third order neurons in the ventral posterolateral nucleus
of the thalamus then project to fourth order neurons in
the leg area of the somatosensory cortex of the
ipsilateral cerebral hemisphere.

This area of the

somatosensory cortex is located almost entirely within the
longitudinal fissure dorsal to the cingulate gyrus
Carpenter,

1991;

Figure 13.13, p. 404).

the paresthesia in RLS,

Thus,

(see

to produce

a reduction in blood flow would

probably have to occur in one of the following areas;
fasiculus gracilis in the spinal cord,
gracilis in the medulla,

the nucleus

the ventral posterolateral
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nucleus in the thalamus,

and/or the leg area of the

somatosensory cortex.
These possibilities can be narrowed down further if
PLMs are taken into account.

Recall that Smith

(1985)

observed that PLMs appear to be spontaneously occurring
Babinski responses.

As noted earlier,

Babinski responses

occur only when pyramidal tract damage is present
Gijn,

1978;

1995).

Thus,

(van

like the paresthesia in RLS,

PLMs may also be caused by a ischemia-induced "functional"
lesion, but in the case of PLMs, the lesion would need to
be somewhere within the pyramidal tract
to occur pe ri od i c a l l y ) .

(and it would need

A large percentage of the cell

bodies of axons that form the pyramidal tracts are located
within the motor and premotor areas of the frontal cortex;
however, many other pyramidal tract neurons are located in
the somatosensory cortex on the post-central gyrus of the
parietal lobe

(Carpenter,

1991, pp.

94-96).

Thus,

a

"functional" lesion of the leg area of the somatosensory
cortex could cause b oth the waking paresthesia of RLS, and
the PLMs that are seen in these patients during sleep.
If the blood supply to this area,
areas listed above,

and to the other

is examined it becomes clear that the

most likely site of the reduced blood flow responsible for
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the paresthesia in RLS

(and for PLMs)

is in the leg area

of the somatosensory cortex.
Beginning first with the fasiculus gracilis,
be seen from Gilman and Newman

it can

(1992; Figure 27, p. 93)

that this area is supplied by branches arising from the
posterior spinal arteries.

However,

the posterior spinal

arteries also supply the fasiculus cuneatus which mediates
somatosensation in the trunk and upper extremities,

so it

is unlikely that reduced flow in these arteries could
produce a paresthesia restricted primarily to the lower
legs.

Moreover,

the pyramidal tracts descend in the

lateral funiculus,
spinal artery
Thus,

which is supplied by the anterior

(see Gilman and Newman,

1992;

Figure 27).

in order to account for both RLS and PLMS via a

spinal blood flow mechanism,

one would have to postulate

reduced flow in all of the major spinal arteries.
did happen,

If this

it seems likely that the symptoms produced

would be restricted to the dermatomes that were affected,
and would include symptoms in addition to those typically
reported in RLS

(e.g. numbness,

as noted earlier,

pain,

tingling).

However,

the anatomical distribution of the

paresthesia in RLS does not match any of the body areas
supplied by any dermatome.

with p erm ission o f th e copyright ow ner. Further reproduction prohibited without p erm ission

If RLS were due to reduced blood flow in the region
of the nucleus gracilis

(which is located in the dorsal

m e d ul la ), then the artery most likely to be involved would
be the posterior inferior cerebellar artery.
to supplying the cerebellum,
the medulla
However,

(Carpenter,

the pyramidal

ventral medulla)

In addition

this artery supplies parts of

1991;
tracts

see Figure 14.3,

p.

439).

(which are located in the

are supplied by branches from the

anterior spinal artery near its point of origin.

Thus,

to

account for both RLS and PLMS via reduced blood flow to
the medulla,

one would have to postulate reduced blood

flow in at least two arteries.

Moreover,

the regions of

the medulla supplied by these arteries are very likely to
include other body areas in addition to the lower legs.
If the paresthesia in RLS was due to reduced blood
flow in the ventral posterolateral nucleus of the
thalamus,

then the arteries most likely to be involved

would be the anterior choroidal artery
the anterior cerebral artery)
arteries

and the thalamogeniculate

(which arise from the posterior cerebral artery;

see Carpenter,
However,

(which arises from

1991;

Figures 14.9 and 14.10,

p.

447).

the ventral posterolateral nucleus of the

thalamus is a relatively small nucleus which also mediates
somatosensation in the trunk and upper limbs.
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seems unlikely that reduced blood flow in this area could
produce a paresthesia restricted primarily to the lower
legs.

In regards to PLMS,

(1991; Figure 14.10)

it can be seen from Carpenter

that the pyramidal tracts descend

near the thalamus in the internal capsule.
can also be seen in Carpenter

However,

(1991; Figure 14.10)

it

that

the internal capsule is supplied by both the anterior
choroidal artery and by other branches from the middle
cerebral artery.

Therefore,

in order to account for both

RLS and PLMS via reduced blood flow in the region of the
thalamus and internal capsule,

one would have to postulate

that blood flow would be reduced in several arteries.
The course of the anterior cerebral artery and its
major branches are best seen in mid-sagittal sections of
the brain

(e.g.

see Carpenter,

1991; Figure 14.5,

p. 442),

while the territory perfused by this artery is best seen
in coronal and mid-sagittal sections
Newman,

1992;

Figure 76, p. 267,

(see Gilman and

for a coronal section

showing the territory perfused by the anterior cerebral
artery).
leg

If one compares the somatosensory cortex for the

(see Carpenter,

1991,

Figure 13.13) with mid-sagittal

and coronal views of the territory perfused by the
anterior cerebral artery,

it can be seen that the distal

territory of the callosomarginal branch of the anterior
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cerebral artery roughly corresponds to the somatosensory
area for the legs.

The more proximal territory of the

callosomarginal branch of the anterior cerebral artery
corresponds to the motor area for the legs.

Thus,

if

blood flow were preferentially reduced in the
callosomarginal branch of the anterior cerebral artery,
one would expect to see symptoms of leg paresthesias,
in addition,

and

one would expect that this reduced flow might

produce a transient "functional"' pyramidal tract lesion.
A careful examination of figures presented in
Carpenter
(1992;

(1991;

Figure 76)

Figure 13.13)

and Gilman and Newman

shows that the territory perfused by the

callosomarginal branch of the anterior cerebral artery
includes the entire lower extremity,
Thus,

including the feet.

the familiar question of why the paresthesias in RLS

occur prim ar il y in the lower legs but not the feet arises
again.

The answer to this question can be found in the

data p resented by Van der Zwan and Hillen

(1990).

These

authors demonstrated that the territories perfused by the
major cerebral arteries were dynamic,
(i.e. contract or expand)

and could shift

if the perfusion pressure

suddenly dropped in one of the major arteries.

Thus,

if

blood flow was preferentially reduced in the
callosomarginal branch of the anterior artery,
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expect that the core area of the territory perfused by
this artery would experience the greatest reduction in
blood flow and the most severe ischemia.
of the figures mentioned above
13.13;

Gilman and Newman,

An examination

(Carpenter,

1992,

Figure 76)

1991,

Figure

shows that the

core area perfused by the callosomarginal branch of the
anterior cerebral artery roughly corresponds to the lower
legs and does not include the somatosensory cortex for the
feet or lower torso/upper thigh.

Therefore,

reduced blood

flow in this artery could explain why the paresthesia in
RLS is restricted to the lower legs excluding the feet.
In summary,

if one assumes that the basic pathology

of both RLS and PLMS involves some impairment of blood
flow,

then it can be argued that the most likely artery

and location for this impairment in blood flow is the
distal territory perfused by the callosomarginal branch of
the anterior cerebral artery.

This argument forms the

basis of the periodic cerebral ischemia theory of RLS and
PLMS.
Some Additional Questions
Even if one accepts the argument presented above,
several additional questions or problems arise as to how
such a reduction in blood flow might occur.

The first of

these questions concerns the issue of how blood flow could
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be preferentially reduced in a single branch of one of the
three major cerebral arteries.

The second question

concerns the issue of how such an abnormal decrease in
blood flow could continue,
produce paresthesia,

to an extent sufficient to

without eliciting a rapid

compensatory increase in cerebral blood flow.

The third

question concerns the issue of why such changes apparently
begin during wakefulness in RLS patients, but do not begin
until sleep is achieved in PLMS patients.

The fourth and

final question concerns the periodicity of PLMs both
during wakefulness

(in RLS patients)

and sleep

(in PLMS

patients).
The first question mentioned above is the most
important.

The Periodic Cerebral

and PLMS asserts,

Ischemia theory of RLS

as argued in the section above,

that

both disorders are caused by periodic reductions in
cerebral blood flow that are largest in the distal
territory perfused by the callosomarginal branches of the
anterior cerebral arteries.

The answer to the question of

how this could happen can be found in the information
presented earlier about the effects of bifurcations and
artery length and radius on resistance to blood flow:
both increasing the length of an artery and decreasing its
radius result in an increased resistance to blood flow.
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An examination of Figure 14.5 in Carpenter

(1991)

shows

that the anterior cerebral

artery and its callosomarginal

branch are relatively long

arteries whose most distal

territories lie a long way

from the point of origin of

the

anterior cerebral artery.

Although it is not depicted

as

such in Carpenter's

figure,

the anterior cerebral artery

has the smallest radius of the three major cerebral
arteries

(e.g. see Moore,

1985,

Figure 7.77,

p. 880).

The

nature of the bifurcations present in the anterior
cerebral artery and its branches also contribute to the
proposed preferential reduction in blood flow in the
callosomarginal branch of the anterior cerebral artery.
Recall that the amount of blood flow into the daughter
branch of an asymmetrical bifurcation is lower than the
flow in the main trunk
Moreover,

(Crowe and Krovetz,

1972) .

two studies have shown that as the angle of

bifurcation increases,

the region of turbulence or

probability of turbulence in the daughter branch
increases,

with a corresponding decrease in total flow

through the daughter branch
Roach et al.,
in Carpenter

1972).
(1991;

(Crowe and Krovetz,

1972;

An examination of figures presented
Figure 14.3 and 14.5)

shows that the

anterior cerebral artery has several asymmetrical
bifurcations.

The first of these is its point of origin
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where it branches off as a daughter branch from the
internal carotid/middle cerebral artery.

The second

bifurcation occurs where the anterior communicating artery
branches off from the anterior artery.

Finally,

the

callosomarginal branch is a daughter branch of the
anterior cerebral artery,

and the callosomarginal branch

has several bifurcations prior to terminating in its most
distal territory.

The combination of these bifurcations

and the long length and small radius of the anterior
cerebral artery and its branches could thus result in a
relative reduction in blood flow that is greatest in the
distal territory perfused by the callosomarginal branch of
the anterior artery.

Another likely possibility that may

contribute to the development of both RLS and PLMS in
certain individuals is that there is probably a
significant variation among individuals in the three
factors listed above:
cerebral artery,

length and radius of the anterior

and the angle of its bifurcations.

Thus,

certain individuals might be at an increased risk of
developing RLS and/or PLMS because of their individual
arterial geometry.
The second question concerns the issue of why the
proposed reduction in blood flow and subsequent ischemia
are not corrected before they proceed to an extent
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sufficient to produce RLS and PLMS symptoms.

The answer

to this question can be found in the data presented above
which suggests that flow-metabolism coupling and cerebral
vasomotor responsiveness to C 0 2 are greatly reduced during
non-REM sleep

(Hajak et al.,

1994;

Hoshi et a l ., 1994;

Sakai et al.,

1980; Townsend et al.,

1973).

All of the

authors in these four studies suggested that cerebral
blood flow during sleep was regulated primarily by central
neurogenic mechanisms rather than by flow-metabolism
coupling.

Thus,

the presence of ischemia in a relatively

small area of the cerebral cortex

(one not involved in the

regulation of cerebral blood flow during sleep) might not
be sufficient to provoke a compensatory increase in
regional or global cerebral blood flow.
In regards to the third question listed above,

the

Periodic Cerebral Ischemia theory of RLS and PLMS proposes
that the same pathology operates in both disorders,

with

the major difference between the two disorders being that
the abnormalities of cerebral blood flow

(i.e. shift from

flow-metabolism coupling to central neurogenic control
with high amplitude B-wave activity)

begin during

wakefulness in RLS, but not until sleep is achieved in
PLMS.

The shift in how cerebral blood flow is regulated

in RLS is proposed to occur when triggered by prolonged
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motor inactivity

(perhaps with some associated drowsiness)

rather than by sleep itself.

There is some limited

evidence to support this assertion.
al.

(1994)

First,

Montplaisir et

found periodic slowing in the EEG of RLS

patients during a Forced Immobilization Task administered
while the patients were awake.
evidence of B-wave activity,

While this is not direct

the close association of CAP

and B-wave activity suggests that B-wave activity may very
well have been present.
(1982)

Second, Oakson and Steriade

found that mesencephalic reticular formation

neurons had periodic oscillations in their firing rates
with periods varying between eight and twelve seconds.
The pertinent finding of interest in their study was that
these oscillations occurred only during non-REM sleep and
during quiet wakefulness without movement.

Finally,

at

least two studies which used transcranial Doppler
sonography to test for the presence of B-waves in normal
subjects found that these oscillations were present during
wakefulness
Thus,

(Diehl et al.,

1991; Mautner et al.,

1989).

it is not unreasonable to posit that a shift in the

regulation of cerebral blood flow from a regional flowmetabolic coupling mechanism to a central neurogenic
mechanism

(with B-wave activity)

can be precipitated by

prolonged motor inactivity during wakefulness.
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The fourth question concerns the periodicity of PLMs,
and a possible periodicity of RLS sensory symptoms.

The

Periodic Cerebral Ischemia theory of RLS and PLMS proposes
that high amplitude B-waves during prolonged motor
inactivity and non-REM sleep are a constant feature of the
cerebral hemodynamics of RLS and PLMS patients.
oscillation in total cerebral blood flow

This

(coupled with the

anatomical and geometrical features peculiar to the
anterior cerebral artery)

causes a periodic cerebral

ischemia that is greatest in magnitude in the distal
territory of the callosomarginal branch of the anterior
cerebral artery.

This periodic ischemia produces both the

sensory and motor symptoms of RLS

(which are predicted to

be periodic in nature), and a periodic "functional" lesion
of the pyramidal tracts that is sufficient to cause the
spontaneous occurrence of a Babinski response
cause a P L M ) .

As noted earlier,

(i.e. to

several investigators

have found that the leg movements that occur during
wakefulness in RLS patients may be periodic
Montplaisir et al.,

1994).

(e.g.

One prediction of this theory

that has not been directly tested is that the paresthesias
in RLS should occur in a periodic fashion similar to PLMs.
This hypothesis actually does receive some support from
the study of Pelletier et al.

(1992),

which found that
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sensory events in RLS patients were almost always
accompanied by waking PLMs.

Unfortunately,

no specific

data regarding the periodicity and duration of the sensory
events experienced by the subjects were presented by these
a uthors.
Although it is proposed that high amplitude B-wave
activity is one of primary abnormalities in RLS/PLMS,
another possibility is that total cerebral blood flow is
lower

(perhaps due to excessive va so c on st ri ct io n ), while

B-wave amplitude is the same.
periodic cerebral
troughs.

If this were the case,

ischemia would still occur at the B-wave

Although this is possible,

several reasons.

then

First,

it seems unlikely for

during wakefulness,

cerebral blood flow is tightly regulated,
very sensitive to hypoxia

total

and the brain is

(e.g. unconsciousness results in

as little as ten seconds if the blood supply to the brain
is cut off,

Ganong,

1995, p. 564).

flow were abnormally low,

Second,

if total blood

one would probably see a variety

of neurological and cognitive symptoms suggestive of
ischemia.
subjects
et al.,

Third,

studies of B-wave activity in normal

(Diehl et al.,
1992)

1991; Droste et al.,

1993; Newell

have found large individual differences in

B-wave amplitude

(e.g.

from + 10 to 30 percent of the mean

flow v elocity), so it has already been demonstrated that
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some individuals have B-waves that are much larger in
amplitude than others.

Thus,

it is proposed that there

are two pathologies in RLS and PLMS patients which
contribute to producing a periodic ischemia which is
greatest in the distal territory of the callosomarginal
branch of the anterior cerebral artery:
large amplitude B-waves,

1) abnormally

and 2) abnormal structural

geometry in the anterior cerebral artery and its branches.
The Periodic Cerebral Ischemia Theory of RLS and PLMS
The arguments presented above can be briefly
summarized into the following statement of the Periodic
Cerebral Ischemia theory of RLS and PLMS.
It is proposed that both RLS and PLMS are caused by a
combination of sleep-related changes in the regulation of
cerebral bl oo d flow and the unique anatomical features of
the anterior cerebral artery and its branches.

These

factors combine to produce a periodic cerebral ischemia
which is greatest in magnitude in the distal territory
perfused by the callosomarginal branch of the anterior
cerebral artery.

This cortical territory contains the

somatosensory and motor cortices for the legs; the central
core of this territory overlaps well with bodily areas in
which RLS paresthesias most commonly occur
legs excluding the feet).

(i.e. the lower

The sleep-related changes in
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cerebral blood flow,

referred to above,

include a shift

from a local flow-metabolism coupling control mechanism to
a central neurogenic control mechanism.

Associated with

the central neurogenic control of cerebral blood flow are
high amplitude B-waves

(i.e. oscillations in total

cerebral blood vol um e) .

These B-waves are proposed to be

significantly higher in amplitude among persons who have
RLS and PLMS than in those who do not,

and to begin during

inactive wakefulness in RLS patients and after sleep onset
in patients with PLMS alone.
The periodic ischemia in the motor and somatosensory
cortices of the leg area occurs during both wakefulness
(in RLS patients)

and non-REM sleep

most RLS patients).

(in PLMS patients and

During wakefulness,

this periodic

ischemia produces the waking sensory and motor symptoms of
RLS.

During non-REM sleep,

the ischemia produces a

periodic "functional lesion" of the pyramidal tracts which
results in the spontaneous occurrence of a Babinski
response.
PLM.

This Babinski response equates to the observed

PLMs are not generally seen in REM sleep for two

reasons:

first, because of the generalized muscle atonia

seen in this sleep stage
second,

(Kanamori et al.,

1980),

and

because total cerebral blood flow during REM sleep
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is similar to that seen in wakefulness

(e.g. Townsend et

a l . , 1973) .
As was done for the existing major pathogenic
theories of RLS and PLMS presented earlier,

an attempt

will be made to see how well the Periodic Cerebral
Ischemia of RLS and PLMS can account for the major
features of both disorders.
The restriction of paresthesias in RLS to the lower
legs excluding the feet can be explained by the
observation that the territories perfused by the cerebral
arteries are dynamic and can contract when the perfusion
pressure falls.

It is suggested that this occurs in the

callosomarginal branch of the anterior cerebral artery,
with the result that only the central core of this
territory

(which includes the somatosensory areas for the

lower legs but not the feet)

is affected.

The precipitation of RLS symptoms by inactivity can
be explained by the observation that prolonged inactivity
may trigger a shift in how cerebral blood flow is
regulated

(from a local flow-metabolic coupling mechanism

to a central neurogenic control m e c h a n i s m ) .

Associated

with this shift to a central neurogenic control of
cerebral blood flow are high amplitude B-waves and a
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reduced cerebral vasomotor responsiveness to vasodilator
metabolites,

including C 0 2.

The relief of RLS symptoms by vigorous activity can be
explained by suggesting that such activity causes a shift
from the central neurogenic control of cerebral blood flow
back to the flow-metabolism coupling control seen in
normal active wakefulness.

The vigorous leg activity in

particular causes increased metabolism in the sensory and
m otor cortices for the legs,

with a subsequent increase in

cerebral blood flow to this region.

This increased blood

flow alleviates the ischemia that was causing the
symptoms.
The circadian and sleep-related appearance of RLS and
PLMS can be explained by suggesting that there is a normal
tendency for the control of cerebral blood flow to shift
to a central neurogenic control mechanism in the evening
and during sleep.
The higher than normal prevalence of RLS and PLMS in
the various patient groups mentioned above can be
e xpla in ed by the observation that most of these disorders
are associated with either anemia or circulatory
impairments.

Thus,

persons with these disorders already

have a tendency towards insufficient oxygen delivery to
the body and brain.
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The effectiveness of the various drugs reviewed above
in treating RLS and PLMS can be explained by the
observations that several of them appear to improve
circulation,

including cerebral blood flow,

correction of anemia,
sclerotherapy)

dextran,

while others

L-DOPA,

directly

(e.g.

clonidine,

(benzodiazepines,

opioids,

a nti-convulsants) ma y reduce the amplitude of B-waves by
acting directly on brainstem vasomotor areas
Haxhiu et al.,
Finally,

(e.g. see

1989).
the periodicity of PLMS can be explained by

the suggestion that it is high amplitude B-wave activity
that underlies the generation of these movements.
The issue of treatment of RLS and PLMS deserves
further comment.

If the above theory is correct,

then the

best type of drug to treat both RLS and PLMS would clearly
be some type of vasodilator.
theory is correct,

In addition,

if the above

it would suggest that the effectiveness

of most of the drugs currently used to treat RLS and PLMS
is the result of their hemodynamic effects.

This

underscores the fact that the mechanism by which these
drugs exert their beneficial effects on RLS and PLMS
remains unknown.

Although some of these drugs do have

hemodynamic effects
DOPA,

(e.g. vasodilation in the case of L-

reduced cardiac output and peripheral vasodilation
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in the case of cionidine,

and reduction of B-wave

amplitude in the case of some benzodiazepines),

these are

usually not the primary effect of these drugs.

In

addition, many of these drugs have significant undesirable
side effects.

For example,

L-DOPA has been shown to cause

morning rebound and daytime augmentation of symptoms in
RLS patients,

while cionidine and anti-convulsants may

cause excessive sedation.
depressants,

and as such,

Benzodiazepines are respiratory
are contraindicated in many

older patients who have sleep-related breathing disorders.
Although vasodilators are not without side effects and
risks,

they are probably as safe or safer than many of the

drugs currently being used to RLS and PLMS.

In summary,

if the PCI theory of RLS and PLMS can be shown to be
correct, major changes in the treatment of these disorders
would be indicated.
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Study Overview.

Technical Considerations,

and Hypotheses

The study described below represented an attempt to
test several of the main tenets of the theory outlined
above.

Near infrared spectroscopy

(NIRS)

was utilized to

assess regional cerebral hemoglobin oxygen saturation and
total cerebral blood flow in RLS patients,
and normal c o n t r o l s .

PLMS patients,

Studies were conducted during both

wakefulness

(during a Suggested Immobilization Test,

SIT)

and sleep.

It was predicted that the RLS patients would

have B-wave activity during both wakefulness and sleep,
and that the amplitude of those oscillations would be
greater than those in normal controls.

In addition,

it

was predicted that the PLMS patients would have B wave
activity primarily during sleep,

and that the amplitudes

of their B-waves during sleep would be greater than those
in normal controls,

but not significantly different from

those in RLS patients.

Although it was considered likely

that both PLMS patients and normal controls would have
some B-wave activity while awake

(i.e. during the SIT),

it

was predi ct ed that the waking B-wave amplitude in both
groups w ould be significantly lower than that seen in the
RLS p a t i e n t s .

It was also predicted that the B-wave

troughs w ou ld be associated with the sensory and motor
163
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symptoms experie nc ed by the RLS patients during
wakefulness,

and with PLMs experienced by both RLS and

PLMS patients during sleep.
Before proceeding,

some methodological aspects of

NIRS assessment of regional cerebral oxygenation,
specific details of the cerebral oximeter used
Somanetics

INVOS 3100A Cerebral Oximeter)

briefly reviewed.

Cui,

(the

need to be

Several excellent reviews of NIRS and

the Somanetics oximeter have been published
Slavin,

and some

Lewis,

and Ausman,

1991; Slavin et al.,

1994),

(Dujovny,

1994; McCormick et al.,

and the following review is

based on these sources.
The wavelengths of light used in NIRS are in the
near-infrared range

(700 to 1100 nanometers),

penetrate m o s t human tissues,

including bone.

and easily
The light

can penetrate to a depth of several centimeters,
absorbed by several molecules,
deoxyhemoglobin,

and is

including oxyhemoglobin,

and oxidized cytochrome c oxidase

(McCormick et al.,

1991).

Both oxyhemoglobin and

deoxyhemoglobin can absorb near-infrared light throughout
the range of wavelengths used in NIRS

(typically 7 00 to

900 run), but oxyhemoglobin absorbs a greater percentage of
photons at longer wavelengths

(e.g. at about 900 n m ) ,

while deoxyhemoglobin absorbs a greater percentage of
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photons at shorter wavelengths

(e.g. at about 700 n m ) .

At

a wavelength that is referred to as the "isobestic point"
(803 nm in humans),

the percentage of infrared light

photons absorbed by both oxyhemoglobin and deoxyhemoglobin
is the same,

and the amount of light absorbed will

correlate with total hemoglobin.

Thus,

absorption at the

isobestic point can be used as a measure of total blood
volume.
(e.g.

If absorption at one other wavelength is obtained

700 nanometers),

the two measures can be compared to

determine how much hemoglobin is "saturated" with oxygen.
The cerebral oximeter manufactured by the Somanetics
corporation

(Troy, Michigan)

two wavelengths:
communication,

emits near-infrared light at

730 and 805 nm

June,

1997).

(Ron Widman,

personal

This provides measures of

total hemoglobin and deoxyhemoglobin,

which are then used

to compute regional oxyhemoglobin levels.

The value,

which is referred to as the "rS02 index" is then displayed
on the oximeter's monitor,
digitally,
device.

and can be also stored

and/or sent to an analog chart recording

The measure of total hemoglobin

at the isobestic point)

absorption

can also be stored digitally for

later review and analysis.
an event marker button,

(i.e.

In addition,

the oximeter has

which allows the user to mark

clinically relevant events.

These marks are displayed on
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the monitor,

and can also be stored digitally for later

review.
The light emitter and sensors used with the
Somanetics oximeter are unique in that they are designed
in such a way as to provide a measure of oxyhemoglobin in
brain tissue only.

They are specifically designed so that

the rS02 in both brain tissue and in the overlying bone
and skin can be measured.

This is accomplished by the use

of two sensors which are located at different distances
(30 and 40 mm)

from the infrared light emitter.

sensor that is closer

The

(at 30 mm) measures predominately

extracerebral rS02 (i.e. in the scalp,

bone, and

meninges), while the sensor at 40 m m measures both
cerebral and extracerebral rS02.

The value obtained from

the closer sensor is then subtracted from the value
obtained from the more distant sensor,

yielding a measure

indicative of brain tissue rS02.
The term "rS02 index" is used
corporation)

(by the Somanetics

to indicate that the displayed value is a

measure of regional oxyhemoglobin which includes both
arterial and venous oxyhemoglobin.

It should not be

confused with the signal measured by peripheral pulse
oximetry,

which is a measure of arterial oxyhemoglobin

saturation only.

The measure obtained by pulse oximetry
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is usually referred to as a Sa02 value
indicating " a r t e r i a l " ) .
brain,

(the lowercase "a"

Of the total blood volume in the

about 70 percent is venous blood

1986, pp.

55-60).

Thus,

(Mchedlishvilli,

the rS02 index, while measuring

both arterial and venous oxyhemoglobin,

has average values

which are much closer to the oxyhemoglobin saturation of
venous blood.

For example,

subjects by Dujovny et al.
of 68.6%,

a normative study of 100
(1992)

found a mean rS02 index

and a standard deviation of 5.6%.

The

preponderance of venous blood within the brain does not
affect the ability of the Somanetics cerebral oximeter to
detect cerebral hypoxia

(Duncan,

1995; Williams,

Hardy, Mortimer,

1994).

Picton,

In fact,

Ruckley,

and Wildsmith,
and McCollum;

because cerebral hypoxia often results

from circulatory insufficiency rather than from abnormally
low arterial oxyhemoglobin values in the blood entering
the brain

(e.g.

such as those that might be caused by

respiratory d i s e a s e ) , the ability of NIRS to measure
venous oxyhemoglobin actually enhances its ability to
detect cerebral hypoxia.

A large number of clinical

studies have demonstrated the usefulness of NIRS in
detecting cerebral hypoxia
Slavin et al.,

(e.g.

Duncan et a l ., 1995;

1994; Williams et al.,

1994).
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The sampling rate and data averaging algorithms used
by the Somanetics oximeter also need be mentioned.

The

absorption data from both sensors is sampled at a rate of
15 Hz.

Instead of being displayed and updated

continuously,

the oximeter collects 50 data points

takes 3.33 seconds),

(which

and then averages these data and

outputs the result to the monitor.

The processing and

outputting of the 50 data points takes approximately one
and half seconds,

and during this time the oximeter does

not sample absor pt io n data.

The result is that the rS02

value displayed on the monitor,
in memory,

and all data points stored

including the rS02 index and the total

hemoglobin measure,
five seconds

are updated approximately once every

(it should be noted that a published review

of the Somanetics

instrument,

Dujovny et al.,

1994,

incorrectly stated that the instrument updates the rS02
value once every four s e c on ds ).

This data averaging

technique has the potential to slightly attenuate changes
in the absorption signal such as those that might occur
during oscillations of cerebral blood flow
If oscillations are present,

(i.e. B-waves).

data averaging can also shift

the peaks and troughs of the signal,

although the degree

of shifting is dependent on both the number of data points
averaged and the period of the oscillation.

However, the
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data averaging window used by the Somanetics oximeter is
only 3.3 seconds,

which should result in only very minimal

signal attenuation and shifting.
the Somanetics NIRS instrument
the present study)

The primary drawback to

(at least for purposes of

is that only one data point can be

obtained every five seconds.
The sensors supplied for the Somanetics oximeter are
small

(3.75 by 1.75 inches)

and self-adhesive.

typically placed on the forehead,

They are

and it is recommended

that they not be placed over the midline in order to avoid
oversampling venous blood from the mid-sagittal sinus.
The recommended placement location on the forehead
positions the sensor over the frontal p o l e s — areas which
are perfused predominately by the middle cerebral artery.
This recommended sensor location was used in the present
study.

Because B-waves are thought to reflect vasomotor

activity that occurs simultaneously throughout the entire
cerebral arterial tree,
present study,

an assumption was made in the

that recording rS02 over the frontal poles

would accurately reflect the rS02 changes that were
occurring elsewhere in the brain,

including those in the

distal territory of the callosomarginal branch of the
anterior cerebral artery.

Thus,

it was assumed that the

recording location used in this study would not prevent

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission .

170

valid tests of the experimental hypotheses from being
conducted.

None the less,

it should be pointed out that

the variables measured by the Somanetics oximeter
and absorption at the isobestic point)

(rS02

are not direct

measures of intracranial pressure or blood flow velocity,
and at present it is unknown if these oximetry variables
correlate with variables measured by other techniques that
have been used to measure B-waves

(intracranial pressure,

blood flow velocity).
In the present study,
a personal computer,

the rSO- data was sent to both

and to a polygraph chart recorder to

be displayed along with several other physiologic
variables being monitored.

Unfortunately,

of a voltage attenuater with the polygraph,

despite the use
the small

changes in rS02 that were present were essentially not
visible on the chart recording.

It was initially hoped

that changes in the rS02 signal would be visible on the
chart recorder so that figures showing the relationship
between the rS02 signal and sensory/motor events could be
generated from the analog chart recording.
The proposed study included three groups of subjects:
one group with moderate to severe RLS, one group with PLMS
only,

and one group of control subjects who are without

any sleep complaints.

Each subject underwent a Suggested
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Immobilization Test

(SIT)

lasting one hour,

one full night of polysomnography.

just prior to

During the SIT,

the

subject was required to lie supine on the bed while
attempting to remain completely still.

This test was

originally designed as a method of documenting the
excessive motor activity that occurs in RLS patients
during prolonged inactivity
1990).

During the SIT,

(Lorrain and Montplaisir,

lower leg motor activity and

several other physiologic variables were recorded
po ly gr ap hi ca l ly .

Abnormal leg sensations were recorded by

having the subjects depress a switch which placed a mark
on the time line signal of the polygraph.

The

polysomnographic recordings included measurements of
cerebral oximetry

(rS0;) , EEC activity,

(electrooculogram,
activity,

air flow,

eye movements

E O G ) , submental electromyogram
respiratory effort,

(smEMG)

electrocardiogram,

and muscle activity from the anterior tibialis muscles
(atEMG).
The following experimental hypotheses were tested:
1) It was predicted that the RLS patients would have
significantly greater sensory and motor indices (number of
events per hour) during the SIT than the PLMS subjects and
the control subjects, while no significant difference
between the PLMS and control subjects were expected.
2) It was predicted that the RLS and PLMS patients would
have significantly higher PLM indices than the control
subjects, and more disturbed sleep as indicated by the
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following: Lower sleep efficiency, lower slow wave sleep
percent, higher Stage 1 percent, more sleep stage changes
per hour of sleep, more Stage 1 periods per hour of sleep,
and more transient arousals per hour of sleep (the sum of
the spontaneous and PLM arousal indices was u s e d ) • In
addition it was predicted that the RLS patients would have
significantly less total bed time during the recording
period, and a significantly longer sleep onset latency,
than the PLMS and control subjects.
3) It was predicted that the abnormal leg sensations in
RLS patients during the SIT would be brief (averaging less
than five seconds in duration) and periodic (at least 80
percent of the total number would to conform to the
scoring criteria currently in use for P LM S) .
4) It was predicted that the mean peak to trough amplitude
of the B-wave activity (in the rS02 index) in RLS patients
during periods where symptoms were present during the SIT
would be significantly greater than the mean amplitude of
B-wave activity occurring in normal subjects and PLMS
patients during the SIT.
The B-wave amplitudes between
the PLMS and control groups were not expected to differ
significantly.
5) It was predicted that the mean peak to trough amplitude
of the B-wave activity in RLS and PLMS patients during
sleep (when PLMs were present) would be significantly
greater than the mean peak to trough amplitude of B-wave
activity during sleep in the normal control subjects.
The
B-wave amplitudes between the RLS and PLMS groups were not
expected to differ significantly.
6) It was predicted that the sensory and motor events in
RLS patients during the SIT would occur at the rS02 B-wave
troughs, and that the average rS02 values occurring at the
beginning of the sensory and motor events would be
significantly lower than the average B-wave trough rS02
values (or average rS02 values if no B-waves were present)
of the PLMS and normal control subjects.
Similarly, it
was predicted PLMs during sleep would occur at rS02 B-wave
troughs, and that the average rS02 values at the beginning
of PLMs in the RLS and PLMS subjects would be
significantly lower than the average B-wave trough rS02
values (or average rS02 values if no B-waves were present)
of the normal controls during sleep.
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7) It was predicted that in RLS and PLMS subjects, the
average rS02 values occurring at the beginning of each
sensory and motor event during the SIT, and at the
beginning of each PLM during sleep, would be significantly
lower than the average rS02 values occurring at the next
peak of the B-wave cycle (or the highest value in the next
40 seconds if no B-waves were pre se nt ) .
8) It was predicted that in RLS and PLMS patients, a
significantly greater percentage of sensory and motor
events during the SIT, and PLMs during sleep, would occur
at a single point in the B-wave cycle (i.e. trough, peak,
ascending limb, descending limb) rather than occurring
randomly in the c y c l e .

Subjects
Subjects were nine patients with moderate to severe
RLS

(five males,

four females, mean age 50.3 years),

patients with PLMS

(four males,

two females, mean age 49.2

y ea r s ) , and eleven normal controls
females,

mean age 4 6.2 years)

six

(five males,

six

who were without clinically

significant sleep complaints or abnormal sleep/wake
cycles.

Two additional subjects were run,

from the data analyses;

but excluded

one because of unacceptably poor

signal quality readings in the rS02 data for most of the
night,

and one because she could not be classified as

either a PLMS or control subject based on the criteria
described below.

In addition,

the SIT data from one

control subject were not used because he fell asleep
repeatedly during the SIT.

There were no significant

differences among the groups in age

(F

2, 23, = 0.41, p =

.67) .
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In order to be included in the RLS patient group,
subjects had meet the International RLS Study Group
criteria for RLS

(Walters,

1995).

Briefly,

they had to

report all four of the following characteristics:
desire to move the limbs,
paresthesias,

1) A

usually associated with

2) Motor restlessness,

3)Symptoms worse at

rest with at least partial relief by activity,

and 4)

Symptoms had to be worse in the evening and/or night.

A

modification of the A SD A severity criteria for RLS
(D.C.S.C.,

1990) was used to define "severe" RLS.

Specifically,

RLS patients were included only if they meet

the following modification of the D.C.S.C.
"severe" RLS:

criteria for

1) symptoms cause significant delay of

sleep onset, moderate disruption of sleep,

and mild

impairment of daytime functions, and 2) symptoms occur
three or more times a week.

Significant delay of sleep

onset was defined as a sleep onset latency of thirty
minutes or greater during nights when symptoms were
present, while moderate disruption of sleep was defined as
a total sleep time of six and half hours or less during
nights when symptoms were present or a self-report of
moderately disturbed sleep.

This modification of the

severity criteria was based on clinical experience which
has shown that many patients have symptoms that are

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

175

relatively frequent while being moderate in severity.
Seven of the nine RLS patients had been previously
diagnosed with RLS by a physician,

and six of these were

being treated at the time they entered the study (three
with L-Dopa,

two with clonazepam,

propoxyphene).

and one with

As per the study protocol,

these subjects

did not take their RLS medications on the day
they participated in the study.

(and night)

All of these subjects

obtained written approval from their physician to
participate in the study,

and to abstain from their

medication for 24 hours.

Phone interviews and a 42-item

self-report questionnaire called the "Restless Legs
Questionnaire"

(Hurry,

unpublished;

see Appendix 1) were

used to assist in making a probable diagnosis of RLS in
the two patients who had not formally diagnosed with RLS,
and also to confirm the diagnosis in those who had been
previously diagnosed.

Seven of the nine RLS subjects had

PLMS while asleep.
It was initially proposed to require PLMS subjects to
have ten or more PLMs per hour of sleep.

However, because

of the difficulty in finding and recruiting these
subjects,

one subject with a PLMi of seven was included

(the other five subjects all had a PLMi of ten or m o r e ) .
PLMs were recorded and scored according to standard
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criteria

(ASDA Atlas Task Force,

1993).

Briefly,

each

movement had to be a 0.5 to 5.0 second burst of anterior
tibialis EMG activity that was part of a sequence of at
least four such movements,

each of which were separated by

more than 5 but less than 90 seconds.

In order to be

certain that only unambiguous PLMs were used in the data
analyses,

only those PLMs which occurred in a series of at

least ten PLMs were used in the data analyses.

All six of

the PLMS subjects were recruited as normal controls; none
had any complaint of insomnia or non-restorative sleep.
The normal control subjects did not have any
significant sleep disturbances or excessive daytime
sleepiness as indicated by their responses on the
screening questionnaires

listed below.

They also reported

having relatively normal and typical sleep/wake cycles;
e.g., bedtimes after sunset,
after sunrise daily,
each day.

wake times soon before or

with no more than two hours variation

Three of the control subjects had PLM indices

of five or more

(5.5,

5.6,

and 6.0), but were included as

controls because none of their movements occurred in a
series of at least ten movements.

Another subject who had

a PLMi of 14.8 with no movements occurring in a series of
least ten movements was excluded from the study because
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the highly variable IMIs of her movements cast doubt on
whether or not they were actually PLMs.
Four subjects
control)

(one with RLS,

two with PLMS, and one

had an Apnea plus Hypopnea Index of ten or more

(the AHIs were 10,

14,

16, and 22, all indicative of a

mild or moderate disorder).

In two of these subjects,

events occurred primarily in supine REM,

the

in one subject

the events occurred primarily in REM regardless of sleep
position,

and in one subject the events occurred primarily

near sleep onset regardless of sleep position.

Because

the respiratory events in these subjects were not related
to any observed PLMs,

and because sufficient sleep time

free from respiratory events occurred in these subjects,
all four of these subjects were included in the data
an a l y s e s .
As part of the subject screening and selection
process,

all subjects

(patients and controls)

the Sleep Disorders Inventory,

a 64-item questionnaire

used to screen for a range of sleep disorders
unpublished;

see Appendix 1) .

completed

(Waters,

Each subject was also

required to complete two weeks each of an 11-item Sleep
Diary
1987),

(filled out each morning; modified from Lacks,
and a 15-item Daily Sleepiness Scale-Form D (Hurry

and Waters,

1996;

see Appendix 1) which was filled out
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each evening.

These measures were used to rule out

subjects with suspected sleep apnea syndromes,
psychophysiological insomnia,

narcolepsy,

and other sleep

disorders.
RLS patients were recruited by several methods,
including a men ti on of the study in a local
LA) newspaper editorial column

(Baton Rouge,

(Smiley Anders'

column in

The Advoc at e ) , notices placed at several local area
department and grocery stores,

letters describing the

study that were sent to members of the local Restless Legs
Syndrome Foundation Support Group,

and a notice describing

the study that was placed on the Psychology experiment
sign-up board in Audubon Hall.

The RLS patients who were

receiving medica ti o n for their RLS were required to obtain
written approval from their physician to temporarily
withdraw from treatment before participating in the
research project

(for one day/ni gh t) .

As noted earlier,

all six of the PLMS subjects were

recruited as normal control subjects;
previously diagnosed with PLMS,

none had been

nor were any of them

receiving any medication for any sleep-related problem.
The PLMS subjects were recruited from among the older
L.S.U. undergraduate psychology students and parents of
younger L.S.U.

students enrolled in undergraduate
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psychology courses.

PLMS subjects who were students

themselves were given extra credit in their psychology
courses for their participation in the study.

PLMS

subjects who were the parents of students were not
directly compensated for their participation.

However,

their children were given extra credit in their psychology
courses for their assistance in recruiting their parents
as subjects for the study.
The normal subjects were also recruited from among
the older L.S.U.

students and parents of students enrolled

in undergraduate psychology classes.
group,

As with the PLMS

control subjects who were students themselves were

given extra credit in their psychology courses for their
p articipation in the study.

Control subjects who were the

parents of students were not directly compensated for
their participation;

instead,

their children were given

extra credit in their psychology courses for their
assistance in recruiting their parents as subjects for the
study.

Near the end of the data collection period,

approval was obtained from the Institutional Review Board
to recruit control subjects with notices placed at local
department and grocery stores,

and to compensate these

subjects with a $25.00 payment for their participation.
Two control subjects were recruited in this manner.
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Cancellations,

no-shows,

and last-minute rescheduling

were a problem during the data collection period,

and

contributed to the low sample sizes achieved.

In all,

there were eleven instances of cancellations,

no-shows,

last-minute rescheduling;

or

almost all of these involved

weekend nights.

The SIT and polysomnograms were conducted in the
L.S.U.

Department of Psychology's Psychophysiological

Laboratory,

which contained a ten by eleven foot sound-

attenuated subject room,
room.

and a similarly sized instrument

The subject room was furnished with a full-size bed

(measuring approximately 54 by 75 inches), a recliner,
nightstand,

a television and VCR,

containing s u p p l i e s .
infrared lamp

a

and two cabinets

The room was also equipped an

(mounted above the door) , and a JVC model

TK-S240V video camera.

These were used to monitor the

subject visually during the recordings.

The camera was

connected to a Toshiba TVM-1202 12 inch black and white
monitor which was located in the instrument room.
The cerebral oximeter used in the study was the
Somanetics

(Troy, Michigan)

INVOS 3100A cerebral oximeter

with software version V5.13X5.
small sensor
small

This device consisted of a

(3.5 by 1.75 inches)

that connected to a

(7.5 by 5.3 by 1.75 inch) preamplifier via a five
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foot cable.

The Somanetics corporation loaned us two of

these instruments for use in the study.
were located in the subject room,

The preamplifiers

and were connected to

the oximeters via the supplied fifteen foot cable.
oximeters were located in the instrument room,
relatively small in size
Analog output
index)

The

and were

(13.6 by 12.3 by 6.4 inches).

(a zero to ten volt signal of the rS02

from the oximeter was sent to the J5 input of a

Grass Instruments Model 7P122 low level DC amplifier with
the signal amplitude reduced down to a maximum of one volt
with a locally constructed voltage divider

(instructions

for making the voltage divider were provided by the
Somanetics c o r p o r a t i o n ) .

The digital output from the

oximeter was sent to a Dell Optiplex GXi Pentium
processor-based personal computer via a null modem cable.
The Hyperterminal program included with Windows 95 was
used to display and store the data on the computer.

The

data were retrieved for subsequent analysis by loading
them into a spreadsheet program

(Microsoft Excel).

Leg movement activity from both legs,
sensations,

one channel of EEG

respiratory effort,

(C4/A1),

abnormal leg

nasal airflow,

and peripheral pulse oximetry were

recorded during the SIT on a Grass Instruments
Massachusetts)

Model 7D polygraph.

(Quincy,

Specifically,
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tibialis EMG was recorded from both legs using Grass
Instruments 10 mm gold cup electrodes,
electrode site placements

and standard

(ASDA Atlas Task Force,

1993).

Each of the tibialis EMG signals was sent to a Grass
Instruments Model 7P511 EEG amplifier,

with the

sensitivity set so that a slow 30 degree dorsiflexion and
plantarflexion of the great toe produced an EMG burst that
was 7 5% of the amplitude of the full scale deflection
range of the pen.

Leg sensations were recorded by having

the subjects depress a signal marker that was connected to
the power supply of the Grass polygraph via an eight foot
cable.

This signal was displayed on the time line of the

chart recorder.

EEG

(C4/A1) was recorded with Grass

Instruments 10 m m gold cup electrodes,

with the signal

sent to a Grass Instruments Model 7P511 EEG amplifier with
the sensitivity set at 5 uV/mm.

Nasal airflow was

recorded with Rochester Electro-Medical "no casing" wiretype thermocouple which was taped beneath the nose.
Respiratory effort was recorded with an EPM Systems
(Midlothian,

Virginia)

"Resp-EZ respiratory belt.

Both

the airflow and respiratory effort signals were sent to
Grass Instruments Model 7P511 EEG amplifiers,

with the

sensitivity settings varied to keep the waveform between
50 and 75% of the full scale deflection of the
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Peripheral pulse oximetry was recorded

with a Criticare Systems
oximeter.

(Waukesha, WI)

Model 504 PONI

The "clothespin-type" sensor supplied with the

oximeter was attached to either the index or middle finger
of the left hand.

The analog output signal from the

oximeter was sent to a Grass Instruments Model 7P122 lowlevel DC amplifier.
The polysomnograms were recorded on a Bio-Logic
Systems Sleepscan computerized polysomnograph.
EOG,

submental EMG,

electrocardiogram,

The EEG,

and tibialis EMG

signals were transduced with Grass Instruments 10 mm gold
cup electrodes.

The airflow signal was recorded with an

oral/nasal thermocouple manufactured by Pro-Tech Services
(Woodinville,

Washington).

Respiratory effort was

recorded with an EPM Systems "Resp-EZ" respiratory belt.
Procedure
All subjects were initially screened by phone to
determine if they were likely to meet criteria for
inclusion into the study.

If they did,

they were sent a

packet of questionnaires containing two copies of the
consent form
Inventory,
Scales

(see Appendix 2) , the Sleep Disorders

the Daily Sleep Dairy,

and Daily Sleepiness

(RLS patients also received the Restless Legs

Qu es t i o n n a i r e ) .

These packets took two weeks to complete.

After they were returned,

all questionnaires were
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reviewed,

and a final decision was made to either include

or exclude each potential subject in/from the study.
Subjects selected for inclusion into the study were
required to report to Audubon Hall at L.S.U.
three hours prior to their normal bedtime.

approximately
In order to

run the SIT as close as possible to a subject's normal
bedtime,

all electrodes and recording devices were

attached prior to conducting the SIT.
The EEG electrode sites

conformed to the

international "Ten/Twenty" system specified by Jasper
(1958), and included electrodes at the following sites on
the scalp and mastoids:
channel of EEG
polygraph,

(C4/A1)

Oz, Al, A2, C3,

One

was recorded on the Grass

while two channels

on the Sleepscan.

and C 4 .

(C3/A2,

0z/C3)

were recorded

The C4/A1 and C3/A2 derivations are the

standard bipolar derivations recommended by Rechtschaffen
and Kales
derivation

(1968)

for recording sleep.

(0z/C3)

The occipital

was included so that alpha activity

could be optimally visualized.

Submental EMG was recorded

by placing gold cup electrodes on the chin and over the
masseter muscle.

Electrooculogram was

gold cup electrodes at sites

recorded by placing

that were one centimeter away

from the outer canthus of each eye, with both electrodes
referred to the Al electrode.

The oral/nasal thermocouple
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was taped just under the nares with a hypoallergenic cloth
tape

(Dermicel,

Johnson & J o h n s o n ) .

The electrocardiogram

was recorded by placing one gold cup electrode near each
shoulder just under the clavicle,
Lead 1 ECG lead.

thus approximating the

Respiratory effort was recorded by

placing the respiratory belts over the bedclothes just
below the ribcage
n a va l) .

(approximately three inches above the

Regional cerebral hemoglobin oxygen saturation

was recorded by placing the
sensor on the

Somanetics self-adhesive

forehead just lateral to the midline.

The

left side of the forehead was used for all but four
subjects.

The right side was used for two RLS subjects

who reported having worse symptoms in their left legs,
for two of the controls

and

(to control for any possible

hemispheric differences in blood flow and hemoglobin
oxygen saturation).
and one PLMS subject)

In three bald subjects

two recording sites were used for

measuring cerebral oximetry:
of the head.

(two controls

the forehead and the vertex

For the vertex recording sites,

the sensor

was placed on

the same side as the forehead sensor,with

the long edge

of the sensor at the midline,

midpoint of the sensor at the Cz site.
end of the sensor was placed anteriorly.

and the

The light emitter
This site should

have placed the sensor over the sensory/motor cortex for
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the legs and torso.

Anterior tibialis EMG was recorded

with gold cup electrodes placed over the anterior tibialis
muscle as specified by the ASDA Atlas Task Force

(1993).

EEG electrodes were attached to the scalp using collodion
soaked gauze squares,
blower.

which were dried with a small air

Gold cup electrodes attached to sites other than

the scalp were secured with nypoallergenic cloth tape
(Dermicel,

Johnson & J o h n so n) .

All electrode sites in

which Grass gold cup electrodes were used
submental EMG,

ECG,

tibialis EMG) were cleaned and

slightly abraded with a pumice based soap
Weaver & Co.).
conductive paste

(EEG, EOG,

(Omni-Prep,

D.O.

The gold cup electrodes were filled with a
(Ten20,

D.O. Weaver & Co.).

The

recording site for the Somanetics sensor was cleaned with
an alcohol/acetone prep pad as per the manufacturer's
recommendations.

The EEG electrodes were removed in the

morning with gauze soaked in an acetone/water solution.
After all electrodes and recording devices were
attached

(which took approximately one hour and forty-five

minutes), the subjects were allowed to move around for
several minutes,

so that any restlessness that developed

during the electrode hookup could be alleviated.
Suggested Immobilization Test

The

(SIT) began with the subject

being instructed to lie down quietly in the bed with eyes
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open, while attempting to remain completely still.

The

subjects were further instructed that if they felt as if
they had to move,

they should move as little as possible

and for as short of a period of time as possible.

Only

one RLS subject actually had to get up out of bed during
the SIT.

The subjects were also instructed to depress the

button on the hand-held event marker whenever they felt an
abnormal sensation in their legs.

During the SIT,

the

experimenter continuously monitored the polygraph and
cerebral oximeter,

and about once ev er y 90 seconds

simultaneously marked the time on b oth instruments by
depressing the event marker on each.

The time associated

with the event mark in the oximetry data

(which was

displayed on the computer monitor)

was subsequently noted

on the polyg ra ph chart recording.

The SIT lasted for a

period of 60 m i n u t e s .
Following the SIT,
restroom,
night.

subjects were allowed to use the

and then the lights were turned out for the

A recording period of at least six hours was

required during each PSG.

During the recording,

the

experimenter m ar k e d each PLM by depressing the event
marker on the oximeter.

The oximeter time and Sleepscan

epoch were also frequently marked and noted on the chart
recording.

A f t e r the PSG was terminated,

the electrodes
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and other recording devices were removed,
was asked to fill out a Daily Sleep Diary.
thanked for their participation,

and the patient
They were then

and allowed to go home.

The polysomnograms were scored manually using sleep
stage criteria specified by Rechtschaffen and Kales
(1968), arousal scoring criteria specified by the American
Sleep Disorders Association

(1992), apnea and hypopnea

scoring criteria specified by Bliwise,
and Dement

(1984),

Bliwise,

Kraemer,

and leg movement scoring criteria

specified by the A S D A Atlas Task Force

(1993).

The

following summary statistics were derived from the PSG
data:

total bed time expressed as a percentage of total

lights out time,

sleep efficiency

(i.e. total sleep time

expressed as a percentage of total bed t i m e ) , sleep onset
latency

(time in minutes

from lights out until the first

three consecutive minutes of sleep), percent Stage 1
sleep, percent Stage 2 sleep, percent slow wave sleep
(Stage 3 plus Stage 4 time expressed as a percentage of
total sleep t i m e ) , percent REM sleep

(expressed as a

percentage of total sleep time), number of PLMs per hour
of sleep,
sleep

number of apneas plus hypopneas per hour of

(the Apnea plus Hypopnea Index, A H I ), number of

transient and PLM-related arousals per hour of sleep
arousal index included all arousals not related to
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respiratory e v e n t s ) , number of sleep stage changes per
hour of sleep,

and number of Stage 1 periods per hour of

sleep.
The SIT recordings were marked in five second epochs
according to the time marks noted during the recording,
and the time data in the computer data file.

Each five

second epoch was then scored for movement in each leg and
for sensory events.

This information was then entered

into the spreadsheet data file containing the downloaded
oximetry data.
It was originally proposed to hand score individual
B-waves

(using a locally derived set of criteria)

as any

wave occurring in a series of at least four waves with a
period of between 15 and 120 seconds,

and an amplitude of

at least ten percent of the mean rS02.
proved to be far too time-consuming,

This initially

so spectral analysis

(using the "Proc Spectra" procedure in SAS)
determine wave periodicities,
to measure wave amplitudes.

was used to

while hand scoring was used
Subsequently,

B-wave

wavelengths were scored by hand for the r S02 index in
order to calculate the wave-to-wave change in wavelength.
To control

for individual variability in the absolute

value of the rS02 index,

the average B-wave amplitudes for

each subject were expressed as a percentage of the mean
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rSO; index for that subject.

Wave amplitudes were much

lower than the originally proposed ten percent value.
Wave periods were determined from the spectral analysis
graphs

(called p e r i o d o g r a m s ) which plotted spectral

density on the y-axis and wave period on the x-axis.
Spectral density is an indicator of relative wave
frequency and amplitude.
showed multiple peaks
more on occasion)

The periodograms typically

(varying in number from 2 up to 8 or

in the 15 to 90 second range.

A peak

was defined as any point that was 17% or higher than each
of the adjacent troughs
trough amplitude).

(17% represents one sixth of the

For each subject,

up to two peaks were

counted in each of four 20 second ranges:
seconds,
seconds.

31 to 50 seconds,

11 to 30

51 to 70 seconds,

and 71 to 90

The period axis was divided into these four

ranges because there was a clear tendency for the spectral
density value to increase as the period increased

(most

likely due to higher amplitudes in waves with longer
wavelengths) .

The 0 to 10 second range was excluded

because 10 seconds represented the m i n i m u m wavelength that
could be measured with the oximeter's 0.2 Hz sampling
rate; thus,

the periodograms contained no spectral density

values in the 0 to 10 second range.

Peaks were counted

only if they were at least 17% higher in amplitude than
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the third highest p ea k in the twenty second range

(both

peaks were counted if no third peak was p r e s e n t ) .

The

periods associated with these peaks were estimated to the
nearest second dir ec t ly from the graphs.
For the analyses investigating where PLMs and SIT
sensory and motor events occurred in the B-wave cycle,
set of scoring rules were developed

(see Appendix 3) to

determine if a given rS02 point was a trough,
point,

a peak,

a d es ce nd in g point,

an ascending

or a stable point.

similar analyses w i th the total hemoglobin data,
points were scored

(trough,

a

ascending,

peak,

For

only four

descending) ,

because the data points varied on a much finer scale,
were never stable for more than two observations.

and

This

was in contrast to the r S02 data which could remain at the
same value for m uch longer periods of time.
reliability of these scoring rules,

To assess the

two scorers

independently scored eight rS02 files and thirteen total
hemoglobin files.

The percent agreement between the two

scorers was 99% for the r S02 files and 92% for the total
hemoglobin files.
If any subject had respiratory events during the PSG,
then the oximetry data recorded during the event,
minute prior to and after the event,
analysis.

Similarly,

and one

were excluded from

if a normal control subject did have
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PLMs during the PSG,
sequence(s)

the oximetry data throughout the PLM

were excluded from the data analyses.

B-wave amplitudes and periods were scored for the
entire SIT period for all subjects

(no RLS subject had any

substantial period during the SIT without any symptoms) .
For the sleep data in PLMS subjects,

B-wave amplitudes and

periods were scored during all PLM series that contained
at least ten PLMs each.

Three of the thirteen subjects

who did have PLMS had one such PLM series,
series,

two had three series,

The rS02 data

seven had two

and one ha d four series.

(e.g. wave amplitudes,

rS0 2 at PLMs) were

averaged across all periods for each subject,

with the

duration of each series being used to weight the data
points for each s e r i e s .
PLMS subjects,

To obtain the rS02 data in non-

single 60-minute sections of sleep were

used for three subjects,

and two 30-minute sections of

sleep were used for eleven subjects.

These sections of

sleep were specifically selected to exclude awakenings and
major arousals associated with sleep posi ti on changes,
were also matched to the sleep cycle
selected for the PLMS subjects

(e.g.

and

of the sleep periods
first,

second,

third,

etc 90-minute sleep c y c l e ) .
Statistical Analyses
Because of the small sample sizes,

and the number of

tests needed to analyze all the questions of interest,
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alpha level adjustment procedure
employed.

(described below)

was

The hypotheses stated above were divided into

two groups which differed in their importance with respect
to testing the PCI theory of RLS and PLMS,

and with

respect to the nature of the dependent variables involved.
The most important hypotheses tested were those concerning
group differences in the rS02 index during the SIT and
PSG, the analyses concerning within subjects differences
in the rS02 index at the beginning of RLS/PLMS symptoms
compared to the rS02 index occurring at the B-wave peaks,
and the analyses concerning within subjects differences in
the percentage of RLS sensory/motor events and PLMs
occurring at different points in the B-wave cycle.

The

hypotheses of secondary importance were those concerning
group differences in the SIT and PSG variables.
Differences in these variables were expected to occur
(based on the procedures used to define the grou p s) , but
were not directly relevant to tests of the PCI theory of
the pathogenesis of RLS and PLMS.
In order to use alpha levels that reflected the
differing importance of the experimental hypotheses,

the

statistical tests of the rS02 data employed an alpha level
based on the total number of tests used to analyze the
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rSO: data

(20), while the statistical tests of the SIT and

PSG data employed an alpha level based on the total number
of statistical tests used in the entire study

(53).

This

use of different alpha levels to test hypotheses of
differing importance is recommended by Tabachnick and
Fidell

(1989,

pp. 49-50).

In addition to this,

a multistage Bonferroni

procedure for adjusting alpha levels described by
Larzelere and Mulaik

(1977)

was used.

Although this

procedure was developed for use in correlational analyses,
Huberty and Morris

(1989)

recommended it for studies in

which multiple ANOVAs were to be used.
based on Monte Carlo studies,
Larzelere and Mulaik

(1977),

The procedure is

briefly described in
which showed that the

Bonferroni procedure is unnecessarily conservative when a
large percentage of the hypotheses tested involve null
hypotheses that are actually false.

This multistage

Bonferroni correction procedure is conducted as follows.
In the first stage,

the traditional Bonferroni procedure

of dividing the alpha level

(.05)

(20 and 53 in the proposed study)
initial alpha level.

by the number of tests
is used to determine the

If none of the statistical tests

reaches significance at this level,

then one stops

none of the null hypotheses having been rejected).
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or more tests do reach significance at this
one moves to the second stage.

level,

then

In the second stage, a new

corrected alpha level is determined by dividing the
traditional

.05 alpha level by the number of tests in the

first stage in which the null hypothesis was not rejected.
The results of the statistical tests are then re-examined
using this new alpha level.

As before,

of the tests are significant,

one stops if none

or moves to another stage if

at least one of the null hypotheses is rejected.

The

procedure ends when one reaches the point at which none of
the remaining null hypotheses are rejected.
To employ this procedure in the proposed study,

the

twenty tests involving the rS02 data were initially
examined using an alpha level of .0025, while the tests
involving the SIT and PSG variables were examined using an
alpha level of

.001.

The tests of the rS02 B-wave amplitude during the SIT
and PSG involved a total of six pairwise comparisons of
interest.

These included all three possible pairwise

comparisons of the rS02 B-wave amplitude during the SIT,
and all three possi bl e pairwise comparisons of the rS02 Bwave amplitude during the PSG.
analyzed with p l a n n e d F-tests,
for the two group means.

These six tests were
using weights of 1 and -1

For the directional hypotheses,
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the p level attained was divided by two,

since the

statistical package that was used only gives a p value for
a two-tailed hypothesis.
The analyses involving the rS02 value at the
beginning of SIT sensory/motor events and the beginning of
PLMs during sleep involved a total of five tests.

These

included all three pairwise comparisons for SIT motor
events

(both RLS and PLMS subjects had motor events,

they

were compared to each other and to the control m e a n ) , RLS
versus controls for SIT sensory events

(the PLMS and

control subjects did not have sensory events) , and all
patients with PLMs versus controls for the sleep data.
It was originally proposed to compare the average
rS02 values occurring at the beginning of these events in
patients

(SIT sensory and motor events,

and PLMs in sleep)

to the average B-wave trough rS02 values in the normal
subjects.

This was proposed because it was predicted that

events in the patients would occur at the B-wave troughs.
This prediction was not confirmed;
those comparisons,

therefore,

in lieu of

non-directional tests were performed

comparing the average rS02 values at the event onsets in
the patients to the mean values for the controls

(the

small number of SIT epochs with movement in the control
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subjects were not used in computing their average rS02
v a l ue s) .
There were six additional tests proposed involving
within subjects analyses.
following:

These tests included the

(1) in RLS subjects,

the average rS02 at SIT

sensory and motor events were to be compared to the
average rS02 value at the next B-wave peak
(2) in all patients with PLMs
subjects),

(two tests);

(both RLS and PLMS

the average rS02 at PLMs were to be compared to

the average rS02 value at the next B-wave peak

(one test);

(3) the percentage of SIT sensory and motor events in RLS
subjects occurring at each point in the rS02 B-wave cycle
were to be compared using a within subjects ANOVA
Square goodness of fit test was used instead;
and

(4)

(a Chi

two tests);

in all patients with PLMs the percentage of PLMs

occurring at each point in the B-wave cycle were also to
be compared using a within subjects ANOVA

(again,

Square goodness of fit test was used; one test) .

a Chi
Because

the last three tests were so important for testing the PCI
theory,

it was decided to conduct three similar tests with

the total hemoglobin data.

These additional tests

increased the total number of tests to twenty for the
oximetry data.

As noted above,

the prediction that PLMs

and SIT sensory/motor events would occur at B-wave troughs
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was not confirmed.

Therefore,

in lieu of those analyses

(the first three discussed ab o v e ) , non-directional pairedsample t-tests were performed comparing the rSO- values at
the onset of PLMs and SIT sensory/motor events to the
average rSO; values where no abnormal sensations,
movement,

or PLMs were present.

Table 1 summarizes the 20 tests involving che
oximetry data,

and the predictions made for each of them.

The last two tests listed in the table actually represent
a total of six tests

(SIT sensory and motor events in both

the rS02 and total hemoglobin B-wave cycles
subjects),

and PLMs in both B-wave cycles

(for the RLS
(for the PLMS

subjects).
The SIT and PSG data involved a total of 33 pairwise
comparisons,
tests.

all of which were tested with planned F-

These 33 tests and the predictions associated with

them are summarized in Table 2.

All of the hypotheses for

tests involving comparisons between the RLS and normal
control groups were directional,

while six of the eleven

comparisons between the PLMS group and the normal group,
and five of the eleven comparisons between the RLS and
PLMS group,

were directional.

Two of the comparisons

between the PLMS and normal controls

(those for the SIT

sensory index and total bed time variables)

involved
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Table 1. Sum ma ry of Statistical Tests of rS02 Data

Comparison

V a r i a b l e (s )

Prediction

RLS & Normals

SIT B-wave amplitude

RLS > Normals

PLMS & Normals

SIT B-wave amplitude

none

RLS & PLMS

SIT B-wave amplitude

RLS > PLMS

RLS & Normals

PSG B-wave amplitude

RLS > Normals

PLMS & Normals

PSG B-wave amplitude

PLMS > Normals

RLS & PLMS

PSG B-wave amplitude

RLS = PLMS

RLS & Normals

SIT sensory/mean rS02

RLS = Normals

RLS & Normals

SIT motor/mean rS 0 2

RLS = Normals

PLMS & Normals

SIT motor/mean rS 0 2

PLMS = Normals

RLS & PLMS

SIT motor event rS02

RLS = PLMS

PLMS & Normals

PLM/mean rS02

PLMS = Normals

RLS

(Within Ss)

SIT sensory rSO;

event=no event

RLS

(Within Ss)

SIT motor rS02

event=no event

PLM and no-event rS02

PLM = no PLM

% of events at various
points in B-wave cycle

significant

% of PLMs at various
points in B-wave cycle

significant

PLMS
RLS

PLMS

(Within Ss)
(Within Ss)

(Within Ss)

predictions that there would be no group differences,
while no p rediction was made for the PLMS/normal group
comparisons on three other dependent variables.
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Table 2. Summary of Statistical Tests of SIT and PSG Data

Variable

RLS/Normals

PLMS/Normals

RLS/PLMS

SIT Sensory

RLS > Normals

PLMS

RLS > PLMS

SIT Motor

RLS > Normals

none

RLS > PLMS

PLM Index

RLS > Normals

PLMS > Normals

none

Bed Time

RLS < Normals

PLMS = Normals

RLS < PLMS

Efficiency

RLS < Normals

none

RLS < PLMS

Latency

RLS > Normals

none

RLS > PLMS

Light Sleep

RLS > Normals

PLMS > Normals

none

Percent SWS

RLS < Normals

PLMS < Normals

none

Arousals

RLS > Normals

PLMS > Normals

none

Stage Changes

RLS > Normals

PLMS > Normals

none

Stg 1 Periods

RLS > Normals

PLMS > Normals

none

Similarly,

Normals

no prediction was made for the RLS/PLMS

comparisons on six dependent variables because it was
unclear from the RLS/PLMS literature whether or not such
differences should be expected.

The eleven tests in which

either no prediction was made or in which no group
differences were predicted were tested with two-tailed
tests.
Finally,

one of the experimental hypotheses

2) was descriptive in nature,

(number

and did not require the use
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of an inferential statistical test.

This was the

prediction that waking sensory events in RLS subjects
would be brief and periodic.
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Results
SIT and PSG Data
The group means and standard deviations

for the SIT

sensory and motor indices and the nine sleep variables are
listed in Table 3.

A n examination of the standard

deviations shows that the RLS group had relatively high

Table 3. Group means for SIT and PSG data.

Variable1

RLS

PLMS

Controls

0.1

(0.3)

(12.8)

5.3

(5.7)

22.5

(14.3)

2.3

(2.5)

(15.3)

99.2

(1.2)

98 .7

(1.3)

89.6

(124.2)

19.2

(13.1)

21.5

(20.5)

Efficiency

67.0

(19.9)

84.4

(13.4)

81.6

(9.8)

Stage 1 %

12.4

(5.7)

(5.4)

14.5

(7.2)

SWS %

12.4

(13.6)

13. 9 (9.0)

14.7

(7.2)

Arousals

13.5

(4.6)

10.2

(4.4)

13.3

(3.9)

Stg Changes

24.7

(7.2)

23.5

(3.9)

25. 6 (7.2)

6.2

(2.2)

5.6

(2.9)

SIT SI

50.3

(60.4)

SIT MI

86.4

(40.7)

16.5

PLMi

35.0

(33.5)

%TIB

93.3

Latency

SI Periods

0 (-)

9.6

7.6

(2.9)

1) Abbreviations are as follows:
SIT SI = SIT sensory
index, SIT MI = SIT Motor index, PLMi = Periodic Limb
Movement Index, %TIB = Percent time in bed, Arousals =
Arousals per hour of sleep, Stg Changes = stage changes
per hour of sleep, SI Periods = Stage 1 Periods per hour
of sleep.
202
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relatively high standard deviations
group mean)
Similarly,

(relative to their

on the first six variables in Table 3.
the control group had high standard deviations

relative to their means on the four of the first six
variables

(SIT SI,

SIT MI,

PLMi, and L a t e n c y ) .

The SIT

sensory index was noteworthy in that no PLMS subject had
any abnormal sensations during the SIT,

while only one

control subject had a single abnormal sensation.

Levene

tests for homogeneity of variance on all eleven variables
in Table 3 were significant for the first six
MI,

PLMi,

%TIB, Latency,

and Efficiency).

(SIT SI, SIT

Shapiro-Wilk

tests for normality on all eleven variables for all three
groups showed that only two variables
Changes)

(Arousals and Stage

were normally distributed for all three groups.

Because of these departures from normality and homogeneity
of variance,

non-parametric Mann-Whitney U tests were used

in lieu of the planned F-tests for all variables except
Arousals and Stage Changes.

The Mann-Whitney test is a

rank procedure which yields a z-ratio with a p-level
corrected for ties.
Table 4 shows the z and t values

(and the p values

associated with t h e m ) , for the pairwise comparisons on the
eleven SIT and PSG variables.

Using the corrected alpha

level of .001, three of the comparisons in Table 4

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission .

204

Variable

RLS/Controls

SIT SI

-3.22

(.0007)

SIT MI

-3. 68

(.0001)

-2.95

(.0016)

-2.07

.04)

PLMi

-2.79

(.0026)

-0.24

(n.s. )

-3.34

.0004)

%TIB

-0.16

(n.s .)

-0.66

(n.s. )

i
o

CTl

Table 4. Statistical Results for SIT and PSG Data

n. s .)

Latency

-1.52

(n.s.)

-1.18

(n.s. )

-0.20

n. s .)

Efficiency

-1.71

(.04)

-2.36

(.009)

-0.70

n. s .)

Stage 1 %

-0.30

(n.s.)

-0.83

(n.s.)

-1.71

n. s .)

SWS %

-1.48

(n.s.)

-0.94

(n.s . )

1

o

n. s.)

Arousals

-0. 13

(n.s . )

1.43

(n.s.)

-1.49

n. s .)

0.32

(n.s . )

0.62

(n.s.)

-0.33

n. s .)

-1.07

(n.s.)

-0. 94

(n.s.)

-1. 61

n. s.)

would be considered significant:
RLS and controls,

(.0037)

-0.73

CM

SI Periods

-2. 68

PLMS/Controls

O

Stg Changes

RLS/PLMS

(n.s . )

the SIT SI between the

the SIT MI between the RLS and controls,

and the PLMi between the PLMS and controls.
comparisons reached low p values,

Four other

and would probably have

been significant if the sample sizes had been larger:
SIT SI between the RLS and PLMS subjects,
between the RLS and PLMS subjects,
RLS and control subjects,
RLS and PLMS subjects.

the

the SIT MI

the PLMi between the

and sleep efficiency between the

It is also worth pointing out that
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if the corrected alpha level had been set at

.0038

(which

would have held the experiment-wise Type 1 error rate at
0.2),

then the SIT SI and MI comparisons between the RLS

and PLMS groups,

and the PLMi comparison b etween the RLS

and control group would have been significantSIT Sensory Events in RLS Subjects
Individual subject data for the SIT sensory events is
presented in Table 5.

Two of the nine RLS subjects did

not report any abnormal sensations,

although one of these

did report a very low level nearly continuous awareness of
her usual sensory discomfort that she could not precisely
identify as being present at one moment and not the next.
Table 5 also lists the mean sensory event duration and
inter-event-interval

(IEI)

in seconds,

and the percent of

events which occurred in a series of at least

four events

with IEIs of greater than 5 but less than 90 seconds.
Only three subjects

(012,

020,

026) had a majo ri ty of

events that met the PLMS criteria of four events in a
series with IEIs of between 5 and 90 seconds;
when considering the full PLMS criteria

however,

(including event

duration of less than 5 seconds), only subjects 020 and
026 had a majority of their sensory events con f or m to the
full PLMS criteria.

If the IEI criteria were changed to

greater than 20 but less than 90 seconds,

then neither of
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Table 5. SIT Sensory Events in RLS Subjects

Subj1

# of
Events

Mean
Duration

Mean
IEI

% in series of 4
with IEI >5, <90s

012

52

9.5

59. 9

71%

017

24

1.1

145.0

0%

020

156

3.9

15.3

78%

034

22

0.5

163.5

0%

026

165

5.0

11.7

59%

030

9

1.2

375.6

0%

057

41

1.2

83.2

0%

1) Abbreviations:
interval.

Subj = subject,

IEI = inter-event-

these subjects would have ha d more than seven percent of
their events conform to the PLMS criteria.

Three of the

subjects had sensory events of relatively long duration
(012,

020,

and 026).

Not surprisingly,

fewer events had longer IEIs.

subjects with

In general,

the sensory

events observed in these RLS patients did not appear
similar to PLMS in their temporal characteristics.

A good

description of RLS sensory events based on the present
data w o u ld be that their temporal characteristics are
highly variable between subjects.
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The movem e nt data in the RLS subjects also deserve
brief comment.

The average MI for both legs ranged from

21 to 150, with the group mean being 86.

Movement was

much more prominent than abnormal sensations.
example,

when considering group means,

For

abnormal sensations

were present for 18% of the five second SIT epochs,

while

movement was present for 44% of the five second SIT
epochs.

Only three subjects had any clear periodicity to

their movements,
waking PLMs.

including one who appeared to be having

A more common finding,

particularly near the

end of the SIT was that the movements were often of long
duration

(i.e.

greater than 30 seconds)

nearly continuous.

and were sometimes

Similar movement was observed prior to

sleep onset in several subjects during the PSG recording.
In addition,

when symptoms were severe,

observed were quite agitated in nature,

the leg movements
and included

vigorous shaking and even stamping of the legs.

Thus,

abnormal movem en t was a more prominent feature in these
RLS patients than were abnormal s ensations.

Qy;uretry.Pa£.3
Group m ea n s and standard deviations for the SIT rS02
B-wave amplitudes were as follows;
percent,

PLMS:

0.5 percent.

2.5 ± 0.7 percent,

RLS:

3.1 + 0.9

and Controls:

2.6 ±

These values are the group means of the

average wave amplitude for each subject expressed as a
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percentage of that subject's mean rS02 level during the
SIT.

None of the three pairwise comparisons for this

variable reached statistical significance at the .0025
level

(t values:

-1.64, p =
earlier,

.06;

RLS/Controls,
PLMS/Controls,

-1.72, p = .05; RLS/PLMS,
0.15,

p = .88).

As noted

these amplitudes were substantially lower than

expected.
Group means and standard deviations for the PSG rS02
B-wave amplitudes were as follows;
percent,

PLMS:

percent.

2.3 + 0.8 percent,

RLS:

2.6 + 0.9

Controls:

2.2 + 0.3

None of the three pairwise comparisons for this

variable reached statistical significance at the 0.0025
level

(t values:

-0.89, p =

.39;

RLS/Controls,
PLMS/Controls,

-1.08,

p = .15; RLS/PLMS,

-0.06, p = .48).

The mea n and standard deviation for the

(actual)

rSO;,

value at sensory event onset in the RLS subjects was 64.0
+ 6.5.

This was compared to the average rSO, value

no movement or sensory events were present)
entire SIT for the control subjects

(where

during the

(60.2 + 9.5)

non-directional t-test.

This test did not reach

statistical significance

(t = -1.02,

using a

p = .32).

The means and standard deviations for the rS02 value
at motor event onset was 63.3 + 6.0 for the RLS subjects,
and 65.0 ± 3.9 for the PLMS subjects

(recall that the PLMS
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subjects had an average SIT MI of 16.5 movements).

These

values were compared to the control subject mean "no
event" rS02 (60.2 + 9.5) using non-directional t-tests.
None of the three pairwise comparisons reached statistical
significance
RLS/PLMS,

(t values:

RLS/Controls,

t = -0.93,

t = 0.43, p = .67; PLMS/Controls,

p = .36;

t = -1.27,

p =

.22) .
The mean and standard deviation for the rS02 level at
PLM onset in the thirteen subjects who had PLMs was 65.9 +
4.1.

This was compared to the average sleep rS02 value

for the controls
test.

(61.5 ± 7 . 1 )

using a non-directional t-

The result of this test did not reach statistical

significance

(t = -1.89, p = .07).

For the RLS group, the mean rS02 value at sensory
event onset
events)

(for the seven subjects who had sensory

was 64.0 + 6.5.

This was compared to the mean

rS02 value for these seven subjects when no sensory or
motor events were present

(63.6 + 6.7)

directional paired-samples t-test.
statistically significant

(t = 2.12,

using a non-

This test was not
p = .08).

For the RLS group, the mean rS02 value at motor event
onset was 63.3 + 6.0
events) .

(all nine RLS subjects had motor

This was compared to the average rS02 value when

no sensory or motor events were present

(63.0 + 6.1,

for

■
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all nine subjects)
t-test.

using a non-directional paired-samples

This test was not statistically significant

(t =

1.41, p = .20) .
For all subjects with PLMs, the mean rS02 value at
PLM onset was 65.9 + 4.1.

This was compared to the

average rS02 value w he n no PLMs were present

(65.6 + 4.1)

using a non-directional paired-samples t-test.
was not statistically significant

(t = 1.76,

This test

p = .10).

Event Occurrence in the B-Wave _Gv.cle
The percentage of SIT sensory events occurring at
each point in the rS02 B-wave cycle
limb,

peak,

descending limb,

stable)

(trough,

ascending

for the seven RLS

subjects who had sensory events is listed in Table 6.

The

mean percentages and standard deviations for the group are
also listed.
group means

A Chi Square goodness of fit test on the
(entered as frequencies)

was performed to

determine if the percentages were significantly different
from equal percentages in each category
been expected by c h a n c e ) .
56.40,
level.

(which would have

The Chi Square statistic was

a value which was significant b e y o n d the 0.0001 p
Only two subjects

(030 and 057)

had more than 50

percent of their events at any one point in the wave
cycle, both at the rS02 peaks.
The percentage of SIT sensory events in RLS subjects
occurring at each point in the total hemoglobin B-wave
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Table 6.

Pe rcent of SIT Sensory Events in RLS Subjects
O c c u r r i n g at Various Points in the rS 02 B-wave
Cycle.

#

Trough

Ascend

Peak

Descend

Stable

012

51

29.4

5.9

47.1

7.8

9.8

017

23

13 .0

0

39.1

13.0

34.8

020

106

23. 6

18.9

38 .7

17.0

1.9

034

10

30.0

20. 0

30.0

20. 0

0

026

120

25.0

4.2

42. 5

5.8

22.5

030

9

11.1

0

66.7

0

22.2

057

25

4.0

0

76.0

16.0

4.0

Mean

19.4

7.0

48.6

11.4

13. 6

S.D.

10. 1

8. S

16. 6

7.1

13. 1

Subj1

Subj = Subject,
1) Abbreviations are as follows:
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

cycle is listed in Table 7.

A Chi Square goodness of fit

test on the means yielded a value of 32.80,
significant b eyond the 0.0001 p level.
subjects

(017 and 030)

# =

which was

Again,

only two

had more than 50 percent of their

of their events at any one point in the hemoglobin wave
cycle; one at the peaks

(017), and one at the troughs

(030).

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

212
Ta b l e 7. Percent of SIT S e n s o r y Events in RLS Su bj e c t s
Occurring at V a r i o u s Points in the Tot al
Hemoglobin B - w a v e cycle.

Sub j :

# Events

Trough

Ascend

Peak

Descend

012

51

37. 3

5.9

39.2

17. 6

017

23

21.7

4.3

60. 9

13.0

020

106

47.2

9.4

24 .5

18. 9

034

10

20.0

20.0

40.0

20.0

026

120

41.7

5.8

45.0

7.5

030

9

55. 6

0

44 .4

0

057

25

28.0

8.0

40.0

24 .0

Mean

35. 9

7.6

42. 0

14 .4

S.D.

13.3

6.2

10. 8

8.3

1) Abbreviations are as follows:
Subj = Subject,
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

# =

The percentages of SIT motor events in the RLS
subjects occurring at each point in the rS02 B-wave cycle
for the nine RLS subjects are presented in Table 8.

Only

movements occurring in the leg contralateral to the
oximetry sensor were used in this analysis.

A Chi Square

goodness of fit test on the group means yielded a value of
37.70,

which was significant beyond the 0.0001 p level.

Only two subjects

(034 and 057) had more than fifty
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Table 8 . Percent of SIT Motor Events in RLS Subjects
Occurring at Various Points in the rSO, B-wave
Cycle.

Peak

Descend

3.3

42.4

9.8

9.8

28 .8

7.5

32.5

3.8

27.5

121

28. 9

11.6

36.4

21.5

1.7

034

54

20. 4

5.6

55. 6

18.5

0

026

144

23. 6

2.1

41.0

8.3

25.0

030

27

48.1

11.1

22.2

7.4

11.1

050

94

30. 9

7.4

43.6

12.8

5.3

049

24

37.5

20.8

20.8

12.5

8.3

057

29

20.7

0

55.2

20. 7

3.4

Mean

30.4

7 .7

38 .S

12.8

10.2

S.D.

8.9

6.3

12. 4

6.2

9.8

Subj1

#

Trough

012

92

34 .8

017

80

020

Ascend

1) Abbreviations are as follows:
Subj = Subject,
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

Stable

# =

percent of their motor events at any one point in the rS02
B-wave cycle

(both at the p ea k s ) .

The percentages of SIT motor events in RLS subjects
occurring at each point in the total hemoglobin B-wave
cycle for the nine RLS subjects are presented in Table 9.
A Chi Square goodness of fit test on the group means
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Table 9.

Subj ’
•

Percent of SIT Motor Events in RLS S ubj ect s
O c c u r r i n g at Various Points in the H em o g l o b i n
B- wave Cycle.

# Events

Trough

Ascend

Peak

Descend

012

92

50.0

13.0

21.7

15.2

017

80

33.8

13.8

42.5

10.0

020

121

45.5

12.4

22.3

19.8

034

54

35.2

11.1

44 .4

9.3

026

144

41.0

5.6

39. 6

13. 9

030

27

59. 3

11.1

25. 9

3.7

050

94

29. 8

9.6

47 .9

12.8

049

24

29.2

20.8

33. 3

16.7

057

29

41.4

3.4

37. 9

17.2

Mean

40. 6

11.2

35. 1

13.2

S.D.

9.9

5.0

9.8

4.9

1) Abbreviations are as follows:
Subj = Subject,
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

# =

yielded a value of 27.84, which was significant beyond the
0.0001 p level.

Only two subjects had more than 50

percent of their events at any one point in the hemoglobin
wave cycle

(012 and 030), both at the troughs.

The percentages of PLMs occurring at each point in
the rSO, B-wave cycle for the thirteen subjects who had
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Ta ble 10.

Subj:

Percent of Periodi c Limb M o v e m e n t s
PLMS S u b j e c t s Occurring at V a r i o u s
the r S 0 2 B - w a v e Cycle.

Peak

Descend

3.0

42.4

24 .2

0

6.9

18 .1

69.4

2.8

2.8

344

16.3

27.0

48.8

7.6

0.3

033

44

9.1

6.8

56.8

20. 5

6.8

026

305

13.4

6.9

60.0

7.9

11.8

030

139

24 .5

16. 5

48.2

3.6

7.2

052

116

28 .4

15.5

46.6

8.6

0.9

050

24

37. 5

0

25.0

8.3

29.2

049

130

8.5

5.4

61. 5

22. 3

2.3

056

297

14 .8

3.7

56.6

7.4

17.5

060

35

17. 1

8 .6

51. 4

8.6

14.3

066

115

24 .3

2.6

39.1

9.6

24 .3

069

106

14 .2

0

21.7

0

64.2

Mean

18. 9

8.8

48. 3

10.1

14.0

S.D.

9.4

8.1

13. 8

7.5

17.8

#

Trough

012

33

30. 3

020

72

034

Ascend

in RLS and
Points in

Stable

1) Abbreviations are as follows : Subj = Subject,
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

PLMs

# =

(this included seven RLS subjects in addition to the

six PLMS subjects)

are presented in Table 10.
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Square goodness of fit test on the group means yielded a
value of 52.10,
level.

which was significant beyond the 0.0001 p

Seven of the thirteen subjects had more than 50

percent of their PLMs at one point in the B-wave cycle;
six of these were at peaks,
points.

and one was during stable

For eleven of the thirteen subjects the rS02 peak

was the wave point with the highest percentage of their
PLMs.
The percentages of PLMs occurring at each point in
the total hemoglobin B-wave cycle for the thirteen
subjects who had PLMs are listed in Table 11.

A Chi

Square goodness of fit rest on the group means yielded a
value of 23.76,
level.

which was significanr beyond the 0.0001 p

Five subjects had more than 50 percent of their

PLMs at one point in the B-wave cycle;
three subjects,

at the peaks for

and at the troughs for two subjects.

Seven of the subjects had the greatest percentage of their
PLMs at the hemoglobin wave peaks,

while six had the

greatest percentage of their PLMs at the hemoglobin
trou gh s.
In summary,
events,

none of the events studied

SIT motor events, and PLMs)

(SIT sensory

occurred at any one

point in either the rS02 or total hemoglobin B-wave cycle
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Table 11.

Subj 1

Percent of Periodic Limb M o v e m e n t s in RLS
and PLMS Subjects Occurring at V a r i o u s Points
in the T o t al Hemoglobin B-wa ve cycle.

# Events

Trough

Ascend

Peak

Descend

012

33

42. 4

3.0

36.4

18.2

020

72

9.7

11.1

75.0

4.2

034

344

59. 6

14.5

19.8

6.1

033

44

20.5

15. 9

47.7

15.9

026

305

31.8

16.7

44.6

6.9

030

139

15.8

23.7

55. 4

5.0

052

116

35.7

15.5

33. 0

15.7

050

24

33.3

16.7

37.5

12.5

049

130

36.4

9.3

33. 3

20. 9

056

297

25. 9

6.4

51.5

16.2

060

35

28. 6

17.1

31.4

22.9

066

115

48.7

11. 3

28.7

11.3

069

106

52.8

4.7

30.2

12.3

Mean

33. 9

12.8

40.3

12.9

S.D.

14.5

5.8

14 .4

6.1

1) Abbreviations are as follows:
Subj = Subject,
Number of events, Ascend = Ascending, Descend =
Descending, S.D. = Standard deviation

more than 50 percent of the time.
cases however,

# =

In five of the six

the events occurred more often at peaks
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than at any other point in the cycle.

The most consistent

findings were that SIT sensory events and PLMs occurred at
rS02 peaks 49 and 48 percent of the time respectively.
All six of the Chi Square goodness of fit tests were
highly significant

(and well beyond the corrected alpha

level of 0.0025 used for the oximetry d a t a ) .
Figure 1 shows a short segment
raw data during sleep
asterisks)

(6.5 minutes)

of rS02

(with the PLMs m a r k e d with

for subject 034.

This subject had the largest

rSO- B-wave amplitude during sleep of any subject with
PLMs,

and had 4 9 percent of his PLMs at rS02 B-wave peaks.

In the segment shown,
PLM per wave.

there are seventeen B-waves,

Two of the PLMs occurred at troughs,

during the ascending limbs,

five

and ten at the peaks.

Figure 2 shows a short segment

(6.5 minutes)

hemoglobin raw data during sleep for subject 020
PLMs mark e d with a s t e r i s k s ) .

of total
(with

This subject had 75 percent

of his PLMs at the total hemoglobin B-wave p e a k s .
segment shown,

and one

In the

there are fourteen B-waves and eleven PLMs,

ten of which occurred at peaks,

and one which occurred

during an ascending limb.
Spectral Analysis Results
The spectral analyses revealed that the oximetry data
(both the rS02 and total hemoglobin signals)

were

characterized by m ulti p le wavelengths in the 11 to 90
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Figure 1. B-waves in rS02 in a RLS Subject with PLMs
(Note:
PLMs are marked with asterisks)
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figure 2. B-waves in Total Hemoglobin in a RLS Subject
with PLMs. (Note:
PLMs are marked with
asterisks j
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second range for all groups.

Wavelengths were determined

from the spectral analysis periodogram graphs by
determining the wavelength associated with each
periodogram peak.

In the following discussion,

the word

peak refers to a periodogram peak rather than an
individual B-wave peak.
For rS02 during the SIT, the RLS group had an average
of 5.3 peaks per subject,
5.2 peaks per subject,

the PLMS group had an average of

and the Control group had an

average of 4.7 peaks per subject.
during the SIT,

For total hemoglobin

the RLS group had an average of 4.6 waves

per subject,

the PLMS group had an average of 4.3 waves

per subject,

and the Control group had an average of 4.2

waves per subject.
The spectral analyses on the sleep data

(for controls

and subjects with PLMs) were performed with all sleep
segments for each subject combined into a single data
file.

The m e a n number of rS02 peaks was 4.5 + 1.6 for the

PLMS subjects,

and 5.2 ± 0.8 for the controls.

The mean

number of total hemoglobin peaks was 4.5 + 1.8 for both
the PLMS and Control groups.
Table 12 shows the number of periodogram peaks in
each group
counted)

(all peaks for every subject in each group were

in each of the eight 10 second ranges from 11 to
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90 seconds during the SIT.
rS0: and total hemoglobin,

Data are included for both
and are presented to provide

descriptive information only
conducted) .

For both rS02 and total hemoglobin,

groups had few
range.

(no statistical tests were
all three

(if any) peaks in the 11 to 20 second

For rS02 the RLS group had the largest number of

peaks in the 31 to 40 second range,

and the second largest

number of peaks in the 51 to 60 second range.

For total

hemoglobin the RLS group had the greatest number of peaks
in the traditional B-wave wavelength range of 51 to 60
seconds,

and the second largest number of peaks in the 31

to 40 second range.

The PLMS group had the greatest

number of rS02 peaks in the 31 to 40 second range,

and the

second largest number in each of the three ranges from 51
to 80 seconds.

For total hemoglobin the PLMS group had

the greatest number of peaks in the 51 to 60 second range,
and the second largest number of peaks in four ranges
to 50 seconds,

and 61 to 80 s e c o n d s ) .

(31

The control group

had the largest number of rS02 peaks in the 41 to 50
second range,
two ranges

and the second largest number of peaks in

(51 to 60 seconds and 71 to 80 s e c on d s) .

The

control group had the smallest percentage of rS02 peaks of
all three groups in the three ranges from 11 to 40
seconds.

For total hemoglobin,

the control group had the
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Table 12. Number of Periodogram Peaks in Each Group in
the Different Wavelength Ranges during the
Suggested Immobilization T e s t 1

Grp 11 -20

21-30

31-40

41-50

51-60

61-70

71-80

81-90

rSO; Data

RLS

1

7

9

7

8

5

4

7

PLMS

0

3

7

3

5

5

5

3

Con

1

5

4

12

9

8

9

4

Total Hemoglobin Data

RLS

1

4

7

5

10

6

5

3

PLMS

0

3

4

4

5

4

4

2

Con

0

5

7

7

8

9

5

6

1) Abbreviations are as follows:
Grp = group,
control.
(Wavelength ranges are in seconds).

Con =

greatest number of peaks in the 61 to 70 second range,

and

the second greatest number in the adjacent 51 to 60 second
r an ge .
In summary,

the spectral analyses showed that

subjects in all three groups had multiple rS02 and total
hemoglobin

(wavelength)

peaks during the SIT.

These

included wavelengths in the traditional B-wave wavelength
range of 50 to 70 seconds,

and wavelengths in most of the
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other ranges

from 11 to 90 seconds with the exception of

the 11 to 20 second range.
Table 13 lists the number of periodogram peaks for
the thirteen subjects with PLMs
six PLMS subjects)
the eight

(seven RLS subjects and

and for the Control group in each of

10-second wavelength ranges from 11 to 90

seconds for both oximetry variables during sleep.

For

rSO; the PLMS subjects had the greatest number of peaks in
the 41 to 50 second range,

and the second greatest number

of peaks in the 71 to 80 second range.

The control

subjects had the greatest number of peaks in the 51 to 60
second range,

and the second greatest number of peaks in

the 31 to 40 second range.

For total hemoglobin,

the PLMS

subjects had the greatest number of peaks in the 21 to 30
second range,

and the second greatest number of peaks in

the 61 to 7 0 second range.

The control subjects had the

greatest number of peaks in the 21 to 30 second range,

and

the second greatest number of peaks in the 51 to 60 second
r an g e .
In summary,

the distribution of peaks appeared to be

roughly similar for both groups for total hemoglobin,
while for rS02 the PLMS subjects appeared to have a
relatively larger number peaks in the 71 to 90 second
range than the control subjects.

For both groups there
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Table 13. Number of Periodogram Peaks in Control
Subjects and Subjects with PLMs in the
Different Wavelength Ranges during S leep1

Grp 11-20

21-30

31-40

41-50

51-60

61-70

71-80

81-90

rSO; Data

PLMS

2

7

9

12

8

4

10

7

Con

1

8

11

7

12

9

6

3

Total Hemoglobin Data

PLMS

2

11

7

8

8

10

6

6

Con

1

10

4

8

10

8

7

1

1) Abbreviations are as follows : Grp = Group, PLM =
Periodic Limb Movements in Sleep, Con = Control
(Wavelength ranges are in s e c o n d s ! .

were very few peaks in the 11 to 20 second range for both
variables.

As with the SIT data,

the spectral analyses

showed that during sleep both PLMS and control subjects
tended to have a mixture of different wavelengths in their
rS02 and total hemoglobin data.
Finally,

Figure 3 shows a spectral analysis

periodogram for a segment of rS02 data during sleep in a
RLS/PLMS subject.

The values on the period axis in this

figure represent the number of five-second epochs
"5" represents a wavelength of 25 seconds).

(e.g.

The figure
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shows two large peaks at 34 and 58 seconds,
small p e a k at 19 seconds.

an d one very

Figure 4 shows a spectral

analysis periodogram for a segment of total hemoglobin
data dur i ng sleep for a control subject.

The periodogram

shows two large peaks at 48 and 57 seconds,
size p e a k at 34 seconds,

one medium

and one small peak at 29 seconds.

Wave-to-Wave Change in Wavelength Data
For the rS02 data,

individual wave wavelengths were

m easu re d for each subject du ri ng both the SIT and PSG,

and

the m e a n change in wavelength from one wave to the next
wave was computed.

Lower values

for this wave-to-wave

change in wavelength number are indicative of more regular
and u n i f o r m waveforms.

Such uniformity has b e e n reported

to be characteristic of B-wave activity; thus,

this

analysis was done in an attempt to determine h o w many
subjects were having relatively unambiguous B-wave
activity.

A visual examination of the rS02 graphs

suggested that when the mean wave-to-wave change in
w avelength was fifteen seconds or less, there were often
sections in the rS02 signal that appeared to have the
regularity characteristic of B-wave activity.

Individual

subject data on this variable are presented in Table 14.
There were only 14 instances

(out of 51) where the mean

w ave-to-wave change in wa ve le ng th was 15 seconds or less,
and o n ly three instances where it was 10 seconds or less.
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Figure 3. Representative Spectral Analysis - e n o d o g r a m
of rS02 Data
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15

'igure 4. Representative Spectral Analysis Periodogram
of Total Hemoglobin Tata
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Table 14. Wave-to-Wave Change in W avelength

(WWCW)

Data1

Group

SIT WWCW

012

RLS

18 .5

13.3

017

RLS

27.5

19.9

020

RLS

13.2

16.4

034

RLS

10.1

8 .3

033

PLMS

27.0

11. 9

026

RLS

18. 6

18.4

030

RLS

12.2

14.3

052

PLMS

12. 4

12.6

049

RLS

18.9

14.6

050

RLS

14. 6

27.0

051

Control

18 .1

18 .7

054

Control

16.7

21.0

056

PLMS

24.8

17.4

057

RLS

18 .3

18 .9

055

Control

—

24.1

061

Control

23.3

19.4

060

PLMS

11.2

20.5

058

Control

9.2

11. 6

059

Control

17.9

16.4

066

PLMS

27 .8

27 .9

Subject

PSG WWCW

/*_-i~ ~___
4-r \
(table
cont'd)
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SIT WWCW

Group

Subject

PSG WWCW

067

Control

17.6

17.4

068

Control

16. 6

17. 1

073

Control

19.8

21.7

070

Control

18 .4

19.9

074

Control

21.4

19.9

069

PLMS

18.5

18 .6

1) WWCW values are in seconds

Thus,

in general,

the "waves" in the rS02 data were not

uniform and regular from wave to wave for most subjects.
Dual Recording Site Data
Three bald subjects were recruited into the study in an
effort to find one or more bald subjects with PLMS.
all three subjects,
used:

In

two oximetry recording sites were

one on the forehead,

and one the vertex.

The

vertex site sensor was placed so that it would be as close
as possible to the sensory/motor cortex for the legs.
Although none of the three bald subjects had any
significant sleep complaints,
have PLMS

(subject 069).

one of t h e m was found to

There were technical problems

with his forehead sensor just after the SIT,

so the
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polysomnogram was done with only the vertex recording
site.

This subject had a very stable vertex rS02 during

both the SIT and PSG,
his PLMs

(64%)

and consequently,

occurred at stable rS02 points

10 and 11 for this subjects'

troughs

(see Tables

data on PLM occurrence in the

rSO: and total hemoglobin wave c y c l e s ) .
hemoglobin,

the majority of

For total

this subject had the majority of his PLMs at

(52.8%).

Unfortunately,

no other bald RLS or PLMS

subjects could be recruited.
The use of two recording sites in these three
subjects allowed for direct comparison of the data between
the two recording sites.

In order to determine if the

rS02 and total hemoglobin readings were changing
synchronously at the two sites,

the number of peaks at

each recording site were counted,
matches" was determined.
Table 15.

In general,

and the number of "peak

These data are presented in

the vertex sites had fewer peaks

and were more stable than the forehead sites.
addition,

In

there were relatively few peak matches,

suggesting that in these three subjects,

the rS02 and

total hemoglobin at the two different sites were changing
at least partly independently of each other.

Correlations

between the variables at the two different sites were also
computed.

These data are also presented in Table 15.
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Table 15. Dual Recording Site Data

Variable

Forehead
Peaks

Vertex
Peaks

N o . of
Matches

r

Subj1

Test

058

SIT

rS02

187

117

65

.34*

058

SIT

Hgb

202

197

29

.17*

058

PSG

rS02

158

110

5

058

PSG

Hgb

201

215

23

-.13*

070

SIT

rS02

99

35

17

.16*

070

SIT

Hgb

152

91

25

-.55*

070

PSG

rS02

87

29

21

.52*

070

PSG

Hgb

167

112

41

.39*

069

SIT

rS02

84

49

9

.82*

069

SIT

Hgb

135

123

36

.38*

1) Abbreviations are as follows:
Number, Hgb = Hemoglobin.
* p < .0008

subject

Subj = Subject,

-.01

No. =

(070) had two separate segments of PSG/sleep data;

the correlations in Table 15 are for the first segment.
The correlations for his second segment were -.16 for
rS02, and -.61 for total hemoglobin.

There were a total

of 12 correlations performed on this data.

This increased

the number of statistical tests in the study to 65; thus,
these correlations were not regarded as significant unless
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they reached a p level of
65).

.0008

(which is

.05 divided by

Ten of the twelve correlations reached this p level.

This included nine of the ten correlations presented in
Table 15, and the PSG-Hgb correlation from the second
segment of sleep for subject 070.

Although most of the

correlations were highly significant,

the majo r i t y of them

accounted for only proportions of the variance.
less,

None-the-

the presence of significant correlations between the

two recording sites in rS02 and total hemoglobin indicated
that these blood flow parameters were not completely
independent of each other at the two recording sites.
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Discussion
SIT and PSG Data
The first two hypotheses to be tested in the study
concerned group differences on the SIT and PSG variables.
Among the eleven SIT and PSG variables measured,

the three

that were most important were the SIT sensory and motor
indices,

and the PLM index.

Differences on these

variables were expected to occur because these variables
were used

(and are routinely used in clinical practice)

define the three groups.

to

Of the nine possible pairwise

comparisons among the three groups on these three
variables,

there were six directional predictions

Table 2).

Only three of these reached significance at the

m o dified alpha level of 0.001,

(see

although the other three

comparisons all reached p levels of 0.0037 or lower.
finding that one of these comparisons in particular,
RLS/PLMS comparison on the SIT sensory index,

The
the

did not

reach significance at the 0.001 level is surprising when
the means of 50.3

(RLS)

and 0

(PLMS) are considered.

Although the low sample sizes of nine and six subjects
were one obvious reason for the failure of these
comparisons to reach significance at the specified p
level,

the low power that resulted from the selection of

such a stringent initial alpha level of 0.001 was also to
234
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blame.

That decision could be criticized for lowering

power to such an extent that it made the probability of
making a Type II error unacceptably high.

In addition,

these comparisons were confirmatory of known phenomena
(the nature of sleep in RLS and PLMS),
hypotheses.
standards,

not tests of novel

That all were highly significant by typical
but not by the alpha correction based on

experiment-wise error,

indicates that the alpha correction

procedure was excessively conservative and caused Type II
error.

This probl e m represents an example of the often

discussed trade off between Type I and Type II error.
Keppel

(1991, p.

179)

noted that "the concern for

familywise error is usually expressed without regard for
any increase in Type II error that may result".

Keppel

further suggested that if a researcher choose to limit the
familywise

(experiment-wise)

alpha correction procedure,

Type I error rate by using an
then "I strongly urge your

imaginative use of non-traditional values of F W to avoid
losing substantial amounts of power"
180).

(Keppel,

1991, p.

He suggested cumulative Type I error rates of .10

and .25 as starting points for consideration.

In the case

of the three non-significant comparisons above,
familywise error rate of

.20 had been chosen

if a

(as per

Keppel's recommendation), then the corrected alpha level
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would have b e e n

.2 divided by 53

(or 0.0038)

, and all

three comparisons would have been regarded as significant.
Therefore,

those comparisons could be given more weight.

Of the eight remaining PSG variables,

there were

large differences in group means on two others:
latency,

and sleep efficiency

(see Table 3).

Sleep

The group

mean for the RLS group on sleep latency was strongly
influenced b y one subject who had a 6.5 hour sleep
latency; however,

because the Mann-Whitney test that was

employed uses ranks,

this outlier should not have unduly

influenced the results.
most likely to blame.

Again,

the low sample sizes were

For sleep efficiency,

the two

comparisons involving the RLS group did achieve p levels
lower than the traditional 0.05 level used for individual
comparisons

(.04 in the RLS/Control comparison,

in RLS/PLMS c ompari s o n ) .

In these two cases,

and .009

it seems

wise to follow another recommendation by Keppel

(1991).

In cases where the p level attained falls between the
corrected alpha level chosen and the traditional 0.05
level,

Keppel recommended that one should not make a

formal decision regarding the null hypothesis

(fail to

reject H0) , but should instead decide to "suspend
judgement".

In this way, neither a Type I nor a Type II

error is m a d e .
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In reviewing the group means for the other sleep
variables,

two other findings are noteworthy.

First,

the

RLS group had a similar amount of slow wave sleep as the
PLMS and control groups.

This occurred despite the lower

sleep efficiency in this group,

and suggests that even

though the total sleep time of RLS patients may be reduced
because of their RLS symptoms,

their PLMs during sleep

(like those of the PLMS group)

were not sufficiently

disruptive to reduce slow wave sleep.

There was also some

evidence of a "first night effect" in the Control group,
as evidenced by the high number of stage changes per hour
of sleep

(Anderson,

1998).

The large number of sleep

stage changes in the RLS and PLMS groups also illustrates
the primary effect of PLMS, or perhaps a first night
effect for all three groups.
Sensory and Motor Events in RLS Subjects
The next hypothesis concerned the temporal
characteristics of the abnormal sensations of the RLS
subjects during the SIT.

It was predicted that the

sensory events woul d be similar to PLMs in their temporal
characteristics,

and as such, would represent the waking

analog of PLMs.

The results did not confirm this

hypoth e s i s .

Instead,

the sensory events were found to be

highly variable in their temporal characteristics among
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different RLS subjects;

only two of seven subjects had

sensory events that met the scoring criteria used for
PLMS.
The motor symptoms that were observed in the RLS
subjects were also noteworthy.

The observation that

movements could become nearly continuous or be of very
long duration when symptoms were severe is not consistent
with the Periodic Cerebral Ischemia theory for at least
two reasons.

First,

although RLS symptoms are

precipitated by prolonged motor inactivity

(during which

B-wave activity should begin according to the PCI theory),
the subsequent vigorous and long duration movements that
occur when symptoms are severe should be sufficiently
activating to both the cortex and brai n s t e m that B-wave
activity should be eliminated

(i.e.

the control of

cerebral blood flow should revert to the waking mechanism
of local flow-metabolism c o u p l i n g ) .
symptoms

Second,

if the motor

in RLS are caused by cerebral ischemia,

then that

ischemia would have to be of relatively long duration to
account for the observed motor symptoms,
periodic as suggested in the PCI theory.

rather than
This would mean

that some mechanism other than B-wave activity would have
to be used to explain the observed motor symptoms in R L S .
One possibility not previously discussed in this regard is
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endothelin-induced vasospasm.

The endothelins are

peptides that are produced and released by endothelial
cells; they are potent vasoconstrictors with a relatively
long duration of action
Edvinsson,

1994,

(see Cardell,

for a r e v i e w ) .

Uddman,

and

Endothelins are thought

to play role in several cerebrovascular diseases,
including migraine headaches and the vasospasm associated
with subarachnoid hemorrhage.

It has been shown that

hemodynamic shear stress can stimulate the production of
endothelin

(Cardell et al.,

1994).

The turbulent blood

flow that occurs near arterial bifurcations might be one
source of such stress;

thus,

it is not unreasonable to

suggest that vaso s p a s m might be involved in R L S .

This

suggestion would represent a post hoc revision of the PCI
theory.
The absence of PLMS in two of the RLS subjects,
the presence of on l y m i l d PLMS

(PLMi = 15)

subject who had severe waking symptoms,
comment.

and

in another

also deserves

A l though this finding is consistent with

previous work whi c h has shown that only 80% of RLS
subjects have PLMS when studied with a single night of
polysomnography

(Montplaisir et al.,

1994),

these previous

studies have not specifically stated that PLMS could be
absent when severe waking symptoms were present.
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they seemed to imply that PLMS symptoms in patients with
RLS could vary in severity

(and even be absent)

from night

to night in much the same way that RLS symptoms vary from
night to night.

In the present study,

two subjects who

clearly had waking RLS symptoms did not have any PLMs
while asleep.

This finding is somewhat inconsistent with

the PCI theory of RLS and PLMS because it is difficult to
understand how the proposed B-wave induced periodic
cerebral ischemia could present during wakefulness,

then

be absent as little as a few minutes later when the
subject fell asleep.

This finding

(that PLMS can be

absent even when severe RLS symptoms are present)

brings

into question the assumption that both RLS and PLMS are
caused by the same pathogenic mechanism.

This doubt is

further strengthened by the lack of any clear periodicity
in waking RLS sensory and motor symptoms noted in the
present study.
introduction,

In addition,

as pointed out in the

the prevalence of PLMS has been found to be

higher than normal in a fairly large number of medical
conditions,
impotence,

including narcolepsy,

uremia,

organic

and congestive heart failure to name a few.

one of these conditions in particular

(congestive heart

failure,

C H F ) , a PLMS prevalence rate of 75% has been

reported

(Hanly and Zuberi-Khokhar,

1996).

This is very
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similar to the 8 0% value found in RLS subjects
(Montplaisir et a l ., 1994).

Thus,

it is quite possible

that RLS and PLMS may be caused by different pathologies,
and that RLS is one of m a n y conditions in which the
p athology that causes PLMS is more common than normal.
Future PLMS prevalence studies may help to clarify this
issue.
Oxim e t ry. Patfl
There was essentially no support for the primary
hypotheses of interest in the present study.

The most

important of these were the predictions that PLMs and SIT
sensory and motor events would occur consistently at rS02
and total hemoglobin B-wave troughs.
opposite finding

(i.e.,

frequently at peaks)
(PLMs,

In fact,

the

that events tended to occur more

occurred for all three event types

SIT sensory events,

and SIT motor events)

for rS02,

and for PLMs and SIT sensory events for total hemoglobin.
For four event types

(SIT Motor events in the rS02 cycle,

and all three event types in the total hemogl o b i n cycle)

a

relatively large percentage of events also occurred at
troughs.

In order to further explore these results,

and

to determine if the percentages of events at the different
wave limbs were significantly different from one another,
a series of additional post hoc tests were performed
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Appendix 4).
significant

Of the seventeen comparisons that were
(out of a possible 48),

twelve of t hem were

comparisons in which percentages at peaks were higher than
at other wave limbs,

while five were comparisons in which

percentages at troughs were higher than at other wave
limbs.

These tests also confirmed that the percentage of

events at peaks was not significantly different from the
percentage of events at troughs for five of the six
comparisons

(the peak/trough comparison was significant

only for PLMs in the rS02 cycle) .

In addition,

despite

the fact the Chi Square tests were all highly significant,
the failure of any event to occur at any one wave point
(for either rS02 or total hemoglobin)

more than 50 percent

of the time casts additional doubt on whether or not the
events were related in a causal way to cerebral
oxyhemoglobin or total hemoglobin levels.

One possible

interpretation of this finding is that separate,
interconnected,

b ra i n s t e m centers may be responsible for

generating RLS/PLMS symptoms and B-waves.
the case,

but

If this were

then one center might be able to occasionally

entrain the rhythm of the other center.

This possibility

has long been considered to be a potential m e c h a n i s m by
which Traube-Hering and Mayer waves might be generated
(i.e. by influence from the respiratory centers on the
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vasomotor center;

see Koepchen,

this were the case,
the present study

1984,

for a r e v i e w ) .

If

then the two phenomena of interest in

(PLMs and B-waves)

occur synchronously at some times,

would be expected to

but not at others.

The

data obtained in this study are consistent with this idea.
However,

the idea of a brainstem center being directly

responsible for the generation of PLMs is inconsistent
with the idea that PLMs are spontaneous Babinski
responses,

because it has been shown that pyramidal tract

damage is necessary and sufficient to elicit this reflex
(van Gijn,

1978) .

Another possibility that should be mentioned in
regards to the wave cycle data concerns possible lags
between arterial oxyhemoglobin levels and the variable
actually m e a sured by the NIRS equipment used in the
present study.

Because the NIRS instrument used in this

study measures the hemoglobin oxygen saturation of all
blood

(including arterial and venous blood), and because

about 7 0 percent of the cerebral blood is in the venous
compartment,

any lag between the arterial and venous

compartments caused by circulation times could potentially
influence the wave cycle data.

Without simultaneous

measurement of another cerebral blood flow parameter

(such

as blood flow velocity) , it is impossible to know if the
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waves measured b y NIRS occur synchronously with waves
measured by other techniques.

Because the Somanetics

instrument has only been F.D.A. approved in this country
for just over two years,

there are no studies directly

investigating this issue; such a study would be very
useful.

The sampling rate of the Somanetics instrument

(one sample per five seconds)

was also problematical;

this

rate is inadequate for describing continuous brief
phenomena such as B-wave peaks and t r o u g h s .
Another possibility in regards to the wave cycle data
is that the critical physiologic parameter involved in the
generation of PLMs and RLS symptoms might not be
oxyhemoglobin saturation levels, but rather,
instead.

C02 levels

C02 levels cannot be measured with NIRS,

and may

not correlate or vary synchronously with oxyhemoglobin
levels.
It is worth emphasizing at this point that even if
cerebral blood flow parameters are not related to PLMs and
RLS symptoms,

it might still be possible that a

circulatory insufficiency occurring somewhere else within
the nervous system

(e.g. spinal cord,

peripheral nerves)

could be an underlying cause of either RLS symptoms,
symptoms,

or both.

PLMS

Adding substantial weight to this

argument are the findings reviewed in the introduction
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that are suggestive of a circulatory insufficiency
resulting ischemia)

(and

as the cause of both disorders.

These

include the high prevalence of RLS a nd PLMS in anemia and
conditions in which either anemia or circulatory problems
are common,

the transient nature of the symptoms

(i.e.

they are not continuously present throughout the day and
RLS symptoms can be temporarily relieved by movement),

and

the improvement of RLS by treatment with drugs that either
correct anemia or improve circulation
study by Parrow and Werner,

(e.g. the dextran

1966; a n d the sclerotherapy

study in RLS patients with varicose veins by Ranter,
1995) .
Despite the fact that PLMs and RLS sensory/motor
events did not occur at any one p o i n t in the rS02 and
total hemoglobin wave cycle with a high frequency

(i.e.

greater than 7 5% of the t i m e ) , the finding that they
tended to occur frequently at peaks is not only
interesting,

but is also at least partially consistent

with the findings of several other recent studies.
example,

Droste et al.

(1996)

For

used transcranial Doppler

sonography to study B-wave activity in four PLMS p a t i e n t s .
Although they did not assess where the PLMs occurred in
the B-wave cycle,

they did report that the blood flow

velocity in the middle cerebral a rtery was significantly
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higher in all four subjects when PLMs occurred

(suggesting

that they occurred at rS02 and total hemoglobin peaks)
than at the midway points between P L M s .
interesting to replicate their study,

It would be very

and conduct analyses

similar to those used in the present study,

assessing

whether or not PLMs or RLS sensory/motor events occur
consistently at any one point in the blood flow velocity
B-wave cycle.
and Lavigne

In addition,

(1994)

both Montplaisir,

and Parrino et al.

Lapierre,

(1996) have reported

that PLMs occur in association with EEG arousal

(as

assessed by spectral analysis in the Montplaisir et al.
study,

and visual scoring of CAP cycles in the Parrino et

a l . study).

It is likely that EEG arousal is associated

with increased oxyhemoglobin levels
hemoglobin peaks),

(rS02 and total

although the issue of whether or not

the two variables are causally related remains unclear.
Montplaisir et al. however,

reported that waking RLS motor

events were associated with EEG slowing
arousal as was the case for P L M s ) .

(rather than

This EEG slowing

during waking RLS movements is not consistent with the
finding of increased higher oxyhemoglobin levels during
these events that was found in the present study.
Given the failure to find a very consistent
relationship between PLMs and RLS sensory/motor events and
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the B-wave cycle in the present study,

it is not

surprising that the within subjects analyses comparing
rSO: levels at event onset to non-event levels did not
reach significance.

The predictions for those comparisons

were based on the prediction that the events would occur
at very high rates at a single point in the B-wave cycle.
Wave Amplitudes,

Wavelengths,

and Spectral Analyses

As noted in the Results section,

the B-wave

amplitudes m e asured in the present study were m u c h lower
than expected.

T h e y were also much lower than the B-wave

amplitudes found in transcranial Doppler sonography
studies in normal subjects,

which varied between 10 and 30

percent of the m e a n flow velocity in normal subjects
(Diehl et al.,

1991).

One possible explanation for the

low amplitudes observed in the present study again
pertains to the predominately venous nature of the rS02
index measured by the Somanetics NIRS instrument.

Because

veins are not innervated nearly as much as arteries and
arterioles,

they have a much lower motility than do

arteries and arterioles.

Thus,

the overall blood volume

and oxygen saturations may change relatively little, while
arterial blood volume and oxygen saturation change to a
greater extent.

The largest individual rS02 B-waves

observed in any subject in the present study were about
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ten percent of that subjects' mean rS02 level.

This is

one-third of the max i m u m amplitude of B-waves reported by
Diehl et al.

(1991).

Thus,

transcranial Doppler

sonography may be a better tool than NIRS with which to
measure B-wave activity.
The spectral analyses suggested that the waves
observed in both the total hemoglobin and rS02 signals
were characterized by a mixture of many different
wavelengths.

These included wavelengths in the

traditional B-wave wavelength range of 50 to 7 0 seconds,
and perhaps more importantly,

a sizable number of

wavelengths that were similar to the inter-movementintervals typically associated with PLMS
seconds).

(i.e.,

20 to 40

The large number of wavelengths detected by the

spectral analyses

in the present study is in partial

contrast to the results of several other studies which
have investigated the periodicity of B-waves.
example,
et al.

For

in a transcranial Doppler sonography study Droste

(1993)

found that six of ten normal subjects had a

single B-wave wavelength
70 second range,

(periodogram) peak in the 40 to

while two subjects had two wavelength

peaks in the 25 to 70 second range
at 27 and 44 seconds,
67 seconds).

(one subject had peaks

while the other had peaks at 29 and

In another transcranial Doppler study in
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patients with normal pressure hydocephalus,
Krauss

(1993)

Droste and

showed a representative spectral analysis

periodogram from one subject which had one large peak at
about 50 seconds,

and several smaller peaks in the 40 to

90 second range.

In his study of B-waves in intracranial

pressure tracings

from neurological patients,

(1960)

Lundberg

did not per f o r m spectral analyses or other

comprehensive quantitative analysis of B-wave wavelengths;
however,

he did report that the typical wavelength of B-

waves was approximately one minute,

and he also noted that

waves with wavelengths in between those of the one-perminute B-waves and the six-per-minute C waves did
occasionally occur.
In the present study,

waves in the 20 to 40 second

wavelength range were generally more common than those in
40 to 70 second range.

In addition,

it was common for

subjects to have four or more peaks in the entire 10 to 90
second range.
generated)

These findings suggest that both

(brainstem

B-waves and other waves reflective of regional

cortical processes were present in the oximetry variables
measured.

Because NIRS measures oxygen saturation and

blood flow in one small region of the brain,
both processes.

In addition,

it can detect

although cerebral vasomotor

responsiveness to C 0 2 is reduced during sleep,
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reason to believe that regional variations in cortical
metabolic rate

(and subsequent changes in regional

cerebral blood flow and oxygenation)
sleep.

cease to occur during

The relatively large number of different

wavelengths observed in the present study is consistent
with this dual-process explanation.

An o t h e r possibility

that could account for the large number of wavelengths
observed is that B-wave wavelength may change during the
course of the night
Thus,

(perhaps in relation to sleep stage).

it is possible that a one hour segment of sleep may

contain B-waves of several different predominant
wavelengths,

all of which would be detected by spectral

analyses.
Still another possibility that might account for both
the large number of wavelengths and the low wave
amplitudes that were observed was suggested by the data on
the wave-to-wave changes in wavelength.

These data

strongly suggested that the majority of subjects were not
having

(unambiguous)

B-wave activity.

The low amplitudes

and variable wavelengths are exactly what would have been
expected if no B-wave activity was present.
Dual Recording Site Data
The data from the three subjects whose oximetry
variables were recorded from two sites was also not

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

251

consistent with the proposed PCI theory.
subject who had PLMs,

these events did not tend occur at

rS02 and/or total hemoglobin troughs.
subject,

In the one

In fact,

in this

the vertex rS02 and total hemoglobin were more

stable than the forehead rS02 and total hemoglobin.
addition,

In

the small percentage of peak matches between the

two recording sites
between them)

(and the relatively low correlations

indicated that B-wave activity was not

present in these subjects.

A high number of peak matches

and high correlations would have been expected if B-waves
were present.
Conclusions and Suggestions for Future Research
In summary,

no support for the proposed Periodic

Cerebral Ischemia theory was found in the present study.
There were no group differences in B-wave amplitude,
perhaps more importantly,

and

the RLS sensory/motor events and

PLMs did not occur with a high frequency at the troughs in
oxyhemoglobin wave cycle.

Although these negative

findings do not rule out the possibility of circulatory
insufficiency as an underlying cause of RLS and PLMS,

they

do cast additional doubt on this general idea.

it

Thus,

would be useful to replicate the previous studies that
supported this hypothesis.

These would include the

treatment studies of Parrow and Werner

(1966)
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(1995),

in addition to prevalence studies in a fairly

large number of patient groups

(e.g. those with various

kinds of circulatory problems) .

If treatment studies

using blood thinners or vasodilators to treat RLS and PLMS
cannot be justified

(based on our current lack of

knowledge concerning the pathogenesis of RLS and PLMS),
then perhaps the prevalence of RLS and PLMS can be
followed before and after treatment in patients who
receive these drugs for other medical c o n d i t i o n s .

It

would also be useful to extend the work of Droste et al.
(1996) which found that B-waves in blood flow velocity
were related to PLMs.

The simultaneous use of

transcranial Doppler sonography and cerebral oximetry in
such a study would also be useful.

The relationship of B-

waves and PLMS could also be studied in neurological
patients undergoing continuous monitoring of intracranial
pressure as part of an evaluation of neurological
disorders other than RLS or PLMS
hydrocephalus).

If a relationship between cerebral blood

flow oscillations and either RLS,
established,
Conversely,

(e.g. head injury,

PLMS,

or both can be

then treatment studies can be considered.
if such a relationship can be ruled out,

then

researchers can focus on other potential causes of, and
treatments for, both of these disorders.
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Appe nd ix 1 - Questionnaires Used in the Study

Restless Legs Questionnaire
Subject Number_____________________
Date of Birth__________________

Date__________
Age__________

Sex

1)

Please describe the problems you have with your legs.

2)

Please describe the sensations in your legs in as much detail
as you c a n .

3)

At what times do you get the symptoms?

4)

What do you do when you get the symptoms?

5)

Which of the following activities are helpful in relieving
your symptoms:
(please check those that are helpful)
_____ Rubbing or massaging your legs
_____ Moving your legs while in bed
_____ Using a heating pad or taking a warm or not bath
_____ Applying anything cold to the legs
_____ Stretching your legs
_____ Getting up and walking around
_____ Other (please describe below)
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6) Which of the above activities are most helpful in relieving
your symptoms?

7) How old were you when you first began to get the
symptoms? _________
8) Have there been periods of time when the symptoms got better
or worse or even went away completely? Please describe.

9) Are there any things which seem to make your symptoms better
or worse? Please describe below:

10) Are your symptoms worse when you are under stress?
yes or no)
YES
NO

(circle

11) How often have you had the sensations in your legs over the
past 6 months?
Please check the most correct answer.
One or two nights a week
Three or four nights a week
Five or six nights a week
Every night of the week
12) Do you also get the sensations in your legs during the day?
If yes, please note how many days a week you have had them
over the last 6 months.

13) Please use the list below to indicate where the sensations
occur. (Check all that apply)
Feet
Lower legs (between ankle and knees)
Thighs
Groin
Trunk
Shoulders or neck
Upper arms
Forearms
Hands or fingers
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14) Please use the list below to indicate what the sensations in
your legs are most similar to. (Check all that apply)
heat
burning
cold
itching
aching
numbness

_____
_____
_____
_____
_____
_____

cramps or "Charlie horses"
creeping or crawling
pulling orstretching
like your legs "falling asleep"
painful
tingling

15) If the sensations are painful, please describe the pain
below.

16) Do the sensations occur:

_____ on the surface of the skin
just beneath the skin
deep within the legs or
muscles

17) Do you find that the sensations are difficult for you to
describe? (circle yes or no)
YES
NO
18) Have you ever been told that your legs twitch, kick,
during the night? (circle yes or no)
YES
NO

or jump

19) Do you ever wake up and find that you have kicked the covers
off the bed? (circle yes or no)
YES
NO
20) Do your legs or arms ever "jump" or "twitch" suddenly during
the day? (circle yes or n o ) . YES
NO
If yes, please
describe.

21) Did your mother, father, or grandparents have restless legs
or leg movements at night? Please circle the correct answer
below, and indicate in the margin if they restless legs, leg
movements, or both.

Grandmother
Grandmother
Grandfather
Grandfather

(mother's
(father's
(mother's
(father's

.... YES
....YES
side)
___ YES
side)
--- YES
side)
--- YES
sid e ) .... --- YES

NO
NO
NO
NO
NO
NO

DON'T
DON'T
D O N ’T
DON'T
D O N ’T
DON'T
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KNOW

292

22) Did any of your aunts or uncles have restless legs or leg
movements at night? Please describe below.

23) Do any of your children or grandchildren have restless legs
or leg movements at night? Please describe below, and be
sure to indicate if your child or grandchild is a boy or
girl.
If you have no children or grandchildren please note
that below.

24) Use the rating scale below to indicate how severe your
restless legs symptoms usually are:
1
Mild

2

3

4

5

6

7
Severe

25)Do you have difficulty
falling asleep because of your
symptoms?
(circle yes or no)
YES
NO
26a) When you experience symptoms of restless legs, how long does
it take you to fall asleep (on average)?_____________ minutes
26b) When you do not experience symptoms of restless leg, how
long does it take you to fall asleep (on average)?___________
27) Do you wake up frequently during the night?
no)
YES
NO

(circle yes or

28a) When you experience symptoms of restless legs, how many
hours do you sleep at night (on average)?_____________ hours
28b) How many hours do you sleep at night when you do
symptoms of restless legs?___________ hours.

not have

29) Have you ever become depressed because of your restless legs?
(circle yes or no)
YES
NO
If yes, have you been treated for your depression?
YES
NO
30) Have you ever sought treatment for your symptoms of restless
legs (or leg movements at night)? (circle yes or no) YES
NO
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31)

If yes, what treatment or medication did your doctor
prescribe?

32) Was the treatment(s) effective?
33) Have you ever had a sleep study (polysomnogram) done? YES
If yes, what did your doctor tell you they had found?

34)

NO

Please list any other medications which you have taken in the
past (even if they were not prescribed for you restless legs)
which helped reduce vour symptoms of restless leas:

3 5) Have you ever had moderately high or high fevers? YES
NO
If yes, how did this affect your symptoms of restless legs?

3 6) Have you ever given blood? YES
NO
If yes, how did this
affect your symptoms of restless legs?
37)

How does excercise affect your symptoms of restless legs?

38)

Do you get headaches?
YES
NO
If YES, does anything in
oarticular seem to cause you to have headaches?

39)

If you are a woman, and have had children, how did your
pregnancy affect your symptoms of restless legs?

40) Please indicate if you have ever had any of the following
diseases or conditions: (write in a "Y" for yes, or a "N"
for no)
anemia
_____ stroke or head injury
kidney disease/uremia
_____ high blood pressure
_____ low blood pressure
iron deficiency
chronic lung disease
_____ leg cramps
rheumatoid arthritis
_____ fibromyitis/fibrositis
gastric (stomach) surgery _____ diabetes
circulatory problems
_____ neurological disease
heart disease
_____ cold hands, legs, feet
leukemia
_____ weakness in legs\arms
spinal ccrd\back injury
_____ headaches
any other serious illness (list below)
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41) Would you be willing to participate in any future research
projects that we conduct (circle yes or no)
YES
MO
42) On the figures below please fill in the areas where your
restless legs sensations occur.

Thank you for completing this question.-, a ire
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SLEEP OISOROERS INVENTORY

W illiam P. Waters. PH.D.. A8PP. BCSS
Cooroinator. Sleep D isorders Program
Ochsner C lin ic o f Baton Rouge
and
Department o f Psychology. L ouisiana S ta te U n iv ersity
INSTRUCTIONS
*** The Sleep D iso rd ers Inventory is a q u estion n aire th a t i s designed to ob tain
inform ation t h a t w i l l a s s i s t in the d esc rip tio n and d ia g n o sis o f a p a t ie n t 's sle e p
d iso rd er,
i t a ls o provides information th at i s h e lp fu l in determ ining th e causes and
th e co rrect treatm en t o f a p a tie n t's sle e p d iso r d e r .
*** P le a se answer t h e s e q u e stio n s to th e b e st o f your a b i l i t y .
It is understood zr.at some
o f your answers w i l l be approximations, not e x a c t. Such estim a tes are a c c e p ta o le .
A lso , a few o f th e q u estio n s may require inform ation from a person who has observed
your sle e p .
I f you have access to such in form ation , f e e l fr e e to use i t .
*** I f you are asked to g iv e a YES_NO answer, and you are not ce r ta in o f your response,
g iv e the answer th a t is c lo s e s t to th e tru th as b e s t you can determ ine. I f ycu are
asked to g iv e a numerical answer, such as th e number o f minutes i t tak es you t o f a l l
a sle e p , and you are not c e r ta in , giv e an approximate answer that is c l o s e s t to the
tru th as b e s t you can determ ine.
*** P lea se answer ALL o f the q u estio n s.___ I f a YES_NO item does not apply to you. answer
NO. It you en cou n ter an item th a t c a l ls for a num erical response and i t does rot
apply to you . or you cannot g iv e an estim a te, th e number 0 w ill in d ic a te th a t i t does
not apoly or th a t you cannot estim ate.
Before b egin n in g tn e Sleep Disorders Inventory, p le a s e provide tne fo llo w in c
i n f c m a t io r :
NAME: ______________________________________________

QA": ________

SOCIAL SECURITY NUMBER: __________________________

CLINIC NUMBER:

AGE: _________________

HE:^HT. ______

WEIGHT:_________________

THE SIZE- DISORDERS INVENTORY BEGINS ON TriE NEXT ?iGE.
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Page 1

P le a s e CIRCLE tn e appropriate response for eacn o f tn e YES or NO q u e stio n s. P le a se PILL
IN THE BLANK w ith tn e co r re ct nuioer for eacn q u e stio n th a t is f o l l o « d by a blank.
1.

Oc you nave a i f f ’ c u lt y f a llin g asleep a t m gnt ? ..................................................................................NO
I r NO. 50 to t 2
(a ) About how many m g h ts does th is happen each week ? ................................• ■ -----------(b) On n ig n ts when you have th is problem, how many m inutes does i t take you to
f a l l a s le e p ? .............................................................................................................
^...............................
(c ) On m g h ts when you nave th is problem, how many hours do you sleep ; .................. .................

2.

Do you wake uo d uring th e n ight and have d i f f i c u l t y f a l l i n g back to s le e p ?
YES NO
I f NO. go t o I 3
(a ) About how many m g h ts does t h is happen each v«ek ? ............. ......................................... .................
(b) On th e average, how many tim es do you wake up each n ig h t ? ............. .........................................
(c ) How many m inutes does i t take you to f a ll a sle e p a f te r awakening ? .................. .................
(d) On n ig h ts when you have t h is problem, how many hours do you sleep ? .................. .................

3.

Oo you wake up in th e morning b efore your scheduled wake tim e, and cannot
return to s le e p ? ......................
'ES NO
i f NO. SO tO # A
(a) H o many n ig h ts per week do you have t h is problem ? ...................... — .......................................
(b) On m g h ts wnen you have th is problem, hew many hours do you sleep ? .................. .................

a

Oo you wase up during th e night freq u en tly , out f a l l a sle ep soon afterw ards 7 ...Y E S NO
NO. go to # 5
(a) h o w many tim e s a n ig h t do you wake up ? ................................................................................................
CDJ Hew many n ig h ts each week do you have t h is problem ? ................................................... .................
On m g h ts wner. you 00 not have any problem f a l l i n g a sle e p or regaining s le e p ,
h o many m inutes does i t u sually take you to f a l l a sle e p ? ..........................................
Hew many n ig h ts each week do you have sle ep lo s s o f any kind ?.
Hex mary hours cc you sle ep on your o e s t m g n ts ? .............................
Or '•’.a r t s wrer you to not have any orcolem ' a i l i n g a sle e p or regain ing s le e p ,
new many hours "tc yet u su a lly sleep ? ......................................................................................
Dees lack o f s le e p o fte n cause vcu to f a ll a sle ep a t in app rop riate tim es or m
tn e wrong p la c e during the day ? ....................................................................................................

YES

NC

10. Does lack o f s le e p o fte n cause you to have tr o u b le fu n ctio n in g during tn e day

YES

NC

11. Does your Ded p a rtn er d isturb ycur sle ep at n ig h t ? ..........................................................
I * NQ. OC to 4 12
.
; a ; Dees i n s ta u se k u sleep ;ess some or tn e tim e 7 ...............
vcu ' : s e sleep most o f th e r a te 2 ........................
.a . . 1 0 *

YES

NC

YES
YES

NC
NC

YES

NC

;a, Dees t m s cau se y:u sleep le ss some o f tne tim e ? ................
(p.’ is t m s *ry you ose sleep most o f the tim e ? .........................

.YES
YES

NC
NC

Is ycur oecrccm dark enough for s 'e e c at m e m ? ...........................

. VES

NC

YES
VE5

NC
NC

Is veur s eep r s t u r e e c oy er v 'r o n r er cs: 'a s t e r s sucn as tr a f' c . ne’ grpcrs cr
-'ar-^y nem ce-s
...............................................................................................

* -

.•

ZZ

- r

“ ^

C c e s 'fs
Is f " .

i '*

cau se vcu sleep ': s s some
z~s tim e '
.-tu ' : s e s ie e : t e s t :* t _e v e
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14

Is your bedroom temperature comfortable enough fo r s le e p a t n ight ? ........................... YES NO
I f YES. go t o # 15
(a) Does t m s ca u se you sle ep lo ss sane o f th e tim e ? ............................................................ YES NO
(b) Is t m s why you lo s e sle ep most o f the tim e ? ..................................................................... YES NO

15

Oo you sle e p enough nours but have trou b le waking up. f e e lin g unrefreshed ? ...........YES NC

16. Oo you sle e p enough hours Dut f a ll a sleep in v o lu n ta r ily during the day. but only
when r e la t iv e l y unstim ulated ( lik e watching t v ) ?
YES NO
17. Do you s le e p enough hours but f a ll a sleep in v o lu n ta r ily during the day. even
when doing som ething very important ( lik e d r iv in g ) ?
18.

YES NO

Oo you sle e p enough hours but s t i l l have tr o u b le fu n ctio n in g during th e day 7...Y E S

NO

19. How many n ig h ts per month do you:
Snore lou dly and p e r s iste n tly
Thrash about w hile a sleep (Out are n ot dreaming)
Gasp or sn ort w h ile asleep
Stop breathing w h ile asleep
wake up in the n ight and fee l unable t o breathe
20. How many mornings a month do you awaken w ith a headache ? ................................................ ................
21.

22.

Oo you wake up frcm a sound sleep repeated ly b ecau se your le g s jerk ? ........................YES NO
I f YES: Are yo u r le g movements frequent, v ig o ro u s and reg u la r ? ..................................... YES NO
I f y e s - How many n igh ts per month does t h is occur ? ..............................................................................
Is your s le e p ev e r delayed because your le g s f e e l r e s t l e s s o r odd in bed ? ............. YES NO
L nq . go t o # 23
(a) Do you need to move your legs in bed. or g e t up and move to f a ll a sleep 7 . . . YES NO
(b) How*many n ig h ts per month do you leg s f e e t t h i s way 7 .............................................. ................

i

23. Do ycu have sudden and com pelling attack s o f s ’ e e p in e s s . so bad you must stop
what ycu a re d oing and sle ep 7
YES NO
I f NO. go t o # 24
(a ) how many m inutes do you sleep (nap) when you have such an attack 7 ....................
.......
(b) Do you awaken from you nap fe e lin g re fresh e d 7 ..................................................................YES NG
Cc) How many tim es eacn month does t h is occur 7 .......................................................................................
24. wher, you a re s t a r t le d , em otional, e x c ite d , or happy do you o fte n experience
extrem e weakness (fo r example, in your le g s ) or drop th in g s 7 ......................................... YES

NO

25. when you a re s t a r t le d , em otional, e x c ite d , or happy do you c o lla p s e ( f a l l ) ? — YES NO
I f vE.v Are you s t i l l aware o f your surroundings 7 ................................................................. YES NO
25.

As you f a l l a sle e p or wake up. do you o fte n s e e th in g s th a t are not th ere 7
YES NO
I f VES: Is w rat you see very cle a r ano r e a l i s t i c 7
YES NO
-cw many n ights eacn month 7 ............................................................................................... .................

27.

As 'Cu fa * I a sle ep or wake up. oo you o fte n f e e l unaole to move (paralyzed) 7 . . . YES NO
I f VES: h o w many n igh ts each month 7 ................................................................................................ .................

28. On rex many n ig h ts nave nightmares awakened you in tn e l a s t month 7 ...........................................
I f ANY: h o w in te n s e are they: 1-MilC. 2 -F r ig h te m n g . 3 -T erriry in g 7 ............................ .................
29.

Do you o fte n move v’o le n tly during ycur s le e p wfiile_dreanring and sometimes
eve'1 nurt y o u r s e lf or ycur partner by a c c id e n t, or * a ll out o f bed 7
lY 'E T ; -cw rnarv times in tne la st month nas t h i s nacoened 7 ...................................
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30. Oo you awaken from a deep s le e p sw eating, your heart b ea tin g fa s t or
sounding, w ith a f e e lin g o f fea r but with no memory o f a dream ? ...................................YES NO
If NO. go t o # 31
(a) how many tim es in th e l a s t month has t h is happened ? ...................................................................
(b) new in te n s e is t h is ex p erien ce: 1-Mild. 2-F righ tem n g. 3 -T e r n fy in g ? ..............
(c) Do you have sim ila r ex p erien ces during the day as w ell ? ........................................... y£$ nO
31. Oo vou walk in your sle e p ? ......................................................................................................... . YES NC
If ftC. go to # 32
(a) how many tim es a month does t h is happen ? ........................................................................... ................
(b) About how many m inutes p ass by w h ile you are sleetxwalking ? ............................ — _______
32.

Doyou

o fte n t a lk in your sle e p ? ...................................................................................................... YES NO

33.

Doyou

o fte n grin d your t e e th in your sle e p ? ............................................................................. YES- NO

34. Haw many tim es per n ig h t do you wake up s p e c if i c a ll y to use the bathroom ? ............................
35.

how

many n ig h ts per week do you wake up w ith in d ig e stio n or heartburn ? .................. ................

36.

Doyou

o fte n e a t your l a s t meal or a large snack w ith in 2hours o f bedtim e ?

37.

Doyou

o fte n

go

vigorous e x e r c is e w ith in an hour o f bedtime

YES

NC

? .......................................... YES NO

38. How many g la s s e s ( b o t t le s /c a n s ) o f a lc o h o lic drink do you have each day ? ..............................
39. How many n ig h ts each month do you use alcohol to aid sle ep ? .......................................... ................
40.

how

many cups or g la s s e s o f c a ffe in a te d beverages do you drink in a day ? ..............................

41. How many days a week do you drink c a ffe in a te d beverages a f te r 7 p.m. ? .....................................
42. Hew many c ig a r e t t e s a day do you smoke ? ......................................................................................................
43. Do you tak e any m ed ication s th a t co n tain c a f f e in e or stim u la n ts, such as a lle r g y
m ed ication s, nasal d eco n g esta n ts, or oain k ille r s ? .............................................................. YES NC
i~ VE5: Hew many m inutes b efo re try in g to sle e p do you take them ? ........................... .................
44.

is yz'jr s 'e e c problem ca u sec or mace -worse by p hysical
Never:
R arely;
Sometimes.
Green;

45.

Doyou ever *cr< n ig h t s h i f t s (Any 3-12 hour s h i f t s ta r tin g 6 pmto 12 am) ?
YES .NC
If '9 5 : How many n ig h ts p er month ? ..................................................................................................................
Hew many tim es a month do your worfc hours change ? ............................................... ................

46.

Do you work a t ncme a f t e r 8 :0 0 p.m. ? ............................................................................................YES NC
h o w many n ig h ts per week ? ................................................................................................... •_______

47.

Do you i s c r i - i t e s le e p tim e in order : : get m mere 'work o r - 3m ly tim e ? . .
YES
NC
I f * 25: -cw ?*ry hours o er n ig h t ? ................................................................ " ............................... ................
-Cw - -" y m g h ts per week 7 ......................................................................................
...............

43.

On weesencs pr ycur days o f f . co you o fte n sle ep mere than an ncur ia t e r' tnan
your usual wase up tim e ? ..................................................................................................................... YES

50.

discom fort or oam :
Most or A ll o f tn e Time.

VC

when vcu nave s'e e p problem s, do ycu:
(a) Often go t : pec e a r lie r to make up for lo s t or u nrefresnm g sla eo 1 ...................YES NC
CD; Often wake up la t e r to make uo for lo s t or u n -efresh m c s ’eeo 7 .................. YES
NC
I t , Cat up Put pf P9d and.
water tv: . rea-t:
eat: ^ work CHECK all ~- at APPL'
' t "ase niP 3 t .- " r g ncraa' wak’ rg "Cu'S - ..
YES NC
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I f NO
(T)
(2)
(3)

naps, go to # 5L
Hew many tim es per week do you take naps ? . . .
How many m inutes are your naps, on average ? .
Oo you awaken from your naps refreshed 1

Page 4

.................................................yES nC

51.

Is your sle e p problem worse w*ien you are under s t r e s s ? .......................................................YES NC
Do you s le e o b e tte r when you sle ep away frcm home ? ................................................................YES NC

52.

Have ycu been under noteworthy str e s s recen tly ? ......................................................................YES

nC

53. When you tr y t o sle e p , does worrying or problem s o lv in g o fte n keep youawake ?..YES
NO
Oo you o fte n worry about g e t t in g enough sle ep to fu n ctio n th e next day ? ................... YES NO
Oo you o fte n g e t fru stra ted and angry about not g e t t in g to sle e p ? .............................. YES NO
54. Oo you worry to o much in general ? ....................................................................................................YES NO'
55.

Does you r s le e p problem a f f e c t your mood during th e day ? ................................................. YES NO

56.

Are you cu rr en tly diagnosed as having a mood d iso rd er (d ep ressio n )..? .....................

57.

Are you cu r r e n tly diagnosed as having an a n x iety d iso rd er ? .............................................YES NO

58.

Have you eve" been trea ted fo r m en tal/em otion al/d ru g/alcoh ol problems? ......................YES NO
I f YES: Have you e v er been h o sp ita liz e d for such problems ?
YES NC

59. How long have you had your sle e p problem ?

No. Y e a r s

No. Montns

50. Have you p r e v io u sly received non-drug treatm ent fo r s le e o problems ?

YES

NC

No. weeks
YES

NC

51. Have you r e c e n tly taken any p rescrip tio n or o v e r -th e -c o u n te r m edication for
s le e p problems ? ............................................................................................................................................YES NC
If"n o. go to § 62
(a) How many n ig h ts a week do ycu u su allv take t h i s m edication ? .................................................
(b) How many months have you oeen taking sle e p m ed ication ? ........................................... ................
52.

P le a se l i s t winch m edications you are now ta k in g and th e co n d itio n for v*ncn eacn i s
being tak er.
Include p rescr ip tio n and o v er -th e-co u n ter m edications.
me: : : a' i : n
ccnoi' icn
meoicaticn
ccnoiticn

53.

P le a se l i s t any m edications ycu have re ce n tly stopped tak in g and the co n d itio n for
Y
..ar r\r\i n/* taken .
l rtn
_ f he-co
a
2 T 'if'flC
nd nv/Of*
o v er-th
u n ter fnO/ll
m ed f*
ication
s.
rclude p r e sc r ip tio
n an/i
which
ea c- *as
ce m c
MEDICATION
CONDITION
mech .-t ic n
*
CCNC " .: n

Is th e re
m g you would W e to c la r if y or acd. tn a t .irgnt be h e'b 'u ! ?
w r ite you ' to rr en ts te'cw arc ; r ore r e v e 'se s i c e o f t h i s cage:

- - an:<

"5.

iw

.-i '

ing

?- i !

:'ivE 'r:=v
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DAILY SLEEP DIARY
Subject N u m b e r ______________________________ Date_____________________
PLEASE RESPOND TO THESE QUESIONS SOON AFTER YOU WAKE UP FOR THE DAY.
1.

About what time did you first try to fall asleep last night?_____

2. Approximately how many minutes did it take you to fall asleep?________
3. If you awoke from sleep last night, please indicate about how long it
took you to ge t back to sleep.
_min

nun

_min

_mxn

_min

min

min

min

min

min

About what time did you awaken for the day this morning?_
About how many hours did you sleep altogether last night?_
How difficult was it for you to fall asleep last night?

Extremely
difficult

Not very
difficult
7. How rested do you feel this morning?
1

2

3

4
Poorly Rested

Very Rested
3. Rate the quality of last night's sleep.
1

2

3

4
Very Poor

Excellent

9. What was your level of physical tension when you went to bed last
night?

Extremely
Tense

Extremely
Relaxed
10.

Rate your level of mental activity when you went to bed last night.
1
Very Quiet

2

3

4

5
Very Active
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Daily Sleepiness Scale
Form D
Data
Instruction*:
Plaasa u a « « r q w i U o o s I - 14 bafora you go to bad tonight. Bafora
an s w a n n g thasa quastions, think about bow slaapy you fait today. Than, raad aacb
applias to you.

Plaasa answar guaation 15 whan you wala up in tha morning.

1) About how many hours did you slaap last night?
(a)
(b)
(c)
(d)
(a)

5
5
6
6
7

hours or lass
hours
hours
h hours
hours

(f)
(g>
(h)
(i)
(3)

7
8
8
9
9

u* hours
hours
hours
hours
h hours or mora

2) What was tha ovarall quality of your slaap last night?
1

2

3

5

4

Excallant

Vary Poor
3) How difficult was it for you to awaJcan this morning?
1

2

3

5

4

Not at all
difficult

Vary
difficult

4) How of tan did you axparianca a strong dasira to lay down and slaap today?
1

2

3

4

Almost navar

5
Vary Of tan

5) How many tiaas did you -nod off" (or fall aslaap for just a faw saeonds) today
whila you wara angagad in unimportant tctiwitiaj Cfor axampla. wbila watching TV
or raading)’
(a)
Nona
(b)
Onca
(c) Twico

(d)
(a)

Thraa tins*
Four or aora timas

S) How many c u a s did you "nod off" (or fall aslaap for just a faw saeonds) today
whila you wara angagad in important aetlvitias (for axanpla, whila driving or
having a convarsation)?
(a)
Nona
(b)
Onca
(c) Twica

(d)
(a)

Thraa tiaas
Four or aora timas

?) About how many ainutas did you nap today'1
(a) nona
(b) 1 to 20 ainutas
(c) 21 to 40 ainutas

(d) 41 to SO ainutas
<«) 51 ainutas or mora
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8) Ho* of ton did you do thinff to holp yourself stay awaka today? For oxagplo: move
around or u n r u u , . . . waah your face or take a showor, .. . drink coffee or other
caffainated bovorago, ate..
1

2

3

4

Almost navar

5
Vary Ofton

91 How such did sleepiness negatively «ffoct your job performance or normal
activities today?

Hot at
All

v-rY
HUeh

10) How of tan did you hava troublo concentrating or paying attontion today?
1

2

3

4

Almost navar

5
Vory Oftan

11) How much did you yawn today’
1

2

3

4

Almost navar

5
Vory Oftan

12) How oftan did your ayas faal tirwd, hoavy, or droopy today?
1

2

3

4

Almost navar

5
Vory Oftan

13) How ofton did you foal physically tirod or fatiguad (but not nocossanly sloapy)
today’
1

2

3

4

Almost navar

5
Vory Oftan

14) Ovorall. how sloapy war* you today?
1

2

3

4

Not at all
sloapy

Please answor this last quostion whan you wako -so m
15)

5
Vary
iloopy

tha morning.

About how long did it taka you to fall aslaap last night?
(a) 0 to 5 minutos
(b) 4 to 15 ainutas
(c) 16 to 30 ainutas

(d) 31 to 40 ainutas
(a) 41 or mora ainutas

Thank you for completing this questionnaire'
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Appendix 2 - Study Consent Form

L OUISIAN A STATE UNIVER S I T Y - B A T O N ROUGE CAM P U S
Consent Form
1.

Study T i t l e ;

Cerebral Hemoglobin Oxygen S a t u r a t i o n in
Patients with Restless Legs S y n drome and
Periodic Limb Movements in Sleep.

2.

Performance Sites:

3.

I n v estigators :

Louisiana State U n i v e r s i t y

The following investigators are available
for questions at the phone n u m b e r s listed
below.

Name:
Department:
Telep h o n e Number:

W i l l i a m Waters,
P sychology
388-4115

Name:
Department:
Telephone Number:

M a r k Hurry,
Psychology
766-6399

Ph.D.

M.A.

4.

Purpose of S t u d y :
To determine if symptoms of Restless
Legs Syndrome and Periodic Limb M o v e m e n t D i s o r d e r are
associated wit h abnormalities in blo o d flow a n d oxy g e n
transport to the brain.

5.

Patient I n c l u s i o n : The study includes three groups of
subjects aged 19 to 30 years old:
patients w i t h Restless
Legs Syndrome, patients with Periodic Limb M o v e m e n t s in
Sleep, and hea l t h y control subjects.
Each g r o u p will
consist of 12 to 15 subjects.

c.

Patient E x c l u s i o n : Persons younger than 18 or older char. 50
years old, persons with any sleep d i s order o t h e r than
Restless Legs Syndrome or Periodic Limb M o v e m e n t s in Sleep,
persons wi t h any neurological disorder, l i f e - t h r e a t e n i n g
medical condition, or menta l l y disab l i n g m e d i c a l disorder.
Description of the S t u d y : This study consists of two parts.
Part One is a screening process that begins w i t h a phone
interview lasting about ten minutes.
The p u r p o s e of the
phone interview is to m a k e an initial d ec i s i o n about whether
or net you meet the inclusion criteria for the study.
If
ycu do, you will be sent a consent form and p a c k e t of
questionnaires to complete.
After you have r e c e i v e d the
packet, you will again be contacted by phone so that the
study and consent form can be explained to you.
This should
take about ten or fifteen minutes.
The questi o n n a i r e s
include the Sleep Disorders Inventory, wh i c h s h o u l d take
about 20 minut e s to complete.
Participants w it h Restless
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Legs Syndrome will also fill out a questionnaire called the
Restless Legs Q u e stionnaire; this should take about 20
minutes to complete.
In addition, each subject will be
required to complete two short questionnaires, the Daily
Sleep Diary and the D a i l y Sleepiness Scale, each day for a
period of two weeks.
E a c h o f these questionnaires takes
about five minutes to c o m p l e t e each day.
After you have
returned the questionnaires, they will be reviewed, and,
according to the results, you may or may not qualify for
Part Two of the study.
Part Two of the s t u d y will require you to undergo a one
hour test during w h i c h you will try not to move your legs
(Suggested Immobil i z a t i o n Test!, and then undergo an
overnight sleep study o n the same night.
Both tests will be
conducted in the L.S.U. Department of Psychology's sleep
laboratory in A u d u b o n Hall, which is located on L.S.U.'s
Baton Rouge campus.
For some subjects the Suggested
Immobilization Test will consist of 30 minutes of attempting
to remain still, follo w e d b y 15 minutes of walking in place,
and Cher, an additional 30 minutes of attempting to remain
still.
During the S u g g e s t e d Immobilization Test and the
overnight sleep study, b l o o d flew to the brain will be
measured by a small sen s o r placed on the forehead.
Brain
activity, eye movements, m u s c l e tone, heart rate, breathing,
and leg movements will als o be measured during these tests
using sensors a t t a c h e d to the surface of the skin.
It will
take about one hour and fifteen minutes to attach the
recording sensors, sc subjects will be required to arrive at
Che sleep laboratory two and half hours prior to their
normal bedtime, or at abo u t 8:12 p.m..
Subjects will be
awakened at 6:00 a.m. in the morning, and should be ready to
leave about 30 m inutes later.
8.

Benefits:
The stu d y w ill not benefit all subjects directly,
though some subjects m a y choose to have their results sent
to their physician.
The s t u d y will benefit subjects b y
helping physicians u n d e r s t a n d the causes of Restless Legs
Syndrome and P e r iodic Lim b Movement Disorder, and by
enabling researchers to target more specific and effective
treatments for their disorders.

9.

R i s k s : The risks are v e r y small, and include a small
possibility of d e v e l o p i n g mil d skin rashes where recording
devices are at t a c h e d to the skin.
Patients with Restless
Legs Syndrome and P e r i o d i c Limb Movement Disorder who
withdraw from m e d i c a t i o n s being used to treat their disorder
may experience i n c r e a s e d difficulty in falling asleep, a
decrease in the q u a l i t y of their sleep, and an increase m
daytime sleepiness.
Patients with Restless Legs Syndrome
and Periodic Limb M o v e m e n t Disorder who withdraw from
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medical treatment w i l l be required to do this under the
supervision of their physician.
10.

A l t e r n a t i v e s : This s t u d y does not evaluate any treatment
for Restless Legs S y n d r o m e or Periodic Limb Movement
Disorder.
A l t e r n a t i v e methods for measu r i n g blood flow to
the bra i n include transcranial Doppler sonography, which is
technically difficult, and various types of "brain scans",
wh i c h are both c o s t l y and invasive.

11.

Removal:
Subjects w h o agree to p a r ticipate will fulfill all
of the study req u i r e m e n t s when the overnight sleep study is
completed, or w h e n t h e y return the questionnaires to us if
they do not q u alify for Part Two of the study.

12.

Right to R e f u s e :
S u b j e c t s m a y choose NOT to participate or
w i t h d r a w from the s t u d y at any time with no penalty.

13.

Privacy:
The results of the study m a y be p u b l i s h e d as group
data in which no subjects' results are p r e s e n t e d
individually.
The p r i v a c y of participating subjects will be
p r o t e c t e d and the i d e n t i t y of participants will not be
revealed.
The data c o l l e c t e d will not be u s e d for any
purpose not approved b y the participants and the L.S.U.
Institutional R e v i e w Board.

14.

Release of I n f o r m a t i o n :
The questionnaires and recordings
for participants in this study will be r e v iewed by the
investigators, but the identity of the participants will not
be revealed.
If any participant wishes to have results from
their overnight sleep study (or any ether results from the
study) sent to their physician, they may do so b y filling
cut a written request for information form at their
physician's office, or by sending a w r i t t e n request to:
W i l l i a m Waters, Ph.D.
Depar t m e n t of Psychology
236 A u d u b o n Hall
Louis i a n a State U n i v e r s i t y
Ba t o n Rouge, LA 70803

15.

Financial I n f o r m a t i o n : There are no costs to participants
m
the study other than any travel costs that mignt be
incurred in coming to LSU for the overnight sleep study.
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16.

Signatures:
The stu d y has been discussed w ith m e and m y questions have
b e e n answered.
I understand that additional questions
regar d i n g the study should be d i r e c t e d to investigators
list e d above.
I understand that if I have questions about
s ubject rights, or other concerns, I can contact Charles E.
Graham, Chairman, Institutional R e v i e w Board (504-388-1492).
I agr e e with the terms above and a c k n o w l e d g e I have been
giv e n a copy of the consent form.

Signature of Study Participant______________________
Witness _____________________
Investigator___________________

Date___________

D a t e ___________
Date___________

The stu d y subject has indicated to me that she or he is unable to
read.
I certify that I have read this consent form to the
subject an explained that b y compl e t i n g the signature line above
the subject has agreed to participate.
S ignature of Reader_______________________

Date_____________
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Appendix 3 - Scoring Rules for B-Wave Cycle Data
1) The waves in the rS02 and total hemoglobin data should
be thought of as consisting of three equal parts:
troughs, ascending/descending limbs, and peaks.
If the
trough to peak (ascending part of wave) and peak to trough
(descending part of wave) are not equal in height, divide
each segment into equal thirds as described above.
2) To determine wave limb in the rS02 waves,
following guidelines:
a) If the wave height is 1 rS02 point,
peaks & t r o u g h s .

use the

there are only

b) If the wave height is 2 rS02 points, the bottom points
are troughs, the middle ones are either ascending or
descending, and the top points are peaks.
c) If the wave height is 3 rS02 points, the bottom points
are troughs, the two middle ones on each limb are either
ascending or descending, and the top points are peaks.
d) If the wave height is 4 rS02 points, the two bottom
points are troughs, the one middle point is either
ascending or descending, and the two top points are peaks.
e) If the wave height is 5 rS02 points, the two bottom
points are troughs, the two middle points are either
ascending or descending, and the two top points are peaks.
f) If the wave height is 6 rS02 points, the two bottom
points are troughs, the three middle points are either
ascending or descending, and the two top points are p e a k s .
3) Stable points can occur whenever the rS02 value does
not change for 5 or more data points.
Whenever there are
five or more data points at the same rS02 level, the first
two points after the increase or decrease are scored as
either peaks or troughs (peaks if the previous point was
lower, and troughs if the previous point was h i g h e r ) .
Similarly, the last two points before the next increase or
decrease are scored as either peaks or troughs (peaks if
the next point is lower, and troughs if the next point is
higher). All points in the mi dd le are scored as stable
(this can be as few as one data p o i n t ) .
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Appendix 4 - Additional Statistical Tests on B-Wave Cycle
and Periodogram Peak Data
This appendix contains a number of additional
statistical tests on the event occurrence in the B-wave
cycle and spectral analysis p e r i o d o g r a m peak data.

These

tests were done on a post hoc basis to help clarify the
results.

There were a total of 68 of these tests

pairwise comparisons on the wave cycle data,
tests on the perio do g ra m peak data,

(48

14 Chi Square

and six ANOVAs on the

mean number of periodogram peaks among the g r ou ps ).

An

initial alpha level of .004 was use d to assess the
significance of these tests.
tests

This reflects the number of

(68) divi de d into an overall alpha level of .25).

The .25 overall alpha level was u s e d as per the
recommendations of Keppel

(1991).

In addition,

the

multistage Bonferroni correction procedure of Larzelere
and Mulaik

(1977)

was used.

There were 16 tests that

reached significance in the first step of this multi-stage
procedure,

and one test that reached significance

.005 p level)

(at the

in the second step of this procedure.

The data presented in Tables

6 through 11 in the

Results section are summarized in Table A4-1, which lists
the group means
sensory,

for the percentages of events

SIT motor,

and PLMs)

(SIT

occurring at each point in
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Table A4-1.

Event

S u m m a r y of B-Wave C y c l e Data (Percent of
Ev en ts Occurring at e a c h Point in the Cycle)

Trough

Peak

Ascend

Descend

Stable

rSO; Data

Sensory

19.4

7.0

48 .6

11.4

13 .6

Motor

30 .4

7.7

38 .9

12.8

10.2

PLMs

18 .9

8 .8

48 .3

10.1

14 .0

Total Hemoglobin Data

Sensory

35. 9

7.6

42.0

14 .4

—

Motor

40. 6

11.2

35.1

13.2

—

PLMs

33. 9

12.8

40.3

12. 9

—

the rS02 and total hemoglobin B-wave cycles.

The SIT

sensory and motor event means are for RLS subjects only,
while the PLMS means are for the thirteen subjects who had
PLMs

(seven RLS and six PLMS s u b j e c t s ) .

These data were

assessed for normality with Shapiro-Wilk tests,
homogeneity of variance

(within each row in Table A4-1)

with Levene tests for homogeneity of variance.
Shapiro-Wilk tests were significant,
distributions,

and for

for three means:

The

indicating non-normal

the ascending limb for

SIT sensory events in the rS02 cycle,

and the descending
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and stable limbs for PLMs in the rS02 cycle.

The Levene

tests for homogeneity of variance were significant for SIT
motor events in the total hemoglobin cycle and PLMs in the
total hemoglobin cycle.
(within each row)

Differences among the means

in Table A4-1 were assessed with paired-

sample t-tests whenever both means were normally
distributed and had homogeneity of variance,

and Wilcoxin

tests whenever the comparison involved any non-normally
distributed mean or pair of means with unequal variances.
The t values and Wilcoxin z values,
values,
A4-2

for these pairwise comparisons are listed in Table

(for rS02 data)

data) .

and their associated p

and Table A4-3

(for total hemoglobin

For SIT sensory events in the rSO, B-wave cycle,

the percentage of events occurring at peaks was
significantly higher than the percentage of events
occurring at descending or stable limbs.

For SIT motor

events in the rS02 B-wave cycle, the percentages of events
occurring at peaks was significantly higher than the
percentages occurring at ascending,
limbs.

descending,

and stable

The same pattern was seen for the percentage of

events occurring at the troughs, while the peak/trough
comparison was not significant.
wave cycle,

For PLMs in the rS02 B-

the percentage of PLMs occurring at the peaks

was significantly higher than the percentages of PLMs
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Table A4-2.

Summary of Pairwise Comparisons on rS02 B-Wave Data

Comparison1

Event'

Sens

P/T

-3.04
(n.s.)

Mot

-1.24
(n.s.)

PLMs

-5.01
(.001)

1)
2)

P/A

P/D

P/S

-2.37

4.83

4.40

(.003)

(.005)

7.47
(.001)

(n.s.)

-5.25
(.001)

-11.37
(.001)

-3.18
(.002)

T/D

T/S

1.86

0.82

(n.s.)

(n.s.)

(n.s.)

4.68

9.43

4.04

4.75

(.002)

(.001)

(.004)

(.001)

2.67

-2.13

-1.88

(n.s.)

(n.s.)

(n.s.)

-2.62
(n.s.)

T/A

-2.37

Abbreviations are as follows: T = Trough, A = Ascending, P
D = Descending, S = Stable
Abbreviations are as follows: Sens = Sensory, Mot = Motor

A/D

A/S

-1.35

-1.01

(n.s.)

-1.68
(n.s.)

-0.53
(n.s.)

D/S

-0.32

(n.s.) (n.s.)

-0.62

0.50

(n.s.) (n.s.)

-0.47

-0.24

(n.s.) (n.s.)

= Peak,

311

312
T a b l e A4-3.

S u m m a r y of Pairwise C o m p a r i s o n s
H e m o g l o b i n B-wave Data

on Total

Comparison-

Event

Sensory

Motor

PLMs

P/T

P/A

P/D

T/A

T/D

-0.79

-6. 42

4 .61

4 .22

2. 90

-2.86

(n.s.)

(.001)

(.004)

(n.s.)

(n.s.)

(n.s.)

-0. 53

-2. 67

-2. 67

-2.61

-2. 67

(n.s.)

(n.s.)

(n.s.)

(n.s.)

(n.s.)

-0. 66

-3.18

-3.18

-2. 90

-3. 18

(n.s.)

(.002)

(.002)

( .004)

(.002)

A/D

-0.71
(n.s. )

-0.20
(n.s.)

1) Abbreviations are as follows:
T = Trough , A =
Ascending, P = Peak, D = Descending

occurring at troughs,

ascending limbs,

and descending

limbs.
For SIT sensory events in the total hemoglobin B-wave
cycle,

the percentage of events occurring at the peaks was

significantly greater than the percentages of events
occurring at the ascending or descending limbs.

There

were no significant pairwise comparisons for the SIT motor
event occurrence in the B-wave cycle.

For the PLM

occurrence in the total hemoglobin B-wave cycle,
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percentages of events occurring at both peaks and troughs
was significantly greater than the percentages of events
occurring at the ascending and descending limbs.
In summary,
were significant,

of the seventeen comparisons above that
twelve were comparisons in which the

percentage of events occurring at the peak was greater
than the percentages occurring at other wave limbs,

while

five were comparisons in which the percentage of events
occurring at the troughs was greater than the percentages
occurring at the other wave limbs.

Only one of the

peak/trough comparisons was significant

(for PLMs in the

rS02 B-wave cycle) .
In Table 12 (see the Results sectio n) , the number of
p eriod og ra m peaks in the different wavelength ranges for
all three groups during the SIT were presented.

A total

of six Chi-Square tests were done on these data to
determine if the observed frequencies were significantly
different

from equal frequencies in all ranges.

these tests reached significance at the

None of

.004 p level.

In Table 13 (see Results section), the number of
p er io do gr am peaks in the control subjects and in all
subjects with PLMs during sleep were presented.

A total

of four Chi Square tests were run on these data to
determine if the observed frequencies were significantly
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different from equal frequencies in each range.
these four tests reached significance at the
In addition,

None of

.004 p level.

four Chi-Square tests of homogeneity

were run to determine if the groups differed significantly
in their frequencies in the different ranges

(one test

each for rSO; and total hemoglobin data during both the
SIT and P S G ) .
the

None of these tests reached significance at

.004 p level.
Four ANOVAs were run on the group means for the

number of periodogram peaks per subject

(one each for rS02

and total hemoglobin during both the SIT and PSG)

to

determine if there were any group differences in the
number of periodogram peaks.

None of these four ANOVAs

reached significance at the .004 p level.
Finally,

two ANOVAs were run on the group means for

the wave-to-wave change in wavelength data

(see Table 14)

to determine if the groups differed on this variable.
Neither of these two ANOVAs reached significance at the
.004 p level.
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